Multiple	O
forms	O
and	O
fragments	O
of	O
cytosolic	B-protein
glucocorticoid	I-protein
receptors	I-protein
from	O
human	B-cell_type
leukemic	I-cell_type
cells	I-cell_type
and	O
normal	B-cell_type
lymphocytes	I-cell_type
.	O

Therapy	O
with	O
glucocorticoids	O
is	O
generally	O
more	O
effective	O
in	O
acute	O
lymphoblastic	O
leukemia	O
than	O
in	O
other	O
types	O
of	O
human	O
leukemia	O
.	O

Previous	O
studies	O
,	O
however	O
,	O
have	O
not	O
revealed	O
any	O
consistent	O
relationship	O
between	O
clinical	O
responsiveness	O
and	O
the	O
cellular	O
or	O
cytosolic	O
concentration	O
of	O
glucocorticoid-binding	B-protein
sites	I-protein
.	O

The	O
objectives	O
of	O
this	O
study	O
were	O
to	O
determine	O
whether	O
there	O
are	O
intrinsic	O
structural	O
differences	O
among	O
the	O
glucocorticoid	B-protein
receptors	I-protein
in	O
various	O
types	O
of	O
leukemic	B-cell_type
cells	I-cell_type
and	O
normal	B-cell_type
lymphocytes	I-cell_type
and	O
to	O
investigate	O
the	O
role	O
of	O
endogenous	B-protein
peptidases	I-protein
in	O
receptor	O
degradation	O
.	O

Cytosols	O
were	O
prepared	O
from	O
fresh	B-cell_type
or	I-cell_type
rapidly	I-cell_type
frozen	I-cell_type
leukocytes	I-cell_type
from	O
6	O
healthy	O
adults	O
and	O
35	O
high-risk	O
leukemia	O
patients	O
(	O
median	O
white	O
blood	O
cell	O
count	O
,	O
150	O
,	O
000	O
cells/microliter	O
;	O
median	O
age	O
,	O
13	O
years	O
)	O
.	O

Receptors	O
were	O
labeled	O
with	O
[	O
3H	O
]	O
triamcinolone	O
acetonide	O
and	O
quantitated	O
by	O
charcoal-dextran	O
treatment	O
or	O
Sephadex	O
LH-20	O
chromatography	O
.	O

Mean	O
and	O
median	O
cytosolic	O
receptor	O
concentrations	O
in	O
12	O
acute	O
lymphoblastic	O
leukemia	O
specimens	O
lacking	O
the	O
standard	O
B-cell	O
or	O
T-cell	O
markers	O
(	O
``	O
null	O
cells	O
''	O
)	O
were	O
approximately	O
4-fold	O
higher	O
than	O
in	O
23	O
other	O
leukemic	B-cell_type
cell	I-cell_type
specimens	I-cell_type
.	O

No	O
other	O
consistent	O
differences	O
in	O
receptor	O
content	O
were	O
observed	O
.	O

Agarose	O
filtration	O
and	O
ultracentrifugation	O
in	O
hypotonic	O
buffers	O
containing	O
20	O
mM	O
Na2MoO4	O
revealed	O
complexes	O
of	O
similar	O
size	O
and	O
shape	O
in	O
all	O
clinical	O
specimens	O
tested	O
and	O
two	O
established	O
leukemic	B-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

They	O
had	O
Stokes	O
radii	O
(	O
Rs	O
)	O
of	O
8.1	O
+/-	O
0.5	O
(	O
S.D.	O
)	O
nm	O
(	O
n	O
=	O
50	O
)	O
,	O
sedimentation	O
coefficients	O
of	O
9.5	O
+/-	O
0.3S	O
(	O
n	O
=	O
40	O
)	O
,	O
molecular	O
weights	O
of	O
approximately	O
330	O
,	O
000	O
,	O
and	O
axial	O
ratios	O
(	O
a/b	O
)	O
of	O
approximately	O
12	O
.	O

In	O
hypertonic	O
,	O
molybdate-free	O
buffer	O
,	O
these	O
oligomeric	B-protein
complexes	I-protein
were	O
dissociated	O
into	O
subunits	O
with	O
Rs	O
of	O
5.9	O
+/-	O
0.3	O
nm	O
(	O
n	O
=	O
12	O
)	O
and	O
a/b	O
of	O
11	O
to	O
12	O
,	O
as	O
observed	O
previously	O
for	O
other	O
receptors	O
.	O

Fragmentation	O
of	O
the	O
oligomer	B-protein
and	O
the	O
subunit	B-protein
was	O
evident	O
in	O
some	O
cytosols	O
.	O

High	O
activities	O
of	O
peptidases	B-protein
of	O
various	O
specificities	O
were	O
detected	O
in	O
leukemic	O
cell	O
cytosols	O
,	O
as	O
in	O
other	O
cytosols	O
,	O
by	O
fluorometric	O
assays	O
with	O
derivatives	O
of	O
7-amino-4-methylcoumarin	O
.	O

Receptor	O
cleavage	O
by	O
these	O
and	O
other	O
endogenous	B-protein
enzymes	I-protein
may	O
account	O
for	O
previous	O
observations	O
of	O
``	O
abnormal	O
''	O
receptors	O
in	O
cytosols	O
from	O
some	O
leukemic	B-cell_type
specimens	I-cell_type
.	O

We	O
conclude	O
that	O
intrinsic	O
structural	O
defects	O
in	O
the	O
receptors	O
are	O
unlikely	O
explanations	O
for	O
the	O
unresponsiveness	O
of	O
some	O
types	O
of	O
leukemia	O
to	O
steroid	O
therapy	O
.	O

[	NULL
CANCER	NULL
RESEARCH	NULL
44	NULL
,	NULL
3783-3796	NULL
,	NULL
September	NULL
1984	NULL
]	NULL
Multiple	NULL
Forms	NULL
and	NULL
Fragments	NULL
of	NULL
Cytosolic	NULL
Glucocorticoid	NULL
Receptors	NULL
from	NULL
Human	NULL
Leukemic	NULL
Cells	NULL
and	NULL
Normal	NULL
Lymphocytes	NULL
Merry	NULL
R.	NULL
Sherman	NULL
,	NULL
``	NULL
Yee-Wan	NULL
Stevens	NULL
,	NULL
and	NULL
Fe	NULL
B.	NULL
Tuazon	NULL
Endocrine	NULL
Biochemistry	NULL
Laboratory	NULL
,	NULL
Memorial	NULL
Sloan-Kettering	NULL
Cancer	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
ABSTRACT	NULL
Therapy	NULL
with	NULL
glucocorticoids	NULL
is	NULL
generally	NULL
more	NULL
effective	NULL
in	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
than	NULL
in	NULL
other	NULL
types	NULL
of	NULL
human	NULL
leukemia	NULL
.	NULL

Previous	NULL
studies	NULL
,	NULL
however	NULL
,	NULL
have	NULL
not	NULL
revealed	NULL
any	NULL
consistent	NULL
relationship	NULL
between	NULL
clinical	NULL
responsiveness	NULL
and	NULL
the	NULL
cellular	NULL
or	NULL
cytosolic	NULL
concentration	NULL
of	NULL
glucocorticoid-binding	NULL
sites	NULL
.	NULL

The	NULL
objectives	NULL
of	NULL
this	NULL
study	NULL
were	NULL
to	NULL
determine	NULL
whether	NULL
there	NULL
are	NULL
intrinsic	NULL
structural	NULL
differences	NULL
among	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
various	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
normal	NULL
lymphocytes	NULL
and	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
endogenous	NULL
peptidases	NULL
in	NULL
receptor	NULL
degradation	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
from	NULL
fresh	NULL
or	NULL
rapidly	NULL
frozen	NULL
leukocytes	NULL
from	NULL
6	NULL
healthy	NULL
adults	NULL
and	NULL
35	NULL
high-risk	NULL
leukemia	NULL
patients	NULL
(	NULL
median	NULL
white	NULL
blood	NULL
cell	NULL
count	NULL
,	NULL
150,000	NULL
median	NULL
age	NULL
,	NULL
13	NULL
years	NULL
)	NULL
.	NULL

Receptors	NULL
were	NULL
labeled	NULL
with	NULL
[	NULL
°HJtriamcinolone	NULL
acetonide	NULL
and	NULL
quantitated	NULL
by	NULL
charcoal-dextran	NULL
treatment	NULL
or	NULL
Sephadex	NULL
LH-20	NULL
chromatography	NULL
.	NULL

Mean	NULL
and	NULL
median	NULL
cytosolic	NULL
receptor	NULL
concentrations	NULL
in	NULL
12	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
specimens	NULL
lacking	NULL
the	NULL
standard	NULL
B-cell	NULL
or	NULL
T-cell	NULL
markers	NULL
(	NULL
``	NULL
null	NULL
cells	NULL
``	NULL
)	NULL
were	NULL
~4-fold	NULL
higher	NULL
than	NULL
in	NULL
23	NULL
other	NULL
leukemic	NULL
cell	NULL
specimens	NULL
.	NULL

No	NULL
other	NULL
consistent	NULL
differences	NULL
in	NULL
receptor	NULL
content	NULL
were	NULL
observed	NULL
.	NULL

Agarose	NULL
filtration	NULL
and	NULL
ultracentrifugation	NULL
in	NULL
hypotonic	NULL
buffers	NULL
containing	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
revealed	NULL
complexes	NULL
of	NULL
similar	NULL
size	NULL
and	NULL
shape	NULL
in	NULL
all	NULL
clinical	NULL
specimens	NULL
tested	NULL
and	NULL
two	NULL
established	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

They	NULL
had	NULL
Stokes	NULL
radii	NULL
(	NULL
R5	NULL
)	NULL
of	NULL
8.1	NULL
+	NULL
0.5	NULL
(	NULL
S.D	NULL
.	NULL
)	NULL

nm	NULL
(	NULL
n	NULL
=	NULL
50	NULL
)	NULL
,	NULL
sedimentation	NULL
coefficients	NULL
of	NULL
9.5	NULL
+	NULL
0.3S	NULL
(	NULL
n	NULL
=	NULL
40	NULL
)	NULL
,	NULL
molecular	NULL
weights	NULL
of	NULL
~330,000	NULL
,	NULL
and	NULL
axial	NULL
ratios	NULL
(	NULL
a/b	NULL
)	NULL
of	NULL
~12	NULL
.	NULL

In	NULL
hypertonic	NULL
,	NULL
molybdate-free	NULL
buffer	NULL
,	NULL
these	NULL
oligomeric	NULL
complexes	NULL
were	NULL
dissociated	NULL
into	NULL
subunits	NULL
with	NULL
As	NULL
of	NULL
5.9	NULL
+	NULL
0.3	NULL
nm	NULL
(	NULL
n	NULL
=	NULL
12	NULL
)	NULL
and	NULL
a/b	NULL
of	NULL
11	NULL
to	NULL
12	NULL
,	NULL
as	NULL
observed	NULL
previously	NULL
for	NULL
other	NULL
receptors	NULL
.	NULL

Fragmentation	NULL
of	NULL
the	NULL
oligomer	NULL
and	NULL
the	NULL
subunit	NULL
was	NULL
evident	NULL
in	NULL
some	NULL
cytosols	NULL
.	NULL

High	NULL
activities	NULL
of	NULL
peptidases	NULL
of	NULL
various	NULL
specificities	NULL
were	NULL
detected	NULL
in	NULL
leukemic	NULL
cell	NULL
cytosols	NULL
,	NULL
as	NULL
in	NULL
other	NULL
cytosols	NULL
,	NULL
by	NULL
fluorometric	NULL
assays	NULL
with	NULL
derivatives	NULL
of	NULL
7-amino-4-methylcoumarin	NULL
.	NULL

Receptor	NULL
cleavage	NULL
by	NULL
these	NULL
and	NULL
other	NULL
endogenous	NULL
enzymes	NULL
may	NULL
account	NULL
for	NULL
previous	NULL
observations	NULL
of	NULL
``	NULL
abnormal	NULL
``	NULL
receptors	NULL
in	NULL
cytosols	NULL
from	NULL
some	NULL
leukemic	NULL
specimens	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
intrinsic	NULL
structural	NULL
defects	NULL
in	NULL
the	NULL
receptors	NULL
are	NULL
unlikely	NULL
explanations	NULL
for	NULL
the	NULL
unresponsiveness	NULL
of	NULL
some	NULL
types	NULL
of	NULL
leukemia	NULL
to	NULL
steroid	NULL
therapy	NULL
.	NULL

INTRODUCTION	NULL
Differences	NULL
in	NULL
the	NULL
responsiveness	NULL
of	NULL
various	NULL
types	NULL
of	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
to	NULL
treatment	NULL
with	NULL
glucocorticoids	NULL
became	NULL
evident	NULL
*	NULL
This	NULL
research	NULL
was	NULL
by	NULL
Grants	NULL
CA-28392	NULL
,	NULL
CA-32178	NULL
,	NULL
CA-29564	NULL
,	NULL
CA-23742	NULL
,	NULL
and	NULL
CA-08748	NULL
from	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
and	NULL
by	NULL
contributions	NULL
from	NULL
the	NULL
Margolish	NULL
Fund	NULL
and	NULL
the	NULL
Miriam	NULL
Madeline	NULL
Cohen	NULL
and	NULL
Emanuel	NULL
Cohen	NULL
Fund	NULL
.	NULL

*	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Received	NULL
February	NULL
14	NULL
,	NULL
1984	NULL
;	NULL
accepted	NULL
June	NULL
4	NULL
,	NULL
1984	NULL
.	NULL

SEPTEMBER	NULL
1984	NULL
soon	NULL
after	NULL
the	NULL
introduction	NULL
of	NULL
cortisone	NULL
therapy	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

2	NULL
and	NULL
54	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
receptors	NULL
in	NULL
steroid	NULL
hormone	NULL
action	NULL
,	NULL
the	NULL
plausible	NULL
explanations	NULL
for	NULL
unresponsiveness	NULL
include	NULL
a	NULL
reduction	NULL
in	NULL
the	NULL
number	NULL
of	NULL
receptors	NULL
and	NULL
defects	NULL
in	NULL
receptor	NULL
structure	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
11	NULL
,	NULL
16-18	NULL
,	NULL
21	NULL
,	NULL
29	NULL
,	NULL
30	NULL
,	NULL
54	NULL
,	NULL
55	NULL
)	NULL
.	NULL

To	NULL
date	NULL
,	NULL
however	NULL
,	NULL
the	NULL
evidence	NULL
presented	NULL
in	NULL
support	NULL
of	NULL
either	NULL
of	NULL
these	NULL
hypotheses	NULL
has	NULL
not	NULL
been	NULL
definitive	NULL
.	NULL

The	NULL
steroid	NULL
receptors	NULL
detected	NULL
in	NULL
hypotonic	NULL
tissue	NULL
extracts	NULL
(	NULL
cytosols	NULL
)	NULL
are	NULL
large	NULL
oligomeric	NULL
proteins	NULL
composed	NULL
of	NULL
subunits	NULL
bearing	NULL
at	NULL
least	NULL
3	NULL
types	NULL
of	NULL
functional	NULL
domains	NULL
.	NULL

These	NULL
are	NULL
re-sponsible	NULL
,	NULL
respectively	NULL
,	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
steroid	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
components	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
subunits	NULL
to	NULL
each	NULL
other	NULL
(	NULL
6	NULL
,	NULL
37	NULL
,	NULL
44	NULL
,	NULL
48	NULL
,	NULL
49	NULL
,	NULL
52	NULL
,	NULL
55	NULL
)	NULL
.	NULL

It	NULL
is	NULL
a	NULL
remarkable	NULL
fact	NULL
that	NULL
the	NULL
oligomeric	NULL
forms	NULL
of	NULL
the	NULL
receptors	NULL
for	NULL
several	NULL
classes	NULL
of	NULL
steroids	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
species	NULL
and	NULL
tissues	NULL
are	NULL
nearly	NULL
identical	NULL
(	NULL
36	NULL
,	NULL
46	NULL
,	NULL
47	NULL
,	NULL
49	NULL
,	NULL
52	NULL
)	NULL
.	NULL

We	NULL
may	NULL
infer	NULL
that	NULL
this	NULL
highly	NULL
conserved	NULL
structure	NULL
serves	NULL
an	NULL
essential	NULL
function	NULL
in	NULL
steroid	NULL
hormone	NULL
action	NULL
.	NULL

Evaluation	NULL
of	NULL
the	NULL
physicochemical	NULL
parameters	NULL
of	NULL
this	NULL
receptor	NULL
form	NULL
has	NULL
been	NULL
complicated	NULL
by	NULL
the	NULL
ease	NULL
with	NULL
which	NULL
the	NULL
oligomer	NULL
is	NULL
dissociated	NULL
into	NULL
subunits	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
vulnerability	NULL
of	NULL
these	NULL
structures	NULL
to	NULL
cleavage	NULL
by	NULL
endogenous	NULL
proteases	NULL
.	NULL

For	NULL
these	NULL
reasons	NULL
,	NULL
early	NULL
attempts	NULL
to	NULL
characterize	NULL
either	NULL
the	NULL
oligomeric	NULL
or	NULL
the	NULL
monomeric	NULL
form	NULL
of	NULL
the	NULL
receptors	NULL
from	NULL
various	NULL
tissues	NULL
produced	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
results	NULL
and	NULL
led	NULL
to	NULL
considerable	NULL
confusion	NULL
about	NULL
the	NULL
intact	NULL
structure	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
technical	NULL
problems	NULL
have	NULL
been	NULL
resolved	NULL
by	NULL
the	NULL
discovery	NULL
that	NULL
the	NULL
oligomer	NULL
is	NULL
stabilized	NULL
not	NULL
only	NULL
by	NULL
protease	NULL
inhibitors	NULL
(	NULL
45	NULL
,	NULL
48	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
but	NULL
also	NULL
by	NULL
sodium	NULL
molybdate	NULL
and	NULL
related	NULL
salts	NULL
(	NULL
12	NULL
,	NULL
19	NULL
,	NULL
28	NULL
,	NULL
32	NULL
,	NULL
36	NULL
,	NULL
46	NULL
,	NULL
47	NULL
,	NULL
51	NULL
,	NULL
52	NULL
,	NULL
55	NULL
)	NULL
.	NULL

in	NULL
pursuit	NULL
of	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
steroid	NULL
resistance	NULL
,	NULL
we	NULL
began	NULL
this	NULL
detailed	NULL
physicochemical	NULL
study	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
cytosols	NULL
from	NULL
various	NULL
hematopoietic	NULL
cancers	NULL
and	NULL
normal	NULL
lymphocytes	NULL
several	NULL
years	NULL
ago	NULL
.	NULL

The	NULL
samples	NULL
analyzed	NULL
have	NULL
included	NULL
2	NULL
established	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
human	NULL
leukemias	NULL
and	NULL
purified	NULL
leukocytes	NULL
from	NULL
35	NULL
patients	NULL
with	NULL
CLL®	NULL
,	NULL
CML	NULL
,	NULL
diffuse	NULL
poorly	NULL
differentiated	NULL
lymphoma	NULL
,	NULL
and	NULL
several	NULL
subtypes	NULL
of	NULL
ALL	NULL
and	NULL
ANLL	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
patients	NULL
had	NULL
extremely	NULL
high	NULL
WBC	NULL
;	NULL
3Theabbrewaturmsusedare	NULL
CLL	NULL
,	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
;	NULL
ALL	NULL
,	NULL
acute	NULL
MenuuU—Ladmﬁmhonuseeﬂef	NULL
3rAMC	NULL
7-amino-4-meth-	NULL
a	NULL
(	NULL
Ga-1113160	NULL
:	NULL
17a,21-tetrahydroxy-pregna-	NULL
14—da10420-dione16	NULL
17-acetonide	NULL
)	NULL
;	NULL
TdT	NULL
,	NULL
terminal	NULL
deoxynucieotidyt	NULL
transferase	NULL
;	NULL
Tes	NULL
,	NULL
Nnymemymwm-Zm	NULL
ethanesulfonic	NULL
acid	NULL
;	NULL
TE	NULL
,	NULL
buffer	NULL
,	NULL
10	NULL
mm	NULL
N-tri	NULL
2-aminoethanesulfonic	NULL
acid-1.5	NULL
mm	NULL
EDTA	NULL
;	NULL
TTE	NULL
buffer	NULL
,	NULL
12	NULL
mm	NULL
in	NULL
10	NULL
mu	NULL
N-tris	NULL
(	NULL
hydroxymethyi	NULL
)	NULL
methy	NULL
}	NULL
-2-aminoethanesulfonic	NULL
acid	NULL
--	NULL
1.5	NULL
mm	NULL
EDTA	NULL
;	NULL
TTEG	NULL
buffer	NULL
,	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
in	NULL
10	NULL
mm	NULL
N-tris	NULL
(	NULL
hydroxymethyimethyt-2-amincethanesul-mm—1ZmMmonoerol—1SMEDTA1TESW	NULL
0.25	NULL
1m	NULL
sucrose	NULL
in	NULL
10	NULL
mm	NULL
-	NULL
N-ti	NULL
2-aminoethanesulfonic	NULL
acid-12	NULL
mm	NULL
.	NULL

thioglyc-erol-1.5	NULL
mm	NULL
EDTA	NULL
;	NULL
TEG	NULL
buffer	NULL
,	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
in	NULL
10	NULL
mm	NULL
N-tris	NULL
(	NULL
hydroxy-methyi	NULL
)	NULL
methyt-2-aminoethanesulfonic	NULL
acid-1.5	NULL
mm	NULL
EDTA	NULL
.	NULL

3783	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

the	NULL
median	NULL
value	NULL
was	NULL
150,000	NULL
cells/ul	NULL
.	NULL

The	NULL
data	NULL
for	NULL
receptor	NULL
content	NULL
and	NULL
structure	NULL
in	NULL
these	NULL
specimens	NULL
have	NULL
been	NULL
analyzed	NULL
in	NULL
the	NULL
context	NULL
of	NULL
results	NULL
obtained	NULL
on	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
patients	NULL
by	NULL
other	NULL
laboratories	NULL
at	NULL
this	NULL
Center	NULL
.	NULL

They	NULL
have	NULL
also	NULL
been	NULL
compared	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
for	NULL
receptors	NULL
from	NULL
several	NULL
healthy	NULL
and	NULL
malignant	NULL
human	NULL
and	NULL
rodent	NULL
tissues	NULL
.	NULL

The	NULL
following	NULL
specific	NULL
questions	NULL
were	NULL
addressed	NULL
in	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Are	NULL
there	NULL
intrinsic	NULL
or	NULL
apparent	NULL
structural	NULL
differences	NULL
among	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
extracted	NULL
from	NULL
normal	NULL
lymphocytes	NULL
and	NULL
various	NULL
hematopoietic	NULL
cancers	NULL
?	NULL

If	NULL
so	NULL
,	NULL
are	NULL
such	NULL
differences	NULL
correlated	NULL
with	NULL
clinical	NULL
findings	NULL
or	NULL
with	NULL
morphological	NULL
,	NULL
cytogenetic	NULL
,	NULL
cytochemical	NULL
,	NULL
enzymatic	NULL
,	NULL
or	NULL
immunological	NULL
characteristics	NULL
of	NULL
the	NULL
cells	NULL
?	NULL

In	NULL
attempting	NULL
to	NULL
answer	NULL
these	NULL
questions	NULL
,	NULL
we	NULL
have	NULL
evaluated	NULL
and	NULL
compared	NULL
the	NULL
Stokes	NULL
radii	NULL
and	NULL
sedimentation	NULL
coefficients	NULL
of	NULL
the	NULL
molybdate-stabilized	NULL
glucocorticoid-receptor	NULL
complexes	NULL
in	NULL
the	NULL
various	NULL
cytosols	NULL
and	NULL
calculated	NULL
the	NULL
molecular	NULL
weights	NULL
and	NULL
axial	NULL
ratios	NULL
from	NULL
these	NULL
parameters	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
salt-dissociated	NULL
forms	NULL
and	NULL
proteolytic	NULL
fragments	NULL
of	NULL
the	NULL
receptors	NULL
and	NULL
have	NULL
investigated	NULL
the	NULL
effects	NULL
on	NULL
receptor	NULL
structure	NULL
of	NULL
rapidly	NULL
freezing	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
preservatives	NULL
.	NULL

Finally	NULL
,	NULL
in	NULL
view	NULL
of	NULL
the	NULL
observed	NULL
degradation	NULL
of	NULL
the	NULL
receptors	NULL
in	NULL
certain	NULL
cytosols	NULL
,	NULL
we	NULL
have	NULL
begun	NULL
to	NULL
quantitate	NULL
,	NULL
characterize	NULL
,	NULL
and	NULL
look	NULL
for	NULL
possible	NULL
differences	NULL
among	NULL
the	NULL
peptidases	NULL
that	NULL
are	NULL
active	NULL
in	NULL
these	NULL
cytosols	NULL
at	NULL
physiological	NULL
pH	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
materials	NULL
and	NULL
methods	NULL
of	NULL
analysis	NULL
of	NULL
steroid	NULL
receptors	NULL
and	NULL
cytosolic	NULL
peptidases	NULL
have	NULL
been	NULL
described	NULL
in	NULL
detail	NULL
in	NULL
a	NULL
recent	NULL
report	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
materials	NULL
used	NULL
in	NULL
that	NULL
study	NULL
,	NULL
we	NULL
obtained	NULL
Ficoll-Metrizoate	NULL
(	NULL
Lymphoprep	NULL
)	NULL
from	NULL
Accurate	NULL
Chemical	NULL
(	NULL
Hicks-ville	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

HBSS	NULL
(	NULL
15	NULL
)	NULL
and	NULL
RPMI	NULL
1640	NULL
Tissue	NULL
Culture	NULL
Medium	NULL
(	NULL
33	NULL
)	NULL
were	NULL
prepared	NULL
by	NULL
the	NULL
Media	NULL
Laboratory	NULL
of	NULL
this	NULL
Center	NULL
.	NULL

Buffers	NULL
.	NULL

The	NULL
following	NULL
buffers	NULL
were	NULL
prepared	NULL
with	NULL
Tes	NULL
and	NULL
had	NULL
a	NULL
pH	NULL
of	NULL
7.4	NULL
at	NULL
24°	NULL
and	NULL
7.9	NULL
at	NULL
4°	NULL
:	NULL
TE	NULL
buffer	NULL
;	NULL
TEG	NULL
buffer	NULL
;	NULL
TTE	NULL
buffer	NULL
;	NULL
TTEG	NULL
buffer	NULL
;	NULL
and	NULL
TTES	NULL
buffer	NULL
.	NULL

Solutions	NULL
of	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
are	NULL
designated	NULL
as	NULL
+Mo	NULL
.	NULL

Control	NULL
solutions	NULL
(	NULL
-Mo	NULL
)	NULL
had	NULL
KCI	NULL
concentrations	NULL
of	NULL
0	NULL
to	NULL
50	NULL
mm	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Buffers	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
hypertonic	NULL
,	NULL
and	NULL
those	NULL
with	NULL
KCI	NULL
concentrations	NULL
of	NULL
0	NULL
to	NULL
50	NULL
mm	NULL
are	NULL
referred	NULL
to	NULL
as	NULL
hypotonic	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
concentrations	NULL
of	NULL
other	NULL
components	NULL
.	NULL

Cell	NULL
Lines	NULL
.	NULL

Frozen	NULL
cells	NULL
from	NULL
2	NULL
established	NULL
lines	NULL
derived	NULL
from	NULL
human	NULL
nonlymphocytic	NULL
leukemias	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
David	NULL
W.	NULL
Golde	NULL
,	NULL
University	NULL
of	NULL
California	NULL
Medical	NULL
School	NULL
,	NULL
Los	NULL
Angeles	NULL
.	NULL

Line	NULL
KG-1	NULL
was	NULL
established	NULL
by	NULL
Koeffier	NULL
and	NULL
Golde	NULL
(	NULL
24	NULL
)	NULL
from	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
.	NULL

Line	NULL
HL-60	NULL
was	NULL
established	NULL
by	NULL
Collins	NULL
et	NULL
a/	NULL
.	NULL

(	NULL
8	NULL
)	NULL
from	NULL
cells	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Clinical	NULL
Specimens	NULL
(	NULL
Purification	NULL
,	NULL
Characterization	NULL
,	NULL
and	NULL
Storage	NULL
of	NULL
Cells	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
specimens	NULL
consisted	NULL
of	NULL
12	NULL
to	NULL
33	NULL
ml	NULL
of	NULL
heparinized	NULL
peripheral	NULL
blood	NULL
from	NULL
untreated	NULL
pediatric	NULL
patients	NULL
with	NULL
leukemia	NULL
or	NULL
leukemia-tymphoma	NULL
syndrome	NULL
,	NULL
13	NULL
to	NULL
240	NULL
mi	NULL
of	NULL
leukapheresis	NULL
preparations	NULL
from	NULL
adolescent	NULL
or	NULL
adult	NULL
leukemia	NULL
patients	NULL
,	NULL
or	NULL
200	NULL
to	NULL
500	NULL
mt	NULL
of	NULL
blood	NULL
from	NULL
healthy	NULL
adult	NULL
donors	NULL
.	NULL

In	NULL
order	NULL
to	NULL
obtain	NULL
a	NULL
sufficient	NULL
quantity	NULL
of	NULL
cells	NULL
to	NULL
permit	NULL
multiple	NULL
physicochemical	NULL
analyses	NULL
of	NULL
the	NULL
receptors	NULL
,	NULL
we	NULL
requested	NULL
specimens	NULL
primarily	NULL
from	NULL
high-risk	NULL
patients	NULL
(	NULL
having	NULL
a	NULL
WBC	NULL
exceeding	NULL
50,000	NULL
cells/ul	NULL
)	NULL
.	NULL

The	NULL
median	NULL
and	NULL
mean	NULL
WBC	NULL
for	NULL
the	NULL
35	NULL
malignant	NULL
specimens	NULL
used	NULL
in	NULL
this	NULL
study	NULL
were	NULL
150,000	NULL
and	NULL
240,000	NULL
cells/	NULL
ul	NULL
,	NULL
respectively	NULL
.	NULL

A	NULL
few	NULL
specimens	NULL
,	NULL
which	NULL
arrived	NULL
late	NULL
in	NULL
the	NULL
day	NULL
,	NULL
were	NULL
diluted	NULL
with	NULL
RPMI	NULL
1640	NULL
and	NULL
stored	NULL
overnight	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
~24°	NULL
)	NULL
prior	NULL
to	NULL
purification	NULL
of	NULL
the	NULL
leukocytes	NULL
.	NULL

Most	NULL
specimens	NULL
were	NULL
diluted	NULL
promptly	NULL
with	NULL
1	NULL
to	NULL
9	NULL
volumes	NULL
of	NULL
HBSS	NULL
and	NULL
centrifuged	NULL
over	NULL
Ficoll-Metrizoate	NULL
at	NULL
24°	NULL
for	NULL
30	NULL
min	NULL
at	NULL
~150	NULL
x	NULL
g	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
,	NULL
56	NULL
)	NULL
.	NULL

In	NULL
some	NULL
leukemic	NULL
cell	NULL
preparations	NULL
,	NULL
the	NULL
interface	NULL
layer	NULL
from	NULL
the	NULL
initial	NULL
centrifugation	NULL
contained	NULL
visible	NULL
RBC	NULL
contamination	NULL
.	NULL

This	NULL
was	NULL
reduced	NULL
,	NULL
3784	NULL
but	NULL
not	NULL
eliminated	NULL
,	NULL
by	NULL
resuspension	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
HBSS	NULL
and	NULL
recentrifu-gation	NULL
over	NULL
Ficoll-Metrizoate	NULL
.	NULL

Cells	NULL
from	NULL
the	NULL
interface	NULL
layer	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
20	NULL
mi	NULL
of	NULL
HBSS	NULL
,	NULL
resuspended	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°	NULL
to	NULL
promote	NULL
dissociation	NULL
of	NULL
endogenous	NULL
steroids	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
size	NULL
and	NULL
yield	NULL
of	NULL
the	NULL
cells	NULL
varied	NULL
among	NULL
the	NULL
different	NULL
types	NULL
of	NULL
leukemia	NULL
.	NULL

The	NULL
mean	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
the	NULL
mass	NULL
of	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
ALL	NULL
patients	NULL
was	NULL
240	NULL
+	NULL
110	NULL
mg	NULL
(	NULL
n	NULL
=	NULL
16	NULL
)	NULL
/10°	NULL
cells	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
a	NULL
10-ml	NULL
sample	NULL
with	NULL
a	NULL
WBC	NULL
of	NULL
100,000	NULL
cells/ul	NULL
)	NULL
.	NULL

The	NULL
mass	NULL
of	NULL
cells	NULL
recovered	NULL
from	NULL
the	NULL
same	NULL
number	NULL
of	NULL
ANLL	NULL
cells	NULL
,	NULL
440	NULL
+	NULL
170	NULL
mg	NULL
(	NULL
n	NULL
=	NULL
7	NULL
)	NULL
,	NULL
was	NULL
generally	NULL
higher	NULL
than	NULL
from	NULL
the	NULL
ALL	NULL
specimens	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
,	NULL
as	NULL
expected	NULL
from	NULL
the	NULL
size	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Our	NULL
initial	NULL
studies	NULL
of	NULL
normal	NULL
specimens	NULL
confirmed	NULL
previous	NULL
reports	NULL
that	NULL
cells	NULL
fractionated	NULL
as	NULL
described	NULL
above	NULL
include	NULL
a	NULL
significant	NULL
percentage	NULL
of	NULL
monocytes	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
more	NULL
recent	NULL
preparations	NULL
of	NULL
donor	NULL
cells	NULL
,	NULL
the	NULL
lymphocytes	NULL
were	NULL
further	NULL
purified	NULL
by	NULL
allowing	NULL
the	NULL
monocytes	NULL
to	NULL
adsorb	NULL
to	NULL
plastic	NULL
flasks	NULL
(	NULL
Corning	NULL
;	NULL
150	NULL
sq	NULL
cm	NULL
)	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°	NULL
(	NULL
35	NULL
)	NULL
.	NULL

For	NULL
practical	NULL
reasons	NULL
,	NULL
many	NULL
preparations	NULL
of	NULL
purified	NULL
leukocytes	NULL
were	NULL
stored	NULL
at	NULL
-85°	NULL
for	NULL
periods	NULL
of	NULL
1	NULL
day	NULL
to	NULL
more	NULL
than	NULL
1	NULL
year	NULL
prior	NULL
to	NULL
homogenization	NULL
.	NULL

Following	NULL
the	NULL
final	NULL
wash	NULL
with	NULL
RPMI	NULL
1640	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
centrifuged	NULL
for	NULL
10	NULL
to	NULL
15	NULL
min	NULL
at	NULL
200	NULL
x	NULL
g	NULL
into	NULL
weighed	NULL
Nunc	NULL
tubes	NULL
(	NULL
Vanguard	NULL
International	NULL
,	NULL
Neptune	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
placed	NULL
in	NULL
a	NULL
Revco	NULL
freezer	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
``	NULL
Results	NULL
and	NULL
Discussion	NULL
,	NULL
``	NULL
this	NULL
procedure	NULL
caused	NULL
significant	NULL
alterations	NULL
in	NULL
receptor	NULL
structure	NULL
and	NULL
is	NULL
not	NULL
recommended	NULL
for	NULL
future	NULL
studies	NULL
.	NULL

Bone	NULL
marrow	NULL
specimens	NULL
from	NULL
most	NULL
patients	NULL
were	NULL
classified	NULL
by	NULL
morphological	NULL
and	NULL
cytochemical	NULL
criteria	NULL
according	NULL
to	NULL
the	NULL
French-American-British	NULL
system	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
or	NULL
bone	NULL
marrow	NULL
specimens	NULL
were	NULL
characterized	NULL
with	NULL
respect	NULL
to	NULL
immunological	NULL
markers	NULL
by	NULL
the	NULL
Lymphocyte	NULL
Surface	NULL
Markers	NULL
Laboratory	NULL
(	NULL
26	NULL
)	NULL
;	NULL
the	NULL
activities	NULL
of	NULL
TdT	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Department	NULL
of	NULL
Clinical	NULL
Chemistry	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
cytogenetic	NULL
analyses	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
Laboratory	NULL
of	NULL
Cancer	NULL
Genetics	NULL
and	NULL
Cytogenetics	NULL
(	NULL
7	NULL
)	NULL
at	NULL
this	NULL
Center	NULL
.	NULL

Cytosol	NULL
Preparation	NULL
,	NULL
Labeling	NULL
of	NULL
Receptors	NULL
,	NULL
and	NULL
Removal	NULL
of	NULL
Free	NULL
Steroid	NULL
.	NULL

Frozen	NULL
cells	NULL
were	NULL
thawed	NULL
at	NULL
0-4°	NULL
and	NULL
were	NULL
generally	NULL
suspended	NULL
in	NULL
3	NULL
to	NULL
5	NULL
volumes	NULL
of	NULL
TTES	NULL
buffer	NULL
containing	NULL
no	NULL
added	NULL
salt	NULL
or	NULL
30	NULL
mm	NULL
KCI	NULL
(	NULL
-Mo	NULL
cytosols	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
(	NULL
+Mo	NULL
cytosols	NULL
)	NULL
.	NULL

They	NULL
were	NULL
homogenized	NULL
on	NULL
ice	NULL
in	NULL
a	NULL
Potter-Elvehjem	NULL
glass-Teflon	NULL
homogenizer	NULL
.	NULL

As	NULL
fresh	NULL
cells	NULL
are	NULL
more	NULL
resistant	NULL
than	NULL
frozen	NULL
cells	NULL
to	NULL
rupture	NULL
in	NULL
isotonic	NULL
buffer	NULL
,	NULL
the	NULL
fresh	NULL
cells	NULL
were	NULL
usually	NULL
homogenized	NULL
in	NULL
TTE	NULL
buffer	NULL
(	NULL
+Mo	NULL
)	NULL
and	NULL
the	NULL
homogenate	NULL
was	NULL
promptly	NULL
adjusted	NULL
to	NULL
isotonicity	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
one-third	NULL
volume	NULL
of	NULL
1	NULL
m	NULL
sucrose	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
.	NULL

Cell	NULL
breakage	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
confirmed	NULL
by	NULL
light	NULL
microscopy	NULL
.	NULL

For	NULL
studies	NULL
involving	NULL
comparisons	NULL
of	NULL
fresh	NULL
and	NULL
frozen	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
specimen	NULL
,	NULL
the	NULL
fresh-cell	NULL
protocol	NULL
was	NULL
used	NULL
for	NULL
both	NULL
preparations	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
by	NULL
centrifugation	NULL
at	NULL
0°	NULL
for	NULL
25	NULL
min	NULL
at	NULL
246,000	NULL
x	NULL
g	NULL
or	NULL
for	NULL
37	NULL
min	NULL
at	NULL
166,000	NULL
x	NULL
g	NULL
(	NULL
the	NULL
equivalent	NULL
of	NULL
1	NULL
hr	NULL
at	NULL
100,000	NULL
x	NULL
g	NULL
)	NULL
.	NULL

The	NULL
steroid-binding	NULL
specificity	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
normal	NULL
human	NULL
lymphocytes	NULL
and	NULL
leukemic	NULL
cells	NULL
has	NULL
been	NULL
established	NULL
in	NULL
several	NULL
previous	NULL
studies	NULL
(	NULL
11	NULL
,	NULL
22	NULL
,	NULL
29	NULL
,	NULL
56	NULL
)	NULL
and	NULL
was	NULL
not	NULL
reinvestigated	NULL
here	NULL
.	NULL

[	NULL
PH	NULL
]	NULL
}	NULL
-TA	NULL
was	NULL
used	NULL
to	NULL
label	NULL
the	NULL
receptors	NULL
in	NULL
all	NULL
of	NULL
our	NULL
experiments	NULL
,	NULL
because	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
high	NULL
affinity	NULL
for	NULL
the	NULL
receptors	NULL
and	NULL
a	NULL
slow	NULL
rate	NULL
of	NULL
dissociation	NULL
.	NULL

All	NULL
incubations	NULL
of	NULL
cytosols	NULL
with	NULL
steroids	NULL
and	NULL
all	NULL
analyses	NULL
of	NULL
the	NULL
labeled	NULL
complexes	NULL
were	NULL
performed	NULL
at	NULL
0-4°	NULL
.	NULL

Aliquots	NULL
of	NULL
cytosol	NULL
were	NULL
incubated	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
TA	NULL
,	NULL
to	NULL
assess	NULL
the	NULL
total	NULL
and	NULL
nonspecific	NULL
binding	NULL
,	NULL
respectively	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
for	NULL
90	NULL
min	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

For	NULL
routine	NULL
physicochemical	NULL
analyses	NULL
,	NULL
the	NULL
receptors	NULL
were	NULL
labeled	NULL
with	NULL
a	NULL
high	NULL
concentration	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
(	NULL
~40	NULL
to	NULL
100	NULL
nm	NULL
)	NULL
.	NULL

Free	NULL
steroid	NULL
was	NULL
removed	NULL
either	NULL
by	NULL
agitation	NULL
for	NULL
20	NULL
min	NULL
with	NULL
a	NULL
charcoal-dextran	NULL
suspension	NULL
(	NULL
final	NULL
concentrations	NULL
,	NULL
~2	NULL
%	NULL
Norit	NULL
A	NULL
;	NULL
~0.2	NULL
%	NULL
Dextran	NULL
T-40	NULL
)	NULL
and	NULL
centrifugation	NULL
for	NULL
5	NULL
min	NULL
at	NULL
8700	NULL
x	NULL
g	NULL
(	NULL
``	NULL
charcoal	NULL
treatment	NULL
``	NULL
)	NULL
(	NULL
36	NULL
)	NULL
or	NULL
by	NULL
chromatography	NULL
of	NULL
labeled	NULL
cytosol	NULL
(	NULL
up	NULL
to	NULL
2.4	NULL
mi	NULL
)	NULL
on	NULL
a	NULL
column	NULL
of	NULL
Sephadex	NULL
LH-20	NULL
(	NULL
0.7	NULL
x	NULL
23	NULL
cm	NULL
)	NULL
(	NULL
45	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Labeled	NULL
cytosols	NULL
were	NULL
sometimes	NULL
frozen	NULL
prior	NULL
to	NULL
the	NULL
removal	NULL
of	NULL
free	NULL
steroid	NULL
and	NULL
physicochemical	NULL
analysis	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
freezing	NULL
the	NULL
cytosol	NULL
on	NULL
the	NULL
quantity	NULL
and	NULL
structure	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

of	NULL
the	NULL
steroid-receptor	NULL
complexes	NULL
were	NULL
investigated	NULL
.	NULL

For	NULL
the	NULL
evaluation	NULL
of	NULL
the	NULL
dissociation	NULL
constant	NULL
(	NULL
K	NULL
,	NULL
,	NULL
)	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
specific	NULL
binding	NULL
sites	NULL
(	NULL
B	NULL
,	NULL
)	NULL
,	NULL
the	NULL
total	NULL
concentration	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
JTA	NULL
was	NULL
varied	NULL
from	NULL
2	NULL
to	NULL
75	NULL
nm	NULL
.	NULL

The	NULL
total	NULL
binding	NULL
observed	NULL
at	NULL
each	NULL
steroid	NULL
concentration	NULL
was	NULL
corrected	NULL
for	NULL
the	NULL
nonspecific	NULL
binding	NULL
evaluated	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
of	NULL
free	NULL
°H-steroid	NULL
.	NULL

This	NULL
provides	NULL
a	NULL
considerably	NULL
lower	NULL
{	NULL
and	NULL
more	NULL
appropriate	NULL
)	NULL
estimate	NULL
of	NULL
nonspecific	NULL
binding	NULL
than	NULL
that	NULL
measured	NULL
at	NULL
the	NULL
same	NULL
total	NULL
concentration	NULL
of	NULL
°H-steroid	NULL
,	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
a	NULL
significant	NULL
proportion	NULL
of	NULL
the	NULL
total	NULL
°H-steroid	NULL
is	NULL
bound	NULL
.	NULL

Values	NULL
of	NULL
K	NULL
,	NULL
and	NULL
B	NULL
,	NULL
were	NULL
determined	NULL
by	NULL
unweighted	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
data	NULL
for	NULL
the	NULL
ratio	NULL
of	NULL
specifically	NULL
bound	NULL
steroid	NULL
(	NULL
B	NULL
)	NULL
to	NULL
free	NULL
steroid	NULL
(	NULL
F	NULL
)	NULL
as	NULL
a	NULL
function	NULL
of	NULL
B	NULL
.	NULL

Most	NULL
cytosols	NULL
were	NULL
labeled	NULL
with	NULL
a	NULL
single	NULL
,	NULL
nearly	NULL
saturating	NULL
concentration	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
,	NULL
and	NULL
B	NULL
,	NULL
was	NULL
estimated	NULL
using	NULL
the	NULL
equation	NULL
(	NULL
41	NULL
)	NULL
B	NULL
R	NULL
Bo—	NULL
;	NULL
(	NULL
K¢+F	NULL
)	NULL
and	NULL
a	NULL
value	NULL
of	NULL
10	NULL
nm	NULL
for	NULL
K	NULL
,	NULL
(	NULL
10	NULL
)	NULL
.	NULL

The	NULL
reported	NULL
values	NULL
of	NULL
K	NULL
,	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
dexamethasone	NULL
to	NULL
leukemic	NULL
cell	NULL
receptors	NULL
vary	NULL
considerably	NULL
(	NULL
10	NULL
,	NULL
54	NULL
)	NULL
.	NULL

With	NULL
a	NULL
free	NULL
steroid	NULL
concentration	NULL
of	NULL
60	NULL
nm	NULL
,	NULL
however	NULL
,	NULL
the	NULL
resultant	NULL
estimates	NULL
of	NULL
B	NULL
,	NULL
based	NULL
on	NULL
values	NULL
of	NULL
5	NULL
or	NULL
20	NULL
nm	NULL
for	NULL
the	NULL
Ky	NULL
,	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
TA	NULL
would	NULL
be	NULL
93	NULL
or	NULL
114	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
those	NULL
based	NULL
on	NULL
a	NULL
K.	NULL
of	NULL
10	NULL
nM	NULL
.	NULL

Fluorometric	NULL
Peptidase	NULL
Assays	NULL
.	NULL

We	NULL
used	NULL
the	NULL
following	NULL
substrates	NULL
,	NULL
all	NULL
synthesized	NULL
from	NULL
L-	NULL
«	NULL
-amino	NULL
acids	NULL
and	NULL
AMC	NULL
:	NULL
leucyl-AMC	NULL
,	NULL
glutaryt-gtycyl-argmyl—AMC	NULL
succinyl-alanyt-alanyl-prolyt-phenylalanyl-AMC	NULL
,	NULL
suc-	NULL
valyi-tyrosyt-AMC	NULL
and	NULL
t-butyloxycarbonyl-valyHeucyl-lysyI-AMC	NULL
(	NULL
23	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Stock	NULL
solutions	NULL
of	NULL
the	NULL
substrates	NULL
(	NULL
10	NULL
mm	NULL
in	NULL
dimethy	NULL
!	NULL

sulfoxide	NULL
)	NULL
were	NULL
stored	NULL
at	NULL
4°	NULL
prior	NULL
to	NULL
dilution	NULL
in	NULL
assay	NULL
buffer	NULL
to	NULL
concentrations	NULL
of	NULL
10	NULL
or	NULL
20	NULL
um	NULL
.	NULL

Assays	NULL
were	NULL
performed	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
~24°	NULL
)	NULL
in	NULL
2.5	NULL
ml	NULL
of	NULL
TEG	NULL
buffer	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

The	NULL
reaction	NULL
product	NULL
,	NULL
AMC	NULL
,	NULL
was	NULL
detected	NULL
in	NULL
a	NULL
Perkin-Elmer	NULL
spectrofluorometer	NULL
at	NULL
excitation	NULL
and	NULL
emission	NULL
wavelengths	NULL
of	NULL
375	NULL
and	NULL
438	NULL
nm	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Reaction	NULL
velocities	NULL
,	NULL
in	NULL
RFU/hr	NULL
,	NULL
were	NULL
determined	NULL
by	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
at	NULL
least	NULL
3	NULL
readings	NULL
,	NULL
made	NULL
at	NULL
intervals	NULL
of	NULL
20	NULL
min	NULL
to	NULL
1	NULL
hr	NULL
,	NULL
during	NULL
the	NULL
linear	NULL
portion	NULL
of	NULL
the	NULL
reaction	NULL
.	NULL

This	NULL
included	NULL
a	NULL
period	NULL
of	NULL
at	NULL
least	NULL
3	NULL
hr	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
leukocyte	NULL
cytosols	NULL
or	NULL
charcoal-treated	NULL
cytosols	NULL
to	NULL
all	NULL
of	NULL
the	NULL
substrates	NULL
tested	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
significant	NULL
rates	NULL
of	NULL
cleavage	NULL
of	NULL
all	NULL
of	NULL
these	NULL
substrates	NULL
except	NULL
the	NULL
arginine	NULL
derivative	NULL
were	NULL
detected	NULL
using	NULL
20	NULL
um	NULL
substrate	NULL
and	NULL
20	NULL
ul	NULL
or	NULL
less	NULL
of	NULL
cytosol	NULL
.	NULL

Following	NULL
the	NULL
filtration	NULL
of	NULL
cytosols	NULL
on	NULL
agarose	NULL
columns	NULL
(	NULL
see	NULL
Chart	NULL
9	NULL
)	NULL
,	NULL
the	NULL
rates	NULL
of	NULL
cleavage	NULL
of	NULL
the	NULL
phenylalanine	NULL
derivative	NULL
were	NULL
increased	NULL
~20-fold	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mm	NULL
CaCt	NULL
in	NULL
the	NULL
assay	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
kinetics	NULL
of	NULL
cleavage	NULL
was	NULL
nonlinear	NULL
.	NULL

Therefore	NULL
,	NULL
a	NULL
linear	NULL
portion	NULL
of	NULL
the	NULL
assay	NULL
,	NULL
from	NULL
3	NULL
to	NULL
5	NULL
hr	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
enzyme	NULL
,	NULL
was	NULL
used	NULL
to	NULL
evaluate	NULL
the	NULL
relative	NULL
activities	NULL
in	NULL
the	NULL
column	NULL
fractions	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Physicochemical	NULL
Analyses	NULL
(	NULL
Gel	NULL
Filtration	NULL
,	NULL
Uitracentrifugation	NULL
,	NULL
and	NULL
lon-Exchange	NULL
Chromatography	NULL
)	NULL
.	NULL

Three	NULL
or	NULL
4	NULL
internal	NULL
standards	NULL
were	NULL
routinely	NULL
included	NULL
with	NULL
the	NULL
samples	NULL
for	NULL
gel	NULL
filtration	NULL
or	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

These	NULL
proteins	NULL
were	NULL
detected	NULL
either	NULL
spectrophotometri-cally	NULL
(	NULL
myoglobin	NULL
,	NULL
hemoglobin	NULL
,	NULL
catalase	NULL
,	NULL
ferritin	NULL
)	NULL
or	NULL
radiometrically	NULL
,	NULL
after	NULL
reductive	NULL
methylation	NULL
with	NULL
[	NULL
'*CJformaldehyde	NULL
(	NULL
40	NULL
)	NULL
.	NULL

The	NULL
tissue	NULL
sources	NULL
and	NULL
primary	NULL
references	NULL
for	NULL
the	NULL
parameters	NULL
of	NULL
the	NULL
standards	NULL
have	NULL
been	NULL
published	NULL
(	NULL
13	NULL
,	NULL
32	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Gel	NULL
filtration	NULL
was	NULL
performed	NULL
on	NULL
columns	NULL
of	NULL
Agarose	NULL
A-1.5m	NULL
(	NULL
100	NULL
to	NULL
200	NULL
mesh	NULL
;	NULL
1.27	NULL
x	NULL
90	NULL
to	NULL
100	NULL
cm	NULL
)	NULL
at	NULL
flow	NULL
rates	NULL
of	NULL
15	NULL
to	NULL
18	NULL
mijhr	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
various	NULL
salts	NULL
.	NULL

The	NULL
void	NULL
volume	NULL
(	NULL
V	NULL
,	NULL
)	NULL
and	NULL
the	NULL
total	NULL
liquid	NULL
volume	NULL
(	NULL
V	NULL
,	NULL
)	NULL
were	NULL
determined	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
.	NULL

These	NULL
parameters	NULL
and	NULL
the	NULL
elution	NULL
volume	NULL
(	NULL
V	NULL
,	NULL
)	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
distribution	NULL
coefficient	NULL
:	NULL
_	NULL
Va	NULL
-	NULL
Vo	NULL
“	NULL
``	NULL
w—w	NULL
The	NULL
Stokes	NULL
radii	NULL
(	NULL
Ms	NULL
)	NULL
of	NULL
the	NULL
standards	NULL
used	NULL
to	NULL
calibrate	NULL
the	NULL
columns	NULL
were	NULL
:	NULL
myoglobin	NULL
,	NULL
2.01	NULL
nm	NULL
;	NULL
carbonic	NULL
anhydrase	NULL
,	NULL
2.28	NULL
nm	NULL
;	NULL
serum	NULL
albumin	NULL
,	NULL
SEPTEMBER	NULL
1984	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
3.59	NULL
nm	NULL
;	NULL
S-amylase	NULL
,	NULL
4.81	NULL
nm	NULL
;	NULL
ferritin	NULL
,	NULL
6.15	NULL
nm	NULL
;	NULL
and	NULL
thyroglobulin	NULL
,	NULL
8.61	NULL
nm	NULL
.	NULL

The	NULL
Stokes	NULL
radii	NULL
of	NULL
the	NULL
receptors	NULL
and	NULL
peptidases	NULL
were	NULL
computed	NULL
from	NULL
the	NULL
linear	NULL
dependence	NULL
of	NULL
log	NULL
Rs	NULL
on	NULL
K	NULL
,	NULL
for	NULL
the	NULL
standards	NULL
in	NULL
each	NULL
column	NULL
(	NULL
43	NULL
)	NULL
.	NULL

Estimates	NULL
of	NULL
the	NULL
width	NULL
of	NULL
the	NULL
peaks	NULL
were	NULL
obtained	NULL
by	NULL
calculating	NULL
the	NULL
values	NULL
of	NULL
Ms	NULL
corresponding	NULL
to	NULL
the	NULL
left	NULL
and	NULL
right	NULL
sides	NULL
of	NULL
the	NULL
peaks	NULL
at	NULL
two-thirds	NULL
of	NULL
the	NULL
maximum	NULL
height	NULL
(	NULL
see	NULL
Chart	NULL
2	NULL
)	NULL
.	NULL

Comparisons	NULL
of	NULL
the	NULL
extent	NULL
of	NULL
receptor	NULL
cleavage	NULL
in	NULL
various	NULL
preparations	NULL
were	NULL
based	NULL
on	NULL
the	NULL
percentage	NULL
of	NULL
the	NULL
labeled	NULL
complexes	NULL
characterized	NULL
by	NULL
As	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
(	NULL
see	NULL
Charts	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Density	NULL
gradient	NULL
centrifugation	NULL
was	NULL
performed	NULL
at	NULL
0°	NULL
in	NULL
a	NULL
Beckman	NULL
L2-65B	NULL
ultracentrifuge	NULL
.	NULL

Samples	NULL
of	NULL
up	NULL
to	NULL
0.5	NULL
ml	NULL
were	NULL
layered	NULL
onto	NULL
3.8-mi	NULL
linear	NULL
gradients	NULL
of	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
in	NULL
various	NULL
buffers	NULL
and	NULL
centrifuged	NULL
for	NULL
17	NULL
to	NULL
22	NULL
hr	NULL
at	NULL
246,000	NULL
to	NULL
369,000	NULL
x	NULL
g	NULL
in	NULL
a	NULL
Beckman	NULL
SW56	NULL
or	NULL
SW6OTi	NULL
rotor	NULL
,	NULL
as	NULL
indicated	NULL
in	NULL
``	NULL
Results	NULL
and	NULL
Discussion	NULL
.	NULL
``	NULL

Samples	NULL
of	NULL
1	NULL
m	NULL
!	NULL

were	NULL
layered	NULL
onto	NULL
12-mi	NULL
gradients	NULL
of	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerot	NULL
and	NULL
centrifuged	NULL
for	NULL
42	NULL
hr	NULL
at	NULL
148,000	NULL
x	NULL
g	NULL
in	NULL
a	NULL
Beckman	NULL
SW40	NULL
rotor	NULL
.	NULL

The	NULL
sedimentation	NULL
coefficients	NULL
(	NULL
s	NULL
»	NULL
,	NULL
,	NULL
,	NULL
)	NULL
of	NULL
the	NULL
standards	NULL
were	NULL
:	NULL
myoglobin	NULL
,	NULL
2.05	NULL
;	NULL
carbonic	NULL
anhydrase	NULL
,	NULL
3.25	NULL
;	NULL
hemoglobin	NULL
,	NULL
4.4S	NULL
;	NULL
serum	NULL
albumin	NULL
,	NULL
4.48	NULL
;	NULL
aldolase	NULL
,	NULL
7.98	NULL
;	NULL
B-amylase	NULL
,	NULL
9.48	NULL
;	NULL
and	NULL
catalase	NULL
,	NULL
11.35	NULL
.	NULL

Values	NULL
of	NULL
sx	NULL
,	NULL
,	NULL
for	NULL
the	NULL
receptors	NULL
were	NULL
computed	NULL
from	NULL
the	NULL
linear	NULL
correlation	NULL
of	NULL
$	NULL
20	NULL
,	NULL
,	NULL
with	NULL
fraction	NULL
number	NULL
for	NULL
the	NULL
internal	NULL
standards	NULL
.	NULL

The	NULL
molecular	NULL
weight	NULL
of	NULL
each	NULL
receptor	NULL
form	NULL
was	NULL
calculated	NULL
from	NULL
4224	NULL
(	NULL
Sz20w	NULL
-As	NULL
)	NULL
,	NULL
where	NULL
sx	NULL
,	NULL
was	NULL
in	NULL
Svedberg	NULL
units	NULL
,	NULL
Rs	NULL
was	NULL
in	NULL
nm	NULL
,	NULL
and	NULL
the	NULL
factor	NULL
was	NULL
based	NULL
on	NULL
a	NULL
value	NULL
of	NULL
0.732	NULL
cu	NULL
cm/g	NULL
for	NULL
the	NULL
partial	NULL
specific	NULL
volume	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
serum	NULL
albumin	NULL
(	NULL
43	NULL
,	NULL
50	NULL
)	NULL
.	NULL

The	NULL
frictional	NULL
ratio	NULL
due	NULL
to	NULL
shape	NULL
,	NULL
(	NULL
f/foaap	NULL
Was	NULL
calculated	NULL
from	NULL
13.93	NULL
(	NULL
Rs/M	NULL
,	NULL
*	NULL
)	NULL
,	NULL
in	NULL
which	NULL
a	NULL
hydration	NULL
of	NULL
0.2	NULL
g/g	NULL
of	NULL
protein	NULL
was	NULL
assumed	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
axial	NULL
ratio	NULL
(	NULL
a/b	NULL
)	NULL
of	NULL
a	NULL
hydrodynamically	NULL
equivalent	NULL
prolate	NULL
ellipsoid	NULL
was	NULL
determined	NULL
from	NULL
{	NULL
f/folsnape	NULL
and	NULL
a	NULL
published	NULL
table	NULL
(	NULL
42	NULL
)	NULL
.	NULL

lon-exchange	NULL
chromatography	NULL
was	NULL
performed	NULL
on	NULL
columns	NULL
of	NULL
DEAE-cellulose	NULL
(	NULL
Whatman	NULL
DES52	NULL
;	NULL
1.5	NULL
cm	NULL
diameter	NULL
x	NULL
6	NULL
cm	NULL
)	NULL
in	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Adsorbed	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
a	NULL
linear	NULL
gradient	NULL
prepared	NULL
from	NULL
80	NULL
ml	NULL
each	NULL
of	NULL
0	NULL
and	NULL
0.6	NULL
m	NULL
KCI	NULL
in	NULL
the	NULL
buffer	NULL
.	NULL

Other	NULL
Methods	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
using	NULL
flu-orescamine	NULL
(	NULL
4	NULL
)	NULL
,	NULL
with	NULL
bovine	NULL
serum	NULL
albumin	NULL
as	NULL
the	NULL
standard	NULL
.	NULL

In	NULL
cytosols	NULL
prepared	NULL
from	NULL
frozen	NULL
cells	NULL
,	NULL
the	NULL
protein	NULL
concentrations	NULL
were	NULL
consistently	NULL
higher	NULL
(	NULL
13	NULL
to	NULL
37	NULL
%	NULL
)	NULL
than	NULL
in	NULL
the	NULL
corresponding	NULL
preparations	NULL
from	NULL
fresh	NULL
cells	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
(	NULL
as	NULL
indicated	NULL
in	NULL
``	NULL
Results	NULL
and	NULL
Discussion	NULL
``	NULL
)	NULL
,	NULL
the	NULL
cytosolic	NULL
protein	NULL
concentration	NULL
was	NULL
supplemented	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
ovalbumin	NULL
,	NULL
in	NULL
order	NULL
to	NULL
minimize	NULL
proteolysis	NULL
of	NULL
the	NULL
receptors	NULL
.	NULL

Radioactivity	NULL
in	NULL
aqueous	NULL
samples	NULL
of	NULL
up	NULL
to	NULL
0.8	NULL
ml	NULL
was	NULL
measured	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
Aquasol	NULL
,	NULL
and	NULL
the	NULL
data	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
results	NULL
reported	NULL
for	NULL
most	NULL
parameters	NULL
indicate	NULL
the	NULL
number	NULL
of	NULL
determinations	NULL
(	NULL
n	NULL
)	NULL
on	NULL
which	NULL
the	NULL
mean	NULL
and	NULL
the	NULL
standard	NULL
deviation	NULL
were	NULL
based	NULL
.	NULL

Calculations	NULL
of	NULL
statistical	NULL
significance	NULL
were	NULL
based	NULL
on	NULL
the	NULL
2-tailed	NULL
Student	NULL
's	NULL
t	NULL
test	NULL
.	NULL

Coefficients	NULL
of	NULL
determination	NULL
of	NULL
linear	NULL
regressions	NULL
(	NULL
r*	NULL
)	NULL
and	NULL
the	NULL
95	NULL
%	NULL
confidence	NULL
intervals	NULL
of	NULL
the	NULL
slopes	NULL
and	NULL
intercepts	NULL
were	NULL
computed	NULL
as	NULL
described	NULL
by	NULL
Snedecor	NULL
and	NULL
Cochran	NULL
(	NULL
53	NULL
)	NULL
.	NULL

Our	NULL
computer	NULL
programs	NULL
are	NULL
available	NULL
upon	NULL
request	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Overview	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
relationship	NULL
of	NULL
cytosolic	NULL
receptor	NULL
content	NULL
to	NULL
leukemic	NULL
cell	NULL
subtype	NULL
,	NULL
the	NULL
structure	NULL
of	NULL
the	NULL
glucocorticoid-receptor	NULL
complexes	NULL
,	NULL
and	NULL
the	NULL
properties	NULL
of	NULL
several	NULL
cytosolic	NULL
peptidases	NULL
.	NULL

The	NULL
results	NULL
have	NULL
been	NULL
evaluated	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
conditions	NULL
under	NULL
which	NULL
the	NULL
specimens	NULL
were	NULL
stored	NULL
,	NULL
pro-cessed	NULL
,	NULL
and	NULL
analyzed	NULL
.	NULL

Very	NULL
high	NULL
concentrations	NULL
of	NULL
receptor	NULL
were	NULL
found	NULL
in	NULL
cytosols	NULL
from	NULL
one	NULL
immunological	NULL
subtype	NULL
of	NULL
leukemic	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

The	NULL
major	NULL
forms	NULL
and	NULL
fragments	NULL
of	NULL
the	NULL
receptors	NULL
from	NULL
various	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
normal	NULL
lymphocytes	NULL
have	NULL
been	NULL
characterized	NULL
by	NULL
physicochemical	NULL
techniques	NULL
.	NULL

The	NULL
receptor	NULL
forms	NULL
analyzed	NULL
are	NULL
:	NULL
the	NULL
large	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
stabilized	NULL
by	NULL
protease	NULL
inhibitors	NULL
and	NULL
by	NULL
molybdate	NULL
in	NULL
buffers	NULL
of	NULL
low	NULL
and	NULL
moderate	NULL
ionic	NULL
strength	NULL
(	NULL
Charts	NULL
1	NULL
to	NULL
4	NULL
;	NULL
Table	NULL
2	NULL
)	NULL
;	NULL
a	NULL
subunit	NULL
3785	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

of	NULL
this	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
detected	NULL
in	NULL
molybdate-free	NULL
,	NULL
hypertonic	NULL
buffers	NULL
(	NULL
Charts	NULL
7	NULL
and	NULL
8	NULL
;	NULL
Table	NULL
3	NULL
)	NULL
;	NULL
the	NULL
smallest	NULL
fragment	NULL
which	NULL
retains	NULL
the	NULL
bound	NULL
steroid	NULL
,	NULL
called	NULL
the	NULL
mero-receptor	NULL
(	NULL
Charts	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
and	NULL
fragments	NULL
of	NULL
intermediate	NULL
size	NULL
(	NULL
Charts	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
fragments	NULL
appear	NULL
to	NULL
be	NULL
the	NULL
products	NULL
of	NULL
endogenous	NULL
peptidases	NULL
,	NULL
several	NULL
of	NULL
these	NULL
enzymes	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
Chart	NULL
9	NULL
)	NULL
.	NULL

In	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
several	NULL
technical	NULL
issues	NULL
were	NULL
resolved	NULL
.	NULL

Two	NULL
methods	NULL
for	NULL
the	NULL
removal	NULL
of	NULL
free	NULL
steroid	NULL
from	NULL
labeled	NULL
cytosols	NULL
were	NULL
compared	NULL
;	NULL
the	NULL
effects	NULL
of	NULL
freezing	NULL
the	NULL
labeled	NULL
cytosols	NULL
on	NULL
the	NULL
amount	NULL
of	NULL
bound	NULL
steroid	NULL
subsequently	NULL
detected	NULL
were	NULL
analyzed	NULL
;	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
presence	NULL
of	NULL
molybdate	NULL
in	NULL
the	NULL
homogenate	NULL
and/or	NULL
the	NULL
gel	NULL
filtration	NULL
buffer	NULL
were	NULL
investigated	NULL
(	NULL
Charts	NULL
2	NULL
to	NULL
5	NULL
)	NULL
;	NULL
and	NULL
effects	NULL
on	NULL
receptor	NULL
structure	NULL
of	NULL
rapidly	NULL
freezing	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
preservatives	NULL
were	NULL
examined	NULL
(	NULL
Charts	NULL
6	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Comparison	NULL
of	NULL
Methods	NULL
Used	NULL
to	NULL
Remove	NULL
Free	NULL
Steroid	NULL
from	NULL
Labeled	NULL
Cytosols	NULL
.	NULL

While	NULL
adsorption	NULL
to	NULL
dextran-coated	NULL
charcoal	NULL
permits	NULL
the	NULL
rapid	NULL
removal	NULL
of	NULL
free	NULL
and	NULL
loosely	NULL
bound	NULL
steroid	NULL
from	NULL
labeled	NULL
cytosols	NULL
,	NULL
a	NULL
chromatographic	NULL
technique	NULL
is	NULL
sometimes	NULL
advantageous	NULL
.	NULL

Chromatography	NULL
on	NULL
small	NULL
columns	NULL
of	NULL
Sephadex	NULL
or	NULL
Sephadex	NULL
LH-20	NULL
is	NULL
preferable	NULL
for	NULL
cytosols	NULL
or	NULL
other	NULL
receptor	NULL
preparations	NULL
with	NULL
very	NULL
low	NULL
protein	NULL
concentrations	NULL
,	NULL
from	NULL
which	NULL
there	NULL
may	NULL
be	NULL
a	NULL
significant	NULL
loss	NULL
of	NULL
receptors	NULL
by	NULL
adsorption	NULL
to	NULL
charcoal	NULL
(	NULL
44	NULL
)	NULL
.	NULL

in	NULL
addition	NULL
,	NULL
the	NULL
receptors	NULL
can	NULL
be	NULL
rapidly	NULL
equili-brated	NULL
with	NULL
a	NULL
new	NULL
buffer	NULL
during	NULL
chromatography	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
previously	NULL
that	NULL
better	NULL
resolution	NULL
of	NULL
bound	NULL
from	NULL
free	NULL
steroid	NULL
is	NULL
obtained	NULL
with	NULL
the	NULL
hydrophobic	NULL
derivative	NULL
,	NULL
Sephadex	NULL
LH-20	NULL
,	NULL
than	NULL
with	NULL
unmodified	NULL
Sephadex	NULL
(	NULL
51	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
under	NULL
the	NULL
conditions	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
the	NULL
elution	NULL
of	NULL
bound	NULL
steroid	NULL
from	NULL
small	NULL
columns	NULL
of	NULL
Sephadex	NULL
LH-20	NULL
is	NULL
nearly	NULL
as	NULL
rapid	NULL
as	NULL
the	NULL
recovery	NULL
of	NULL
the	NULL
supernatant	NULL
following	NULL
charcoal	NULL
treatment	NULL
and	NULL
centrifugation	NULL
.	NULL

In	NULL
a	NULL
preliminary	NULL
experiment	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
Scatchard	NULL
plots	NULL
(	NULL
41	NULL
)	NULL
of	NULL
data	NULL
obtained	NULL
by	NULL
charcoal	NULL
treatment	NULL
and	NULL
by	NULL
chromatography	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
for	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
binding	NULL
to	NULL
a	NULL
leukemic	NULL
cell	NULL
cytosol	NULL
with	NULL
a	NULL
high	NULL
protein	NULL
concentration	NULL
(	NULL
14	NULL
mg/ml	NULL
)	NULL
.	NULL

A	NULL
slightly	NULL
lower	NULL
estimate	NULL
of	NULL
K	NULL
,	NULL
was	NULL
obtained	NULL
by	NULL
the	NULL
chromatographic	NULL
technique	NULL
,	NULL
and	NULL
the	NULL
difference	NULL
was	NULL
just	NULL
significant	NULL
at	NULL
the	NULL
level	NULL
of	NULL
0.05	NULL
.	NULL

The	NULL
results	NULL
for	NULL
K	NULL
,	NULL
and	NULL
the	NULL
95	NULL
%	NULL
confidence	NULL
intervals	NULL
were	NULL
16.1	NULL
(	NULL
14.5	NULL
to	NULL
18.2	NULL
)	NULL
nm	NULL
using	NULL
Sephadex	NULL
LH-20	NULL
and	NULL
21.1	NULL
(	NULL
18.3	NULL
to	NULL
24.8	NULL
)	NULL
nm	NULL
using	NULL
charcoal	NULL
.	NULL

We	NULL
also	NULL
noted	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
nonspecific	NULL
binding	NULL
determined	NULL
by	NULL
charcoal	NULL
adsorption	NULL
was	NULL
higher	NULL
than	NULL
that	NULL
determined	NULL
chromatographically	NULL
.	NULL

At	NULL
the	NULL
highest	NULL
concentration	NULL
of	NULL
[	NULL
°HJTA	NULL
used	NULL
in	NULL
this	NULL
experiment	NULL
(	NULL
~70	NULL
nm	NULL
)	NULL
,	NULL
the	NULL
nonspecific	NULL
binding	NULL
corresponded	NULL
to	NULL
8	NULL
%	NULL
of	NULL
the	NULL
total	NULL
binding	NULL
detected	NULL
by	NULL
charcoal	NULL
treatment	NULL
but	NULL
was	NULL
<	NULL
1	NULL
%	NULL
of	NULL
that	NULL
detected	NULL
with	NULL
Sephadex	NULL
LH-20	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
values	NULL
of	NULL
the	NULL
binding	NULL
capacity	NULL
(	NULL
B	NULL
,	NULL
)	NULL
obtained	NULL
by	NULL
these	NULL
techniques	NULL
were	NULL
not	NULL
significantly	NULL
different	NULL
at	NULL
the	NULL
level	NULL
of	NULL
0.05	NULL
.	NULL

From	NULL
these	NULL
results	NULL
and	NULL
analogous	NULL
data	NULL
for	NULL
another	NULL
ALL	NULL
specimen	NULL
,	NULL
we	NULL
inferred	NULL
that	NULL
similar	NULL
amounts	NULL
of	NULL
binding	NULL
would	NULL
be	NULL
detected	NULL
by	NULL
both	NULL
methods	NULL
if	NULL
the	NULL
cytosols	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
nearly	NULL
saturating	NULL
concentration	NULL
of	NULL
[	NULL
PH	NULL
]	NULL
JTA	NULL
.	NULL

The	NULL
method	NULL
used	NULL
to	NULL
remove	NULL
the	NULL
free	NULL
steroid	NULL
did	NULL
,	NULL
however	NULL
,	NULL
affect	NULL
the	NULL
form	NULL
of	NULL
the	NULL
complex	NULL
detected	NULL
by	NULL
centrifugation	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
see	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

Preliminary	NULL
experiments	NULL
also	NULL
indicated	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
specific	NULL
binding	NULL
was	NULL
not	NULL
decreased	NULL
by	NULL
freezing	NULL
the	NULL
labeled	NULL
+Mo	NULL
cytosols	NULL
before	NULL
removing	NULL
the	NULL
free	NULL
steroid	NULL
.	NULL

This	NULL
was	NULL
tested	NULL
using	NULL
aliquots	NULL
of	NULL
4	NULL
leukemic	NULL
cell	NULL
cytosols	NULL
which	NULL
were	NULL
analyzed	NULL
immediately	NULL
after	NULL
incubation	NULL
with	NULL
[	NULL
°HJTA	NULL
and	NULL
after	NULL
storage	NULL
at	NULL
-85°	NULL
for	NULL
up	NULL
to	NULL
1	NULL
year	NULL
.	NULL

The	NULL
binding	NULL
detected	NULL
after	NULL
freezing	NULL
was	NULL
113	NULL
+	NULL
7	NULL
%	NULL
(	NULL
n	NULL
=	NULL
4	NULL
)	NULL
of	NULL
that	NULL
detected	NULL
before	NULL
freezing	NULL
.	NULL

Relationship	NULL
of	NULL
Receptor	NULL
Concentration	NULL
to	NULL
Diagnosis	NULL
and	NULL
Other	NULL
Characteristics	NULL
of	NULL
Leukemic	NULL
Cells	NULL
.	NULL

We	NULL
have	NULL
correlated	NULL
our	NULL
results	NULL
for	NULL
cytosolic	NULL
receptor	NULL
content	NULL
with	NULL
clinical	NULL
data	NULL
and	NULL
results	NULL
obtained	NULL
by	NULL
other	NULL
laboratories	NULL
at	NULL
this	NULL
Center	NULL
.	NULL

Diagnoses	NULL
were	NULL
based	NULL
on	NULL
clinical	NULL
and	NULL
hematological	NULL
findings	NULL
,	NULL
morphological	NULL
and	NULL
cytochemical	NULL
criteria	NULL
(	NULL
1	NULL
,	NULL
3	NULL
)	NULL
,	NULL
and	NULL
cytogenetic	NULL
data	NULL
,	NULL
particularly	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
Philadelphia	NULL
chromosome	NULL
(	NULL
7	NULL
)	NULL
.	NULL

in	NULL
addition	NULL
,	NULL
we	NULL
considered	NULL
the	NULL
following	NULL
parameters	NULL
:	NULL
WBC	NULL
(	NULL
31	NULL
of	NULL
35	NULL
of	NULL
our	NULL
leukemic	NULL
specimens	NULL
had	NULL
>	NULL
50,000	NULL
cells/ul	NULL
)	NULL
;	NULL
age	NULL
of	NULL
the	NULL
patient	NULL
(	NULL
24	NULL
of	NULL
27	NULL
of	NULL
our	NULL
acute	NULL
leukemic	NULL
specimens	NULL
were	NULL
from	NULL
children	NULL
)	NULL
;	NULL
TdT	NULL
activity	NULL
(	NULL
31	NULL
)	NULL
;	NULL
and	NULL
immunological	NULL
classification	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Among	NULL
the	NULL
22	NULL
specimens	NULL
of	NULL
ALL	NULL
which	NULL
were	NULL
studied	NULL
,	NULL
8	NULL
were	NULL
classified	NULL
as	NULL
T	NULL
cells	NULL
,	NULL
12	NULL
were	NULL
classified	NULL
as	NULL
``	NULL
null	NULL
cells	NULL
,	NULL
``	NULL
and	NULL
one	NULL
was	NULL
reported	NULL
to	NULL
be	NULL
``	NULL
abnormal	NULL
inconclusive	NULL
``	NULL
by	NULL
the	NULL
Lymphocyte	NULL
Surface	NULL
Markers	NULL
Laboratory	NULL
.	NULL

One	NULL
ALL	NULL
specimen	NULL
was	NULL
not	NULL
evaluated	NULL
immunologically	NULL
.	NULL

Although	NULL
the	NULL
major	NULL
focus	NULL
of	NULL
our	NULL
research	NULL
was	NULL
the	NULL
structure	NULL
rather	NULL
than	NULL
the	NULL
quantity	NULL
of	NULL
receptors	NULL
,	NULL
we	NULL
noticed	NULL
that	NULL
all	NULL
cytosols	NULL
that	NULL
had	NULL
very	NULL
high	NULL
concentrations	NULL
of	NULL
receptors	NULL
(	NULL
>	NULL
900	NULL
fmol/mg	NULL
protein	NULL
)	NULL
were	NULL
from	NULL
ALL	NULL
cells	NULL
classified	NULL
as	NULL
``	NULL
null	NULL
cells	NULL
.	NULL
``	NULL

Such	NULL
cells	NULL
lack	NULL
the	NULL
standard	NULL
B-cell	NULL
and	NULL
T-cell	NULL
markers	NULL
;	NULL
/.e	NULL
.	NULL

,	NULL
they	NULL
lack	NULL
surface	NULL
immunoglobulins	NULL
and	NULL
are	NULL
unable	NULL
to	NULL
form	NULL
rosettes	NULL
with	NULL
sheep	NULL
erythrocytes	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
absence	NULL
of	NULL
these	NULL
surface	NULL
markers	NULL
,	NULL
however	NULL
,	NULL
most	NULL
``	NULL
null-cell	NULL
``	NULL
leukemias	NULL
appear	NULL
to	NULL
be	NULL
precursors	NULL
committed	NULL
to	NULL
the	NULL
B-cell	NULL
lineage	NULL
at	NULL
the	NULL
gene	NULL
level	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
,	NULL
which	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
of	NULL
Table	NULL
1	NULL
Cytosolic	NULL
receptor	NULL
concentrations	NULL
in	NULL
subsets	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
in	NULL
normal	NULL
lymphocytes	NULL
Cytosols	NULL
were	NULL
incubated	NULL
with	NULL
several	NULL
concentrations	NULL
of	NULL
[	NULL
°HJTA	NULL
or	NULL
with	NULL
a	NULL
single	NULL
,	NULL
nearlysannhngconeen-tration	NULL
.	NULL

Binding	NULL
was	NULL
evaluated	NULL
by	NULL
charcoal-dextran	NULL
treatment	NULL
or	NULL
by	NULL
Sephadex	NULL
LH-20	NULL
medatawereandyzedtodetermnnemecormtmﬁonofmm	NULL
as	NULL
described	NULL
in	NULL
MateﬂaIsand	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
resultant	NULL
values	NULL
were	NULL
divided	NULL
by	NULL
cytosolic	NULL
protein	NULL
concentration	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
are	NULL
based	NULL
on	NULL
the	NULL
mean	NULL
value	NULL
for	NULL
each	NULL
specimen	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
cells	NULL
or	NULL
cytosols	NULL
were	NULL
frozen	NULL
or	NULL
whether	NULL
the	NULL
cytosols	NULL
contained	NULL
molybdate	NULL
.	NULL

Binding	NULL
capacity	NULL
(	NULL
fmol/mg	NULL
protein	NULL
No	NULL
.	NULL

of	NULL
__	NULL
Median	NULL
WBC	NULL
-	NULL
Median	NULL
age	NULL
_	NULL
Binding	NULL
capacity	NULL
(	NULL
fmol/mg	NULL
protein	NULL
)	NULL
_	NULL
Specimen	NULL
specimens	NULL
(	NULL
calls/ul	NULL
)	NULL
(	NULL
yr	NULL
)	NULL
Median	NULL
-	NULL
Mean	NULL
+	NULL
S.D	NULL
.	NULL

Range	NULL
``	NULL
Null-cell	NULL
``	NULL
ALL	NULL
12	NULL
93,000	NULL
11	NULL
1000	NULL
1200	NULL
+930	NULL
130-2800	NULL
T-cell	NULL
ALL	NULL
8	NULL
430,000	NULL
14	NULL
240	NULL
-	NULL
270+120	NULL
120-	NULL
420	NULL
Other	NULL
leukemic	NULL
cells	NULL
15°	NULL
130,000	NULL
13	NULL
280	NULL
300	NULL
+210	NULL
-	NULL
50-	NULL
840	NULL
Norma	NULL
!	NULL

lymphocytes	NULL
6	NULL
ND	NULL
``	NULL
Adult	NULL
130	NULL
-	NULL
150	NULL
+110	NULL
_	NULL
70-	NULL
380	NULL
*	NULL
These	NULL
included	NULL
2	NULL
specimens	NULL
of	NULL
unclassified	NULL
ALL	NULL
,	NULL
5	NULL
of	NULL
ANLL	NULL
,	NULL
2	NULL
of	NULL
CLL	NULL
,	NULL
5	NULL
of	NULL
CML	NULL
,	NULL
and	NULL
1	NULL
of	NULL
diffuse	NULL
poorty	NULL
differentiated	NULL
®	NULL
ND	NULL
,	NULL
notdetemuned	NULL
The	NULL
mean	NULL
WBC	NULL
for	NULL
normal	NULL
adult	NULL
specimens	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
6700	NULL
+	NULL
3000	NULL
cells/ul	NULL
(	NULL
n	NULL
=	NULL
100	NULL
)	NULL
.	NULL

3786	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

Yarbro	NULL
et	NULL
al	NULL
.	NULL

(	NULL
57	NULL
)	NULL
,	NULL
who	NULL
detected	NULL
higher	NULL
whole-cell	NULL
binding	NULL
levels	NULL
in	NULL
``	NULL
null-cell	NULL
``	NULL
ALL	NULL
than	NULL
in	NULL
T-cell	NULL
ALL	NULL
,	NULL
using	NULL
specimens	NULL
from	NULL
patients	NULL
with	NULL
lower	NULL
WBC	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
study	NULL
(	NULL
57	NULL
)	NULL
,	NULL
the	NULL
median	NULL
WBC	NULL
for	NULL
the	NULL
``	NULL
null-cell	NULL
``	NULL
specimens	NULL
was	NULL
<	NULL
18,000	NULL
cells/ul	NULL
,	NULL
compared	NULL
with	NULL
a	NULL
median	NULL
value	NULL
of	NULL
93,000	NULL
cells/ul	NULL
in	NULL
our	NULL
specimens	NULL
.	NULL

Other	NULL
groups	NULL
have	NULL
also	NULL
reported	NULL
higher	NULL
receptor	NULL
levels	NULL
in	NULL
``	NULL
null-cell	NULL
``	NULL
ALL	NULL
specimens	NULL
than	NULL
in	NULL
T-cell	NULL
ALL	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

21	NULL
and	NULL
54	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
cytosolic	NULL
receptor	NULL
levels	NULL
are	NULL
generally	NULL
higher	NULL
in	NULL
``	NULL
null-cell	NULL
``	NULL
than	NULL
in	NULL
T-cell	NULL
ALL	NULL
specimens	NULL
,	NULL
regardless	NULL
of	NULL
the	NULL
WBC	NULL
.	NULL

Our	NULL
results	NULL
for	NULL
cytosolic	NULL
receptor	NULL
concentration	NULL
,	NULL
in	NULL
units	NULL
of	NULL
fmol/mg	NULL
protein	NULL
,	NULL
are	NULL
not	NULL
directly	NULL
comparable	NULL
to	NULL
results	NULL
for	NULL
glu-cocarticoid	NULL
binding	NULL
to	NULL
whole	NULL
cells	NULL
,	NULL
expressed	NULL
as	NULL
sites/cell	NULL
.	NULL

Some	NULL
investigators	NULL
have	NULL
made	NULL
such	NULL
correlations	NULL
by	NULL
assuming	NULL
a	NULL
certain	NULL
value	NULL
for	NULL
the	NULL
mass	NULL
of	NULL
cytosolic	NULL
protein/cell	NULL
.	NULL

In	NULL
our	NULL
opinion	NULL
,	NULL
however	NULL
,	NULL
such	NULL
an	NULL
assumption	NULL
is	NULL
not	NULL
appropriate	NULL
for	NULL
comparative	NULL
studies	NULL
of	NULL
different	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
,	NULL
since	NULL
they	NULL
may	NULL
vary	NULL
greatly	NULL
in	NULL
size	NULL
and	NULL
morphology	NULL
,	NULL
and	NULL
hence	NULL
in	NULL
the	NULL
mass	NULL
of	NULL
cytosolic	NULL
protein/cell	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
protein	NULL
recovered	NULL
in	NULL
the	NULL
cytosol	NULL
may	NULL
vary	NULL
with	NULL
the	NULL
methods	NULL
of	NULL
cell	NULL
storage	NULL
and	NULL
cytosol	NULL
preparation	NULL
.	NULL

In	NULL
view	NULL
of	NULL
previous	NULL
reports	NULL
of	NULL
discrepancies	NULL
between	NULL
whole-cell	NULL
binding	NULL
and	NULL
cytosolic	NULL
binding	NULL
(	NULL
mea-sured	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
molybdate	NULL
)	NULL
(	NULL
22	NULL
)	NULL
,	NULL
more	NULL
extensive	NULL
comparisons	NULL
of	NULL
receptor	NULL
levels	NULL
in	NULL
``	NULL
null-cell	NULL
``	NULL
ALL	NULL
and	NULL
other	NULL
types	NULL
of	NULL
leukemia	NULL
should	NULL
be	NULL
done	NULL
by	NULL
both	NULL
techniques	NULL
.	NULL

Sequential	NULL
Fractionations	NULL
of	NULL
the	NULL
Molybdate-stabilized	NULL
Receptor	NULL
from	NULL
ALL	NULL
Cells	NULL
.	NULL

We	NULL
reported	NULL
previously	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
20	NULL
mm	NULL
NaMoO	NULL
,	NULL
stabilizes	NULL
the	NULL
oligomeric	NULL
form	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
rat	NULL
liver	NULL
and	NULL
kidney	NULL
cytosols	NULL
during	NULL
fractionation	NULL
in	NULL
hypotonic	NULL
buffers	NULL
by	NULL
several	NULL
techniques	NULL
in	NULL
sequence	NULL
(	NULL
46	NULL
,	NULL
47	NULL
,	NULL
51	NULL
)	NULL
.	NULL

Similar	NULL
analyses	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
charcoal-treated	NULL
cytosol	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
are	NULL
shown	NULL
in	NULL
Chart	NULL
1	NULL
.	NULL

The	NULL
initial	NULL
fractionation	NULL
on	NULL
an	NULL
agarose	NULL
column	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
revealed	NULL
a	NULL
single	NULL
,	NULL
fairly	NULL
symmetrical	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
(	NULL
Kp	NULL
of	NULL
0.13	NULL
)	NULL
and	NULL
a	NULL
small	NULL
peak	NULL
of	NULL
free	NULL
steroid	NULL
(	NULL
Kp	NULL
of	NULL
1.1	NULL
)	NULL
,	NULL
corresponding	NULL
to	NULL
~8	NULL
%	NULL
of	NULL
the	NULL
total	NULL
steroid	NULL
eluted	NULL
from	NULL
the	NULL
column	NULL
.	NULL

The	NULL
recovery	NULL
of	NULL
PH	NULL
]	NULL
TA	NULL
from	NULL
the	NULL
agarose	NULL
columns	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
excellent	NULL
,	NULL
with	NULL
a	NULL
mean	NULL
value	NULL
of	NULL
93	NULL
+	NULL
10	NULL
%	NULL
(	NULL
n	NULL
=	NULL
50	NULL
)	NULL
.	NULL

The	NULL
large	NULL
size	NULL
of	NULL
the	NULL
steroid-receptor	NULL
complex	NULL
was	NULL
indicated	NULL
by	NULL
its	NULL
coelu-tion	NULL
with	NULL
'*C-methylated	NULL
thyroglobulin	NULL
,	NULL
which	NULL
has	NULL
a	NULL
Stokes	NULL
radius	NULL
of	NULL
8.61	NULL
nm	NULL
(	NULL
13	NULL
)	NULL
.	NULL

More	NULL
rigorous	NULL
evaluation	NULL
of	NULL
receptor	NULL
size	NULL
was	NULL
obtained	NULL
by	NULL
linear	NULL
regression	NULL
analysis	NULL
of	NULL
data	NULL
for	NULL
log	NULL
Rs	NULL
versus	NULL
Ko	NULL
for	NULL
all	NULL
of	NULL
the	NULL
internal	NULL
standards	NULL
.	NULL

In	NULL
replicate	NULL
analyses	NULL
of	NULL
leukocyte	NULL
receptors	NULL
on	NULL
these	NULL
columns	NULL
with	NULL
3	NULL
or	NULL
4	NULL
of	NULL
the	NULL
standards	NULL
listed	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
the	NULL
coefficient	NULL
of	NULL
determination	NULL
(	NULL
r	NULL
?	NULL
)	NULL

of	NULL
these	NULL
regressions	NULL
was	NULL
0.997	NULL
+	NULL
0.005	NULL
(	NULL
n	NULL
=	NULL
49	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
values	NULL
of	NULL
As	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
were	NULL
determined	NULL
From	NULL
the	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
shown	NULL
in	NULL
Chart	NULL
1a	NULL
,	NULL
fractions	NULL
corresponding	NULL
to	NULL
ARs	NULL
of	NULL
8	NULL
to	NULL
9	NULL
nm	NULL
were	NULL
combined	NULL
for	NULL
further	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Chart	NULL
1b	NULL
,	NULL
glycerol	NULL
gradient	NULL
centrifugation	NULL
of	NULL
this	NULL
material	NULL
also	NULL
revealed	NULL
a	NULL
single	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
.	NULL

This	NULL
complex	NULL
comigrated	NULL
with	NULL
an	NULL
internal	NULL
standard	NULL
,	NULL
'*C-methylated	NULL
B-amylase	NULL
,	NULL
which	NULL
has	NULL
a	NULL
sedimentation	NULL
coefficient	NULL
of	NULL
9.4S	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
~40	NULL
%	NULL
of	NULL
the	NULL
recovered	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
remained	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gradient	NULL
.	NULL

This	NULL
radioactivity	NULL
presumably	NULL
represents	NULL
steroid	NULL
that	NULL
dissociated	NULL
from	NULL
the	NULL
receptor	NULL
either	NULL
during	NULL
the	NULL
time	NULL
elapsed	NULL
between	NULL
the	NULL
charcoal	NULL
treatment	NULL
and	NULL
the	NULL
time	NULL
when	NULL
the	NULL
sample	NULL
was	NULL
layered	NULL
onto	NULL
the	NULL
gradients	NULL
(	NULL
~24	NULL
hr	NULL
)	NULL
or	NULL
during	NULL
the	NULL
early	NULL
hours	NULL
of	NULL
centrifugation	NULL
.	NULL

In	NULL
replicate	NULL
analyses	NULL
of	NULL
leuko-	NULL
SEPTEMBER	NULL
1984	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
cyte	NULL
receptors	NULL
on	NULL
gradients	NULL
prepared	NULL
in	NULL
this	NULL
buffer	NULL
,	NULL
the	NULL
recovery	NULL
of	NULL
PHJTA	NULL
was	NULL
87	NULL
+	NULL
12	NULL
%	NULL
(	NULL
n	NULL
=	NULL
40	NULL
)	NULL
.	NULL

The	NULL
linear	NULL
correlation	NULL
Of	NULL
S2ow	NULL
with	NULL
fraction	NULL
number	NULL
for	NULL
3	NULL
or	NULL
4	NULL
internal	NULL
standards	NULL
was	NULL
also	NULL
excellent	NULL
;	NULL
r*	NULL
was	NULL
0.997	NULL
+	NULL
0.003	NULL
(	NULL
n	NULL
=	NULL
36	NULL
)	NULL
in	NULL
gradients	NULL
prepared	NULL
in	NULL
this	NULL
buffer	NULL
(	NULL
TTE	NULL
+Mo	NULL
)	NULL
.	NULL

The	NULL
partially	NULL
purified	NULL
receptor	NULL
from	NULL
the	NULL
agarose	NULL
column	NULL
shown	NULL
in	NULL
Chart	NULL
1a	NULL
was	NULL
also	NULL
analyzed	NULL
by	NULL
chromatography	NULL
on	NULL
DEAE-cellulose	NULL
(	NULL
Chart	NULL
1c	NULL
)	NULL
.	NULL

The	NULL
fraction	NULL
of	NULL
the	NULL
recovered	NULL
radioactivity	NULL
that	NULL
was	NULL
eluted	NULL
in	NULL
the	NULL
wash	NULL
(	NULL
~40	NULL
%	NULL
)	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
detected	NULL
at	NULL
the	NULL
top	NULL
of	NULL
the	NULL
gradient	NULL
in	NULL
Chart	NULL
1b	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
protein-bound	NULL
radioactivity	NULL
in	NULL
this	NULL
peak	NULL
was	NULL
demonstrated	NULL
by	NULL
chroma-	NULL
pe	NULL
T	NULL
T	NULL
T	NULL
CT	NULL
T	NULL
tT	NULL
~~43	NULL
_	NULL
e	NULL
®	NULL
|	NULL
a	NULL
L2	NULL
b	NULL
Glycerol	NULL
a	NULL
Agarose	NULL
A-1.Sm	NULL
Gradient	NULL
150	NULL
|-	NULL
4	NULL
|-	NULL
4	NULL
7.5	NULL
Z	NULL
7.03	NULL
100	NULL
|-	NULL
é	NULL
-	NULL
|	NULL
-|	NULL
5.0	NULL
w-	NULL
7	NULL
=	NULL
4	NULL
e	NULL
A	NULL
a	NULL
$	NULL
C	NULL
so	NULL
}	NULL
Z	NULL
<	NULL
A	NULL
}	NULL
<	NULL
25	NULL
»	NULL
$	NULL
7	NULL
2	NULL
f	NULL
o	NULL
4	NULL
7	NULL
0	NULL
*	NULL
-|	NULL
o	NULL
Tor	NULL
cA	NULL
|	NULL
Co	NULL
B	NULL
Hb	NULL
CA	NULL
t	NULL
t	NULL
i	NULL
1	NULL
1	NULL
1	NULL
t	NULL
it	NULL
+	NULL
6	NULL
0	NULL
0.4	NULL
0.8	NULL
1.2	NULL
1	NULL
15	NULL
30	NULL
Top	NULL
Distribution	NULL
Coefficient	NULL
Fraction	NULL
Number	NULL
CT	NULL
~T	NULL
T	NULL
T	NULL
T	NULL
T	NULL
I	NULL
DEAE	NULL
-Celluiose	NULL
-|	NULL
is	NULL
-|	NULL
10	NULL
{	NULL
s	NULL
1	NULL
1	NULL
1	NULL
1°	NULL
0.2	NULL
-	NULL
o	NULL
0.4	NULL
1	NULL
0.1	NULL
(	NULL
a	NULL
)	NULL
(	NULL
a	NULL
)	NULL
24	NULL
[	NULL
BH	NULL
]	NULL
Triamcinolone	NULL
acetonide	NULL
C	NULL
J	NULL
_	NULL
L_	NULL
1	NULL
20	NULL
0	NULL
.3	NULL
Wash	NULL
Fraction	NULL
[	NULL
KCI	NULL
]	NULL
Gradient	NULL
Chart	NULL
1	NULL
.	NULL

Detection	NULL
of	NULL
a	NULL
single	NULL
,	NULL
large	NULL
glucocorticoid	NULL
receptor	NULL
form	NULL
in	NULL
cytosol	NULL
from	NULL
ALL	NULL
ceils	NULL
by	NULL
size-dependent	NULL
and/or	NULL
charge-dependent	NULL
fractionation	NULL
in	NULL
+Mo	NULL
buffers	NULL
.	NULL

Cytosol	NULL
was	NULL
prepared	NULL
in	NULL
TTES	NULL
+Mo	NULL
buffer	NULL
from	NULL
a	NULL
frozen	NULL
leukapheresis	NULL
specimen	NULL
and	NULL
incubated	NULL
with	NULL
43	NULL
nm	NULL
[	NULL
°HJTA	NULL
.	NULL

in	NULL
a	NULL
,	NULL
charcoal-treated	NULL
cytosol	NULL
(	NULL
2.6	NULL
mi	NULL
)	NULL
was	NULL
filtered	NULL
on	NULL
a	NULL
column	NULL
of	NULL
Agarose	NULL
A-1.5m	NULL
(	NULL
100	NULL
to	NULL
200	NULL
mesh	NULL
;	NULL
1.27	NULL
x	NULL
100	NULL
cm	NULL
)	NULL
in	NULL
TTEG	NULL
+Mo	NULL
buffer	NULL
,	NULL
with	NULL
ferritin	NULL
(	NULL
F	NULL
)	NULL
,	NULL
**C-methylated	NULL
thyroglobulin	NULL
(	NULL
T	NULL
)	NULL
and	NULL
carbonic	NULL
anhydrase	NULL
(	NULL
CA	NULL
)	NULL
as	NULL
internal	NULL
standards	NULL
.	NULL

Distribution	NULL
coefficients	NULL
and	NULL
Stokes	NULL
radii	NULL
(	NULL
Rs	NULL
)	NULL
were	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Fractions	NULL
with	NULL
elution	NULL
volumes	NULL
to	NULL
Az	NULL
of	NULL
8	NULL
to	NULL
9	NULL
nm	NULL
were	NULL
combined	NULL
for	NULL
further	NULL
analysis	NULL
(	NULL
@	NULL
.	NULL

in	NULL
b	NULL
,	NULL
aliquots	NULL
(	NULL
1	NULL
mi	NULL
)	NULL
of	NULL
the	NULL
receptor	NULL
pool	NULL
from	NULL
a	NULL
were	NULL
centrifuged	NULL
for	NULL
42	NULL
hr	NULL
at	NULL
148,000	NULL
x	NULL
g	NULL
through	NULL
12-mi	NULL
gradients	NULL
of	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
in	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
.	NULL

The	NULL
Szow	NULL
of	NULL
the	NULL
receptor	NULL
peak	NULL
at	NULL
Fraction	NULL
16	NULL
was	NULL
9.4	NULL
S	NULL
,	NULL
calculated	NULL
with	NULL
reference	NULL
to	NULL
the	NULL
internal	NULL
standards	NULL
:	NULL
catalase	NULL
(	NULL
Ca	NULL
)	NULL
;	NULL
hemoglobin	NULL
(	NULL
Hb	NULL
)	NULL
;	NULL
'*C-methylated	NULL
S-amylase	NULL
(	NULL
B	NULL
)	NULL
and	NULL
carbonic	NULL
anhydrase	NULL
(	NULL
CA	NULL
)	NULL
.	NULL

In	NULL
c	NULL
,	NULL
another	NULL
aliquot	NULL
(	NULL
2.3	NULL
m	NULL
!	NULL
)	NULL

of	NULL
the	NULL
pool	NULL
from	NULL
a	NULL
was	NULL
loaded	NULL
onto	NULL
a	NULL
DEAE-cellulose	NULL
column	NULL
(	NULL
1.5	NULL
x	NULL
6	NULL
cm	NULL
)	NULL
.	NULL

Free	NULL
steroid	NULL
was	NULL
eluted	NULL
during	NULL
the	NULL
wash	NULL
with	NULL
80	NULL
mi	NULL
of	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
.	NULL

The	NULL
receptor-bound	NULL
radioactivity	NULL
was	NULL
eluted	NULL
by	NULL
the	NULL
sait	NULL
gradient	NULL
and	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
molar	NULL
concentration	NULL
of	NULL
KCH	NULL
lsr—	NULL
h	NULL
I	NULL
3787	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

tography	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
receptor-bound	NULL
radioactivity	NULL
was	NULL
eluted	NULL
by	NULL
a	NULL
KCI	NULL
gradient	NULL
from	NULL
the	NULL
DEAE-cellulose	NULL
column	NULL
as	NULL
a	NULL
single	NULL
,	NULL
slightly	NULL
asymmetrical	NULL
peak	NULL
,	NULL
with	NULL
some	NULL
trailing	NULL
of	NULL
radioactivity	NULL
on	NULL
the	NULL
high-salt	NULL
side	NULL
.	NULL

The	NULL
KCI	NULL
concentration	NULL
corresponding	NULL
to	NULL
the	NULL
maximum	NULL
in	NULL
the	NULL
elution	NULL
profile	NULL
(	NULL
155	NULL
mm	NULL
)	NULL
was	NULL
close	NULL
to	NULL
that	NULL
determined	NULL
for	NULL
the	NULL
receptor	NULL
in	NULL
unfractionated	NULL
cytosol	NULL
from	NULL
fresh	NULL
ALL	NULL
cells	NULL
(	NULL
143	NULL
mm	NULL
,	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
was	NULL
within	NULL
the	NULL
range	NULL
previously	NULL
found	NULL
for	NULL
the	NULL
receptors	NULL
in	NULL
rat	NULL
liver	NULL
and	NULL
kidney	NULL
cytosols	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
the	NULL
data	NULL
in	NULL
Chart	NULL
1	NULL
and	NULL
studies	NULL
of	NULL
other	NULL
specimens	NULL
by	NULL
either	NULL
size-dependent	NULL
or	NULL
charge-dependent	NULL
techniques	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
single	NULL
large	NULL
form	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
most	NULL
ALL	NULL
cell	NULL
cytosols	NULL
that	NULL
were	NULL
analyzed	NULL
in	NULL
buffers	NULL
of	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
with	NULL
moderate	NULL
concentrations	NULL
of	NULL
sait	NULL
(	NULL
0	NULL
to	NULL
0.2	NULL
m	NULL
KCI	NULL
)	NULL
.	NULL

From	NULL
the	NULL
values	NULL
of	NULL
Ms	NULL
(	NULL
8.4	NULL
nm	NULL
)	NULL
and	NULL
S204	NULL
,	NULL
(	NULL
9.48	NULL
)	NULL
determined	NULL
in	NULL
this	NULL
experiment	NULL
,	NULL
a	NULL
molecular	NULL
weight	NULL
of	NULL
330,000	NULL
and	NULL
an	NULL
axial	NULL
ratio	NULL
of	NULL
13	NULL
(	NULL
for	NULL
a	NULL
prolate	NULL
ellipsoid	NULL
)	NULL
were	NULL
calculated	NULL
,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Our	NULL
accumulated	NULL
data	NULL
from	NULL
hydrodynamic	NULL
analyses	NULL
of	NULL
molybdate-stabilized	NULL
receptors	NULL
in	NULL
leukocyte	NULL
cytosols	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
2	NULL
.	NULL

The	NULL
Stokes	NULL
radii	NULL
of	NULL
the	NULL
oligomeric	NULL
receptor	NULL
forms	NULL
in	NULL
cytosols	NULL
from	NULL
fresh	NULL
or	NULL
frozen	NULL
leukemic	NULL
cell	NULL
specimens	NULL
varied	NULL
from	NULL
7.2	NULL
to	NULL
8.5	NULL
nm	NULL
.	NULL

These	NULL
values	NULL
are	NULL
within	NULL
the	NULL
range	NULL
of	NULL
results	NULL
reported	NULL
previously	NULL
for	NULL
As	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
from	NULL
2	NULL
healthy	NULL
tissues	NULL
of	NULL
the	NULL
rat	NULL
,	NULL
the	NULL
kidney	NULL
[	NULL
As	NULL
of	NULL
7.1	NULL
+	NULL
0.3	NULL
nm	NULL
(	NULL
n	NULL
=	NULL
21	NULL
)	NULL
]	NULL
and	NULL
the	NULL
liver	NULL
[	NULL
As	NULL
of	NULL
8.2	NULL
+	NULL
0.4	NULL
nm	NULL
(	NULL
n	NULL
=	NULL
12	NULL
)	NULL
]	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Table	NULL
2	NULL
revealed	NULL
no	NULL
consistent	NULL
difference	NULL
in	NULL
size	NULL
or	NULL
shape	NULL
between	NULL
the	NULL
molybdate-stabilized	NULL
receptors	NULL
in	NULL
cytosols	NULL
prepared	NULL
from	NULL
fresh	NULL
versus	NULL
frozen	NULL
ALL	NULL
or	NULL
CLL	NULL
cells	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
parameters	NULL
of	NULL
the	NULL
cytosolic	NULL
receptors	NULL
from	NULL
lymphoid	NULL
leukemias	NULL
resemble	NULL
those	NULL
of	NULL
the	NULL
receptors	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
.	NULL

In	NULL
comparison	NULL
with	NULL
the	NULL
receptors	NULL
from	NULL
fresh	NULL
or	NULL
frozen	NULL
lymphoid	NULL
leukemic	NULL
cells	NULL
,	NULL
which	NULL
had	NULL
axial	NULL
ratios	NULL
of	NULL
12	NULL
to	NULL
13	NULL
,	NULL
the	NULL
receptors	NULL
from	NULL
frozen	NULL
myeloid	NULL
leukemic	NULL
cells	NULL
appeared	NULL
to	NULL
be	NULL
somewhat	NULL
less	NULL
asymmetrical	NULL
,	NULL
having	NULL
axial	NULL
ratios	NULL
of	NULL
9	NULL
to	NULL
10	NULL
.	NULL

These	NULL
receptors	NULL
resemble	NULL
those	NULL
in	NULL
rat	NULL
kidney	NULL
cytosol	NULL
.	NULL

Only	NULL
a	NULL
few	NULL
myeloid	NULL
leukemic	NULL
samples	NULL
have	NULL
been	NULL
analyzed	NULL
to	NULL
date	NULL
,	NULL
since	NULL
most	NULL
of	NULL
our	NULL
specimens	NULL
were	NULL
from	NULL
children	NULL
,	NULL
in	NULL
whom	NULL
myeloid	NULL
leukemias	NULL
are	NULL
rare	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
preliminary	NULL
data	NULL
suggest	NULL
that	NULL
homogenates	NULL
and/or	NULL
cytosols	NULL
prepared	NULL
from	NULL
such	NULL
specimens	NULL
may	NULL
be	NULL
rich	NULL
in	NULL
receptor-cleaving	NULL
enzymes	NULL
,	NULL
as	NULL
found	NULL
in	NULL
previous	NULL
studies	NULL
of	NULL
the	NULL
rat	NULL
kidney	NULL
(	NULL
47	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Molybdate	NULL
on	NULL
the	NULL
Degradation	NULL
of	NULL
Receptors	NULL
prior	NULL
to	NULL
and	NULL
during	NULL
Fractionation	NULL
.	NULL

in	NULL
the	NULL
experiments	NULL
described	NULL
above	NULL
,	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
was	NULL
present	NULL
in	NULL
all	NULL
of	NULL
the	NULL
buffers	NULL
.	NULL

It	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
at	NULL
which	NULL
stage	NULL
(	NULL
s	NULL
)	NULL
in	NULL
the	NULL
procedure	NULL
the	NULL
presence	NULL
of	NULL
molybdate	NULL
was	NULL
actually	NULL
required	NULL
,	NULL
/	NULL
.	NULL

e.	NULL
,	NULL
during	NULL
homogenization	NULL
of	NULL
the	NULL
cells	NULL
,	NULL
the	NULL
preparation	NULL
and	NULL
labeling	NULL
of	NULL
cytosol	NULL
,	NULL
and/or	NULL
the	NULL
physicochemical	NULL
analyses	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
cytosols	NULL
from	NULL
frozen	NULL
rat	NULL
liver	NULL
revealed	NULL
the	NULL
stabilizing	NULL
effect	NULL
of	NULL
molybdate	NULL
on	NULL
the	NULL
large	NULL
receptor	NULL
form	NULL
during	NULL
agarose	NULL
filtration	NULL
,	NULL
but	NULL
little	NULL
effect	NULL
of	NULL
molybdate	NULL
during	NULL
the	NULL
extraction	NULL
and	NULL
labeling	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
analogous	NULL
experiments	NULL
on	NULL
the	NULL
receptor	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
were	NULL
qualitatively	NULL
similar	NULL
.	NULL

in	NULL
this	NULL
case	NULL
,	NULL
however	NULL
,	NULL
there	NULL
was	NULL
less	NULL
extensive	NULL
degradation	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
molybdate	NULL
than	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
rat	NULL
liver	NULL
receptor	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Chart	NULL
2a	NULL
,	NULL
the	NULL
bound	NULL
steroid	NULL
in	NULL
leukemic	NULL
cell	NULL
cytosol	NULL
was	NULL
eluted	NULL
as	NULL
a	NULL
broad	NULL
peak	NULL
from	NULL
the	NULL
control	NULL
columns	NULL
,	NULL
which	NULL
contained	NULL
50	NULL
mm	NULL
KCI	NULL
,	NULL
regardless	NULL
of	NULL
whether	NULL
the	NULL
homogenate	NULL
contained	NULL
30	NULL
mm	NULL
KCI	NULL
or	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
.	NULL

Only	NULL
a	NULL
small	NULL
increase	NULL
in	NULL
the	NULL
apparent	NULL
proportion	NULL
of	NULL
the	NULL
larger	NULL
components	NULL
within	NULL
the	NULL
mixture	NULL
was	NULL
observed	NULL
when	NULL
molybdate	NULL
was	NULL
present	NULL
prior	NULL
to	NULL
gel	NULL
filtration	NULL
.	NULL

The	NULL
width	NULL
of	NULL
each	NULL
distribution	NULL
was	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
range	NULL
of	NULL
values	NULL
of	NULL
Rs	NULL
was	NULL
5.6	NULL
to	NULL
9.5	NULL
nm	NULL
for	NULL
both	NULL
samples	NULL
.	NULL

Despite	NULL
the	NULL
use	NULL
of	NULL
frozen	NULL
cells	NULL
for	NULL
this	NULL
experiment	NULL
,	NULL
only	NULL
8	NULL
%	NULL
of	NULL
the	NULL
labeled	NULL
complexes	NULL
had	NULL
Rs	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
(	NULL
compare	NULL
Charts	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
heterogeneity	NULL
of	NULL
receptor	NULL
forms	NULL
seen	NULL
in	NULL
Chart	NULL
2a	NULL
may	NULL
be	NULL
due	NULL
to	NULL
limited	NULL
proteolysis	NULL
and/or	NULL
the	NULL
dissociation	NULL
of	NULL
the	NULL
oligomeric	NULL
complex	NULL
into	NULL
subunits	NULL
.	NULL

The	NULL
occurrence	NULL
of	NULL
both	NULL
processes	NULL
is	NULL
suggested	NULL
by	NULL
the	NULL
results	NULL
of	NULL
gel	NULL
filtration	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
see	NULL
Charts	NULL
7	NULL
to	NULL
9	NULL
and	NULL
Table	NULL
2	NULL
Parameters	NULL
of	NULL
the	NULL
major	NULL
molybdate-stabilized	NULL
receptor	NULL
form	NULL
in	NULL
cytosols	NULL
prepared	NULL
from	NULL
fresh	NULL
or	NULL
frozen	NULL
leukocytes	NULL
Cytosols	NULL
were	NULL
prepared	NULL
from	NULL
the	NULL
indicated	NULL
number	NULL
of	NULL
specimens	NULL
that	NULL
were	NULL
either	NULL
fresh	NULL
or	NULL
had	NULL
been	NULL
frozen	NULL
at	NULL
-85°	NULL
for	NULL
up	NULL
to	NULL
1	NULL
year	NULL
.	NULL

Stokes	NULL
radii	NULL
were	NULL
determined	NULL
as	NULL
in	NULL
Chart	NULL
ta	NULL
,	NULL
and	NULL
sedimentation	NULL
coefficients	NULL
were	NULL
evaluated	NULL
by	NULL
centrifugation	NULL
gradients	NULL
of	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
in	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
.	NULL

Molecular	NULL
through	NULL
weights	NULL
and	NULL
axial	NULL
ratios	NULL
were	NULL
calculated	NULL
from	NULL
As	NULL
and	NULL
S25	NULL
.	NULL

,	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

''	NULL
No	NULL
.	NULL

of	NULL
speci	NULL
Cells	NULL
M	NULL
,	NULL
X	NULL
Specimen	NULL
mens	NULL
frozen	NULL
As	NULL
{	NULL
nm	NULL
)	NULL
Szow	NULL
(	NULL
S	NULL
)	NULL
10°	NULL
_	NULL
ab	NULL
ALL	NULL
11	NULL
C	NULL
8s0+05°	NULL
(	NULL
10°	NULL
-	NULL
95+0.3	NULL
(	NULL
8	NULL
)	NULL
320	NULL
-	NULL
12	NULL
9	NULL
+	NULL
8.3102	NULL
(	NULL
9	NULL
)	NULL
9.6	NULL
+	NULL
0.2	NULL
(	NULL
13	NULL
)	NULL
340	NULL
12	NULL
CLL	NULL
2	NULL
-	NULL
8.5	NULL
£	NULL
0.1	NULL
(	NULL
4	NULL
)	NULL
1	NULL
+	NULL
8.4+0.3	NULL
(	NULL
6	NULL
)	NULL
94102	NULL
(	NULL
2	NULL
)	NULL
330	NULL
13	NULL
ANLL	NULL
3	NULL
-	NULL
8.3	NULL
(	NULL
1	NULL
)	NULL
93+0.1	NULL
(	NULL
3	NULL
)	NULL
330	NULL
13	NULL
3	NULL
+	NULL
76104	NULL
(	NULL
2	NULL
)	NULL
98	NULL
£102	NULL
(	NULL
2	NULL
)	NULL
320	NULL
10	NULL
CML	NULL
2	NULL
-	NULL
8.0106	NULL
(	NULL
2	NULL
)	NULL
2	NULL
+	NULL
72	NULL
%	NULL
04	NULL
(	NULL
5	NULL
)	NULL
9.6+02	NULL
(	NULL
5	NULL
)	NULL
290	NULL
9	NULL
Cell	NULL
lines	NULL
HL-60	NULL
+	NULL
85101	NULL
(	NULL
2	NULL
)	NULL
KG-1	NULL
+	NULL
7.9	NULL
(	NULL
2	NULL
)	NULL
Combined	NULL
data	NULL
:	NULL
leukemic	NULL
-	NULL
8.2	NULL
+05	NULL
(	NULL
17	NULL
)	NULL
9.5	NULL
+	NULL
0.3	NULL
(	NULL
11	NULL
)	NULL
330	NULL
12	NULL
cells	NULL
+	NULL
8.0	NULL
+05	NULL
(	NULL
26	NULL
)	NULL
9.6	NULL
+	NULL
0.2	NULL
(	NULL
22	NULL
)	NULL
320	NULL
12	NULL
Normal	NULL
lymphocytes	NULL
1	NULL
-	NULL
9.4	NULL
(	NULL
1	NULL
)	NULL
6	NULL
+	NULL
79	NULL
%	NULL
#	NULL
04	NULL
(	NULL
7	NULL
)	NULL
92+02	NULL
(	NULL
6	NULL
)	NULL
310	NULL
12	NULL
Combined	NULL
data	NULL
:	NULL
leukemic	NULL
-	NULL
8.2+0.5	NULL
(	NULL
17	NULL
)	NULL
9.5	NULL
£	NULL
0.3	NULL
(	NULL
12	NULL
)	NULL
330	NULL
12	NULL
and	NULL
normal	NULL
cells	NULL
+	NULL
8.0£0.5	NULL
(	NULL
33	NULL
)	NULL
9.5	NULL
+	NULL
0.3	NULL
(	NULL
28	NULL
)	NULL
320	NULL
12	NULL
#	NULL
8.1	NULL
£	NULL
0.5	NULL
(	NULL
50	NULL
)	NULL
9.5	NULL
+	NULL
0.3	NULL
(	NULL
40	NULL
)	NULL
330	NULL
12	NULL
``	NULL
Some	NULL
of	NULL
these	NULL
data	NULL
have	NULL
been	NULL
published	NULL
previously	NULL
in	NULL
conference	NULL
proceedings	NULL
(	NULL
36	NULL
,	NULL
46	NULL
,	NULL
52	NULL
)	NULL
.	NULL

®	NULL
-	NULL
,	NULL
fresh	NULL
;	NULL
+	NULL
,	NULL
frozen	NULL
at	NULL
-85°	NULL
for	NULL
up	NULL
to	NULL
1	NULL
year	NULL
.	NULL

©	NULL
Mean	NULL
+	NULL
S.D	NULL
.	NULL

``	NULL
Numbers	NULL
in	NULL
parentheses	NULL
,	NULL
number	NULL
of	NULL
determinations	NULL
.	NULL

3788	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
Control	NULL
Column	NULL
(	NULL
o	NULL
a	NULL
)	NULL
10~	NULL
>	NULL
x	NULL
dpm	NULL
/	NULL
fraction	NULL
0	NULL
Naz	NULL
MoO4	NULL
--	NULL
in	NULL
Column	NULL
(	NULL
0	NULL
e	NULL
)	NULL
[	NULL
°H	NULL
]	NULL
Triamcinolone	NULL
acetonide	NULL
0	NULL
0.3	NULL
0.6	NULL
0.9	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
2.	NULL
a	NULL
,	NULL
degradation	NULL
and/or	NULL
dissociation	NULL
of	NULL
the	NULL
receptor	NULL
into	NULL
subunits	NULL
during	NULL
ge	NULL
!	NULL

filtration	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
molybdate	NULL
;	NULL
b	NULL
,	NULL
stabilization	NULL
of	NULL
a	NULL
single	NULL
,	NULL
large	NULL
complex	NULL
in	NULL
its	NULL
presence	NULL
.	NULL

Frozen	NULL
cells	NULL
from	NULL
a	NULL
16-year-old	NULL
patient	NULL
with	NULL
ALL	NULL
were	NULL
used	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
cytosol	NULL
in	NULL
TTES	NULL
buffer	NULL
containing	NULL
30	NULL
mm	NULL
KCI	NULL
(	NULL
O	NULL
,	NULL
C	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
NazMoO	NULL
,	NULL
(	NULL
@	NULL
,	NULL
EF	NULL
)	NULL
.	NULL

Following	NULL
incubation	NULL
with	NULL
38	NULL
nm	NULL
2.4-mi	NULL
aliquots	NULL
were	NULL
chromatographed	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
in	NULL
TTE	NULL
buffer	NULL
containing	NULL
the	NULL
same	NULL
sait	NULL
as	NULL
the	NULL
cytosol	NULL
,	NULL
and	NULL
fractions	NULL
containing	NULL
the	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
were	NULL
combined	NULL
.	NULL

Aliquots	NULL
(	NULL
1	NULL
m	NULL
)	NULL
of	NULL
each	NULL
preparation	NULL
were	NULL
filtered	NULL
on	NULL
agarose	NULL
columns	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
KCI	NULL
(	NULL
a	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
NazMoO	NULL
,	NULL
(	NULL
b	NULL
)	NULL
.	NULL

The	NULL
internal	NULL
standards	NULL
were	NULL
ferritin	NULL
(	NULL
F	NULL
)	NULL
,	NULL
myoglobin	NULL
(	NULL
M	NULL
)	NULL
,	NULL
'*C-methylated	NULL
thyroglobulin	NULL
(	NULL
7	NULL
)	NULL
and	NULL
either	NULL
serum	NULL
albumin	NULL
(	NULL
S	NULL
)	NULL
or	NULL
carbonic	NULL
anhydrase	NULL
(	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
indicated	NULL
As	NULL
values	NULL
were	NULL
calculated	NULL
at	NULL
two-thirds	NULL
of	NULL
the	NULL
receptor	NULL
peak	NULL
height	NULL
.	NULL

SEPTEMBER	NULL
1984	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

The	NULL
bound	NULL
steroid	NULL
was	NULL
eluted	NULL
as	NULL
much	NULL
narrower	NULL
,	NULL
more	NULL
symmetrical	NULL
peaks	NULL
from	NULL
columns	NULL
containing	NULL
20	NULL
mm	NULL
NaMoO	NULL
,	NULL
(	NULL
Chart	NULL
2b	NULL
)	NULL
.	NULL

The	NULL
peaks	NULL
were	NULL
characterized	NULL
by	NULL
As	NULL
of	NULL
~8.4	NULL
nm	NULL
,	NULL
and	NULL
the	NULL
range	NULL
of	NULL
ARs	NULL
was	NULL
only	NULL
7.3	NULL
to	NULL
9.6	NULL
nm	NULL
.	NULL

Virtually	NULL
identical	NULL
pattems	NULL
were	NULL
obtained	NULL
whether	NULL
the	NULL
cells	NULL
were	NULL
homogenized	NULL
in	NULL
-Mo	NULL
or	NULL
+Mo	NULL
buffer	NULL
.	NULL

These	NULL
results	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
limited	NULL
proteolysis	NULL
of	NULL
the	NULL
receptors	NULL
had	NULL
occurred	NULL
and	NULL
that	NULL
the	NULL
apparent	NULL
integrity	NULL
of	NULL
the	NULL
large	NULL
complex	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
due	NULL
to	NULL
noncovalent	NULL
interactions	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
mechanism	NULL
of	NULL
stabilization	NULL
by	NULL
molybdate	NULL
,	NULL
the	NULL
inclusion	NULL
of	NULL
NazMOoO	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
20	NULL
mm	NULL
in	NULL
the	NULL
gel	NULL
filtration	NULL
buffer	NULL
clearly	NULL
increases	NULL
the	NULL
recovery	NULL
and	NULL
facilitates	NULL
the	NULL
characterization	NULL
of	NULL
the	NULL
large	NULL
receptor	NULL
form	NULL
.	NULL

Stabilization	NULL
by	NULL
Molybdate	NULL
of	NULL
Receptors	NULL
from	NULL
Normal	NULL
Lym-phocytes	NULL
,	NULL
CLL	NULL
Cells	NULL
,	NULL
and	NULL
Leukemic	NULL
Cell	NULL
Lines	NULL
.	NULL

The	NULL
agarose	NULL
filtration	NULL
patterns	NULL
obtained	NULL
after	NULL
continuous	NULL
exposure	NULL
to	NULL
either	NULL
-Mo	NULL
or	NULL
+Mo	NULL
buffers	NULL
are	NULL
shown	NULL
for	NULL
receptors	NULL
extracted	NULL
from	NULL
fresh	NULL
CLL	NULL
cells	NULL
and	NULL
frozen	NULL
normal	NULL
lymphocytes	NULL
in	NULL
Charts	NULL
3	NULL
and	NULL
4	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
discussing	NULL
these	NULL
and	NULL
other	NULL
gel	NULL
filtration	NULL
pat-tems	NULL
,	NULL
we	NULL
have	NULL
considered	NULL
labeled	NULL
complexes	NULL
to	NULL
be	NULL
receptor	NULL
fragments	NULL
if	NULL
their	NULL
apparent	NULL
ARs	NULL
;	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
.	NULL

This	NULL
criterion	NULL
was	NULL
based	NULL
on	NULL
our	NULL
determination	NULL
that	NULL
the	NULL
intact	NULL
steroid-binding	NULL
subunit	NULL
of	NULL
the	NULL
receptor	NULL
has	NULL
As	NULL
of	NULL
~6	NULL
nm	NULL
(	NULL
see	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
T	NULL
T	NULL
T	NULL
1	NULL
[	NULL
w	NULL
2	NULL
B8	NULL
|-	NULL
_	NULL
]	NULL
C	NULL
9	NULL
CX	NULL
E	NULL
a	NULL
O	NULL
x	NULL
-	NULL
6	NULL
|-	NULL
itd	NULL
o	NULL
c	NULL
8	NULL
4	NULL
|-	NULL
_	NULL
S	NULL
&	NULL
Control	NULL
O	NULL
b	NULL
oJ	NULL
€	NULL
@	NULL
5	NULL
3	NULL
21	NULL
.E	NULL
6	NULL
]	NULL
E	NULL
.0	NULL
l	NULL
:	NULL
0	NULL
-	NULL
|	NULL
*	NULL
o	NULL
Cal	NULL
T	NULL
5	NULL
M	NULL
_	NULL
It	NULL
N	NULL
11°	NULL
_	NULL
1	NULL
#	NULL
_i	NULL
L	NULL
O	NULL
0.3	NULL
0.6	NULL
0.9	NULL
1.2	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
3	NULL
.	NULL

Stabilization	NULL
by	NULL
molybdate	NULL
of	NULL
the	NULL
large	NULL
receptor	NULL
form	NULL
in	NULL
cytosol	NULL
from	NULL
CLL	NULL
cells	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
from	NULL
fresh	NULL
cells	NULL
in	NULL
TTE	NULL
buffer	NULL
containing	NULL
30	NULL
mm	NULL
KCI	NULL
(	NULL
0	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
NasMOoO	NULL
,	NULL
(	NULL
@	NULL
)	NULL
and	NULL
were	NULL
adjusted	NULL
to	NULL
isotonicity	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
1	NULL
m	NULL
sucrose	NULL
.	NULL

PHJTA	NULL
and	NULL
ovalbumin	NULL
were	NULL
added	NULL
to	NULL
final	NULL
concentrations	NULL
of	NULL
50	NULL
nm	NULL
and	NULL
4	NULL
mg/ml	NULL
,	NULL
respectively	NULL
.	NULL

After	NULL
incubation	NULL
for	NULL
90	NULL
min	NULL
,	NULL
free	NULL
steroid	NULL
was	NULL
removed	NULL
by	NULL
chromatography	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
,	NULL
as	NULL
in	NULL
Chart	NULL
2	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
each	NULL
sample	NULL
(	NULL
0.8	NULL
mi	NULL
)	NULL
was	NULL
chromatographed	NULL
on	NULL
an	NULL
agarose	NULL
column	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
50	NULL
mm	NULL
KCI	NULL
(	NULL
0	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
NazMoO	NULL
.	NULL

(	NULL
®	NULL
)	NULL
,	NULL
with	NULL
myoglobin	NULL
(	NULL
M	NULL
)	NULL
,	NULL
``	NULL
*	NULL
ited	NULL
serum	NULL
albumin	NULL
(	NULL
S	NULL
)	NULL
and	NULL
thyroglobulin	NULL
(	NULL
T	NULL
)	NULL
as	NULL
internal	NULL
standards	NULL
.	NULL

in	NULL
+Mo	NULL
buffer	NULL
,	NULL
the	NULL
R	NULL
&	NULL
of	NULL
the	NULL
receptor	NULL
was	NULL
8.5	NULL
nm	NULL
.	NULL

In	NULL
-Mo	NULL
buffer	NULL
,	NULL
the	NULL
As	NULL
of	NULL
the	NULL
mixture	NULL
of	NULL
complexes	NULL
was	NULL
4.2	NULL
to	NULL
7.7	NULL
nm	NULL
,	NULL
measured	NULL
at	NULL
two-thirds	NULL
of	NULL
the	NULL
peak	NULL
height	NULL
,	NULL
and	NULL
in	NULL
~20	NULL
%	NULL
of	NULL
the	NULL
complexes	NULL
the	NULL
As	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
(	NULL
--	NULL
--	NULL
)	NULL
.	NULL

3789	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

of	NULL
diffusion	NULL
,	NULL
the	NULL
elution	NULL
profile	NULL
of	NULL
a	NULL
6-nm	NULL
protein	NULL
includes	NULL
detectable	NULL
concentrations	NULL
of	NULL
protein	NULL
in	NULL
fractions	NULL
corresponding	NULL
to	NULL
ARs	NULL
of	NULL
4	NULL
to	NULL
8	NULL
nm	NULL
,	NULL
under	NULL
our	NULL
chromatographic	NULL
conditions	NULL
(	NULL
see	NULL
Chart	NULL
7	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
proportion	NULL
of	NULL
steroid	NULL
bound	NULL
to	NULL
complexes	NULL
with	NULL
ARs	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
provides	NULL
a	NULL
conservative	NULL
estimate	NULL
of	NULL
the	NULL
proportion	NULL
of	NULL
receptor	NULL
fragments	NULL
.	NULL

The	NULL
elution	NULL
pattern	NULL
of	NULL
the	NULL
molybdate-stabilized	NULL
CLL	NULL
cell	NULL
receptor	NULL
(	NULL
Chart	NULL
3	NULL
)	NULL
was	NULL
indistinguishable	NULL
from	NULL
those	NULL
shown	NULL
in	NULL
Charts	NULL
1a	NULL
and	NULL
2b	NULL
for	NULL
ALL	NULL
cell	NULL
receptors	NULL
.	NULL

There	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
degradation	NULL
or	NULL
subunit	NULL
dissociation	NULL
of	NULL
the	NULL
large	NULL
complex	NULL
,	NULL
which	NULL
had	NULL
A	NULL
;	NULL
of	NULL
8.5	NULL
nm	NULL
.	NULL

The	NULL
pattern	NULL
obtained	NULL
in	NULL
-Mo	NULL
buffer	NULL
included	NULL
a	NULL
somewhat	NULL
higher	NULL
proportion	NULL
(	NULL
~20	NULL
%	NULL
)	NULL
of	NULL
complexes	NULL
with	NULL
ARs	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
than	NULL
the	NULL
analogous	NULL
patterns	NULL
for	NULL
ALL	NULL
cell	NULL
receptors	NULL
(	NULL
Chart	NULL
2a	NULL
)	NULL
.	NULL

The	NULL
fragments	NULL
detected	NULL
in	NULL
CLL	NULL
cell	NULL
cytosol	NULL
,	NULL
however	NULL
,	NULL
were	NULL
not	NULL
so	NULL
small	NULL
as	NULL
the	NULL
mero-receptor	NULL
(	NULL
Ms	NULL
of	NULL
2.3	NULL
nm	NULL
;	NULL
see	NULL
Charts	NULL
5	NULL
and	NULL
6	NULL
and	NULL
the	NULL
discussion	NULL
below	NULL
)	NULL
.	NULL

The	NULL
elution	NULL
profiles	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
cytosols	NULL
from	NULL
frozen	NULL
normal	NULL
lymphocytes	NULL
(	NULL
Chart	NULL
4	NULL
)	NULL
differed	NULL
in	NULL
a	NULL
few	NULL
respects	NULL
from	NULL
the	NULL
preceding	NULL
results	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
labeled	NULL
complexes	NULL
with	NULL
Ag	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
in	NULL
the	NULL
control	NULL
buffer	NULL
(	NULL
~25	NULL
%	NULL
)	NULL
was	NULL
slightly	NULL
higher	NULL
than	NULL
in	NULL
+Mo	NULL
buffer	NULL
(	NULL
~17	NULL
%	NULL
)	NULL
,	NULL
but	NULL
there	NULL
was	NULL
clear	NULL
evidence	NULL
of	NULL
receptor	NULL
cleavage	NULL
under	NULL
both	NULL
conditions	NULL
.	NULL

The	NULL
As	NULL
value	NULL
of	NULL
the	NULL
largest	NULL
complex	NULL
detected	NULL
in	NULL
+Mo	NULL
buffer	NULL
(	NULL
7.3	NULL
nm	NULL
)	NULL
was	NULL
smaller	NULL
than	NULL
those	NULL
calculated	NULL
from	NULL
the	NULL
data	NULL
in	NULL
Charts	NULL
1a	NULL
,	NULL
2b	NULL
,	NULL
and	NULL
3	NULL
.	NULL

It	NULL
was	NULL
also	NULL
the	NULL
smallest	NULL
of	NULL
those	NULL
obtained	NULL
in	NULL
7	NULL
analyses	NULL
of	NULL
cytosols	NULL
from	NULL
frozen	NULL
normal	NULL
specimens	NULL
,	NULL
in	NULL
which	NULL
As	NULL
varied	NULL
from	NULL
7.3	NULL
to	NULL
8.5	NULL
nm	NULL
.	NULL

The	NULL
proportion	NULL
of	NULL
labeled	NULL
complexes	NULL
with	NULL
Rs	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
also	NULL
varied	NULL
considerably	NULL
among	NULL
these	NULL
preparations	NULL
,	NULL
from	NULL
6	NULL
to	NULL
24	NULL
%	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
significant	NULL
and	NULL
variable	NULL
cleavage	NULL
of	NULL
the	NULL
receptors	NULL
can	NULL
be	NULL
observed	NULL
in	NULL
cytosols	NULL
from	NULL
normal	NULL
cells	NULL
,	NULL
as	NULL
well	NULL
as	NULL
leukemic	NULL
cells	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
despite	NULL
the	NULL
continuous	NULL
presence	NULL
of	NULL
molybdate	NULL
.	NULL

These	NULL
normal	NULL
cell	NULL
preparations	NULL
,	NULL
however	NULL
,	NULL
were	NULL
purified	NULL
only	NULL
by	NULL
centrifugation	NULL
over	NULL
Ficoll-Metrizoate	NULL
.	NULL

Thus	NULL
,	NULL
contamination	NULL
of	NULL
the	NULL
lymphocytes	NULL
to	NULL
different	NULL
degrees	NULL
by	NULL
cells	NULL
richer	NULL
in	NULL
proteases	NULL
may	NULL
account	NULL
for	NULL
the	NULL
variable	NULL
extent	NULL
of	NULL
receptor	NULL
cleavage	NULL
observed	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
receptor	NULL
metabolism	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
evaluation	NULL
of	NULL
rates	NULL
of	NULL
receptor	NULL
synthesis	NULL
and	NULL
degradation	NULL
,	NULL
are	NULL
facilitated	NULL
by	NULL
the	NULL
use	NULL
of	NULL
established	NULL
cell	NULL
lines	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
of	NULL
interest	NULL
to	NULL
analyze	NULL
the	NULL
structures	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
leukemic	NULL
cell	NULL
lines	NULL
that	NULL
had	NULL
been	NULL
maintained	NULL
in	NULL
culture	NULL
for	NULL
several	NULL
years	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
in	NULL
T	NULL
TES	NULL
+Mo	NULL
buffer	NULL
from	NULL
frozen	NULL
cells	NULL
from	NULL
2	NULL
lines	NULL
of	NULL
nonlymphocytic	NULL
leukemia	NULL
,	NULL
KG-1	NULL
(	NULL
24	NULL
)	NULL
and	NULL
HL-60	NULL
(	NULL
8	NULL
)	NULL
.	NULL

We	NULL
found	NULL
the	NULL
concentrations	NULL
of	NULL
glucoceorticoid-binding	NULL
sites	NULL
in	NULL
these	NULL
cytosols	NULL
to	NULL
be	NULL
<	NULL
100	NULL
fmol/mg	NULL
protein	NULL
.	NULL

These	NULL
values	NULL
are	NULL
within	NULL
the	NULL
range	NULL
of	NULL
the	NULL
receptor	NULL
concentrations	NULL
in	NULL
cytosols	NULL
from	NULL
most	NULL
normal	NULL
lymphocyte	NULL
preparations	NULL
but	NULL
are	NULL
lower	NULL
than	NULL
those	NULL
in	NULL
cytosols	NULL
from	NULL
most	NULL
leukemic	NULL
cell	NULL
specimens	NULL
(	NULL
see	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

Despite	NULL
their	NULL
low	NULL
concentration	NULL
,	NULL
the	NULL
molybdate-stabilized	NULL
receptors	NULL
from	NULL
the	NULL
cultured	NULL
cells	NULL
were	NULL
indistinguishable	NULL
in	NULL
structure	NULL
from	NULL
those	NULL
obtained	NULL
from	NULL
the	NULL
clinical	NULL
specimens	NULL
.	NULL

The	NULL
As	NULL
values	NULL
of	NULL
the	NULL
major	NULL
receptor	NULL
forms	NULL
in	NULL
KG-1	NULL
and	NULL
HL-60	NULL
cells	NULL
were	NULL
7.9	NULL
and	NULL
8.5	NULL
nm	NULL
,	NULL
respectively	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

in	NULL
comparison	NULL
with	NULL
the	NULL
patterns	NULL
shown	NULL
for	NULL
the	NULL
receptor	NULL
from	NULL
frozen	NULL
normal	NULL
lymphocytes	NULL
(	NULL
Chart	NULL
4	NULL
)	NULL
,	NULL
there	NULL
was	NULL
little	NULL
fragmentation	NULL
of	NULL
these	NULL
receptors	NULL
.	NULL

At	NULL
most	NULL
,	NULL
10	NULL
%	NULL
of	NULL
the	NULL
bound	NULL
steroid	NULL
had	NULL
As	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
in	NULL
cytosol	NULL
from	NULL
either	NULL
cell	NULL
line	NULL
.	NULL

Mero-receptor	NULL
Formation	NULL
in	NULL
Cytosols	NULL
from	NULL
Myeloid	NULL
Leuke-mias	NULL
;	NULL
Effects	NULL
of	NULL
Rapidly	NULL
Freezing	NULL
the	NULL
Cells	NULL
.	NULL

in	NULL
previous	NULL
studies	NULL
of	NULL
receptors	NULL
for	NULL
3	NULL
classes	NULL
of	NULL
steroids	NULL
in	NULL
cytosols	NULL
from	NULL
other	NULL
types	NULL
of	NULL
human	NULL
specimens	NULL
and	NULL
several	NULL
rodent	NULL
tissues	NULL
,	NULL
we	NULL
have	NULL
3790	NULL
10°	NULL
``	NULL
x	NULL
dpm	NULL
[	NULL
3H	NULL
]	NULL
Triamcinolone	NULL
acetonide	NULL
j	NULL
_v	NULL
t	NULL
L	NULL
t_	NULL
__|	NULL
0	NULL
0.3	NULL
0.6	NULL
0.9	NULL
1.2	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
4	NULL
.	NULL

Inhibition	NULL
by	NULL
molybdate	NULL
of	NULL
the	NULL
dissociation	NULL
and	NULL
fragmentation	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
normal	NULL
lymphocyte	NULL
cytosol	NULL
.	NULL

Frozen	NULL
lymphocytes	NULL
from	NULL
a	NULL
healthy	NULL
donor	NULL
were	NULL
used	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
cytosols	NULL
in	NULL
TTES	NULL
buffer	NULL
containing	NULL
30	NULL
mm	NULL
KCI	NULL
(	NULL
0	NULL
)	NULL
or	NULL
20	NULL
mm	NULL
NaMoQ	NULL
,	NULL
(	NULL
@	NULL
)	NULL
.	NULL

The	NULL
cytosols	NULL
were	NULL
labeled	NULL
with	NULL
47	NULL
nm	NULL
[	NULL
PH	NULL
]	NULL
JTA	NULL
and	NULL
chromatographed	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
columns	NULL
,	NULL
as	NULL
in	NULL
Chart	NULL
2	NULL
.	NULL

An	NULL
aliquot	NULL
(	NULL
1.1	NULL
mi	NULL
)	NULL
of	NULL
each	NULL
was	NULL
filtered	NULL
on	NULL
an	NULL
agarose	NULL
column	NULL
in	NULL
T	NULL
TEG	NULL
buffer	NULL
containing	NULL
50mmKCl	NULL
(	NULL
O	NULL
)	NULL
or20mMNa¢MoO	NULL
(	NULL
@	NULL
)	NULL
,	NULL
with	NULL
ferritin	NULL
(	NULL
F	NULL
)	NULL
,	NULL
myogioban	NULL
)	NULL
.	NULL

``	NULL
C-methylated	NULL
thyroglobulin	NULL
(	NULL
T	NULL
)	NULL
and	NULL
serum	NULL
albumin	NULL
(	NULL
S	NULL
)	NULL
as	NULL
internal	NULL
standards	NULL
.	NULL

The	NULL
As	NULL
values	NULL
of	NULL
the	NULL
major	NULL
and	NULL
minor	NULL
receptor	NULL
forms	NULL
detectedh+Mobufferwem73m	NULL
2.4	NULL
nm	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
As	NULL
of	NULL
the	NULL
fragment	NULL
detected	NULL
in	NULL
-Mo	NULL
buffer	NULL
was	NULL
2.4	NULL
nm	NULL
,	NULL
and	NULL
that	NULL
of	NULL
the	NULL
mixture	NULL
of	NULL
larger	NULL
forms	NULL
was	NULL
4.2	NULL
to	NULL
8.2	NULL
nm	NULL
,	NULL
measured	NULL
at	NULL
two-thirds	NULL
of	NULL
the	NULL
peak	NULL
height	NULL
.	NULL

For	NULL
approximately	NULL
17	NULL
%	NULL
(	NULL
@	NULL
)	NULL
and	NULL
25	NULL
%	NULL
(	NULL
C	NULL
)	NULL
of	NULL
the	NULL
labeled	NULL
complexes	NULL
,	NULL
R	NULL
&	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
(	NULL
-~-~-	NULL
)	NULL
.	NULL

observed	NULL
wide	NULL
variations	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
receptor	NULL
degradation	NULL
(	NULL
45	NULL
,	NULL
48	NULL
,	NULL
50-52	NULL
)	NULL
.	NULL

Correlated	NULL
studies	NULL
of	NULL
receptor	NULL
structure	NULL
and	NULL
the	NULL
activities	NULL
of	NULL
several	NULL
endopeptidases	NULL
in	NULL
cytosols	NULL
prepared	NULL
from	NULL
fresh	NULL
and	NULL
frozen	NULL
rat	NULL
liver	NULL
and	NULL
kidney	NULL
were	NULL
reported	NULL
recently	NULL
(	NULL
47	NULL
)	NULL
.	NULL

The	NULL
results	NULL
were	NULL
consistent	NULL
with	NULL
a	NULL
relationship	NULL
between	NULL
the	NULL
extent	NULL
of	NULL
receptor	NULL
degradation	NULL
in	NULL
these	NULL
cytosols	NULL
and	NULL
the	NULL
activity	NULL
of	NULL
``	NULL
lysine-specific	NULL
'	NULL
endopeptidase	NULL
(	NULL
s	NULL
)	NULL
,	NULL
detected	NULL
fluorometricaily	NULL
with	NULL
t-butyloxycarbonyl-valyl-leucyl-lysyt-AMC	NULL
(	NULL
47	NULL
)	NULL
.	NULL

A	NULL
partially	NULL
purified	NULL
``	NULL
lysine-specific	NULL
'	NULL
endopeptidase	NULL
from	NULL
rat	NULL
kidney	NULL
cytosol	NULL
was	NULL
subsequently	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
converting	NULL
the	NULL
molybdate-stabilized	NULL
receptor	NULL
in	NULL
human	NULL
CLL	NULL
cell	NULL
cytosol	NULL
into	NULL
the	NULL
mero-receptor	NULL
,	NULL
the	NULL
smallest	NULL
fragment	NULL
that	NULL
retains	NULL
noncovalently	NULL
bound	NULL
steroid	NULL
(	NULL
52	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
proteases	NULL
in	NULL
cytosols	NULL
from	NULL
frozen	NULL
myeloblastic	NULL
cells	NULL
to	NULL
convert	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
to	NULL
fragments	NULL
of	NULL
various	NULL
sizes	NULL
during	NULL
processing	NULL
at	NULL
0-4°	NULL
is	NULL
illustrated	NULL
in	NULL
Charts	NULL
5	NULL
and	NULL
6	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
2	NULL
procedural	NULL
variations	NULL
on	NULL
the	NULL
extent	NULL
of	NULL
receptor	NULL
cleavage	NULL
are	NULL
also	NULL
documented	NULL
.	NULL

The	NULL
cells	NULL
used	NULL
for	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Chart	NULL
5	NULL
were	NULL
classified	NULL
as	NULL
myeloblastic	NULL
CML	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
clinical	NULL
history	NULL
,	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
Philadelphia	NULL
chromosome	NULL
,	NULL
the	NULL
percentage	NULL
of	NULL
blast	NULL
cells	NULL
in	NULL
the	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

5	NULL
T	NULL
T	NULL
T	NULL
T	NULL
G	NULL
.	NULL

o	NULL
12	NULL
}	NULL
-	NULL
Na	NULL
;	NULL
MoQ	NULL
,	NULL
in	NULL
~	NULL
pse	NULL
Homogenate	NULL
p	NULL
§	NULL
Control	NULL
U	NULL
Homogenate	NULL
%	NULL
o	NULL
o	NULL
s	NULL
@	NULL
V	NULL
'	NULL
C	NULL
O	NULL
gx	NULL
O	NULL
Oo	NULL
4	NULL
@	NULL
C	NULL
Le	NULL
}	NULL
O	NULL
=	NULL
'	NULL
o	NULL
3	NULL
E	NULL
,	NULL
of	NULL
T	NULL
OF	NULL
os	NULL
M	NULL
1	NULL
]	NULL
m-	NULL
14	NULL
3	NULL
}	NULL
;	NULL
f	NULL
I	NULL
1	NULL
t-	NULL
)	NULL
0	NULL
04	NULL
0.8	NULL
1.2	NULL
Distribution	NULL
Coefficient	NULL
Mero-reoeptorfommhonhcyhosoisfmmblasbcCMLwlsandits	NULL
molybdate	NULL
in	NULL
the	NULL
medium	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
in	NULL
+Mo	NULL
buffer	NULL
(	NULL
@	NULL
)	NULL
from	NULL
frozen	NULL
cells	NULL
from	NULL
a	NULL
13-year-old	NULL
patient	NULL
with	NULL
mysioid	NULL
blast	NULL
cells	NULL
(	NULL
TdT	NULL
negative	NULL
)	NULL
.	NULL

Na.MoO	NULL
,	NULL
was	NULL
added	NULL
to	NULL
control	NULL
cytosol	NULL
,	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
mw	NULL
.	NULL

Both	NULL
cytosols	NULL
were	NULL
then	NULL
labeled	NULL
with	NULL
26	NULL
mPHNAdeonmmg'aphedonSephadexLH-zocounnshTTE+MoMiar	NULL
fractions	NULL
containing	NULL
the	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
were	NULL
filtered	NULL
on	NULL
agarose	NULL
thEG+Mowfbr	NULL
with	NULL
the	NULL
same	NULL
standards	NULL
as	NULL
in	NULL
Chart	NULL
4	NULL
.	NULL

The	NULL
A	NULL
;	NULL
values	NULL
were	NULL
7.0	NULL
nm	NULL
(	NULL
0	NULL
)	NULL
and	NULL
7.1	NULL
nm	NULL
(	NULL
@	NULL
)	NULL
for	NULL
the	NULL
larger	NULL
complexes	NULL
and	NULL
2.3	NULL
nm	NULL
for	NULL
the	NULL
mero-receptor	NULL
in	NULL
both	NULL
preparations	NULL
.	NULL

marrow	NULL
,	NULL
and	NULL
the	NULL
negligible	NULL
activity	NULL
of	NULL
TdT	NULL
.	NULL

Cytosols	NULL
were	NULL
prepared	NULL
from	NULL
frozen	NULL
cells	NULL
in	NULL
TTES	NULL
buffer	NULL
containing	NULL
or	NULL
lacking	NULL
molybdate	NULL
.	NULL

The	NULL
-Mo	NULL
cytosol	NULL
was	NULL
made	NULL
20	NULL
mm	NULL
in	NULL
NaaMoO	NULL
,	NULL
prior	NULL
to	NULL
labeling	NULL
with	NULL
[	NULL
°HJTA	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
difference	NULL
between	NULL
the	NULL
2	NULL
gel	NULL
filtration	NULL
pattems	NULL
in	NULL
Chart	NULL
5	NULL
reflects	NULL
processes	NULL
that	NULL
occurred	NULL
during	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
cytosols	NULL
.	NULL

The	NULL
following	NULL
inferences	NULL
can	NULL
be	NULL
drawn	NULL
from	NULL
these	NULL
results	NULL
:	NULL
(	NULL
a	NULL
)	NULL
endogenous	NULL
enzymes	NULL
in	NULL
some	NULL
myeloid	NULL
leukemic	NULL
specimens	NULL
are	NULL
capable	NULL
of	NULL
cleaving	NULL
the	NULL
receptor	NULL
into	NULL
the	NULL
mero-receptor	NULL
;	NULL
(	NULL
b	NULL
)	NULL
much	NULL
of	NULL
the	NULL
observed	NULL
cleavage	NULL
occurred	NULL
within	NULL
the	NULL
first	NULL
hr	NULL
after	NULL
homogenization	NULL
of	NULL
the	NULL
cells	NULL
;	NULL
(	NULL
c	NULL
)	NULL
this	NULL
process	NULL
was	NULL
retarded	NULL
,	NULL
but	NULL
not	NULL
prevented	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
molybdate	NULL
in	NULL
the	NULL
homogenate	NULL
;	NULL
(	NULL
d	NULL
)	NULL
the	NULL
largest	NULL
receptor	NULL
form	NULL
observed	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Rs	NULL
of	NULL
7.0	NULL
to	NULL
7.1	NULL
nm	NULL
)	NULL
was	NULL
smaller	NULL
than	NULL
those	NULL
detected	NULL
in	NULL
cytosols	NULL
from	NULL
the	NULL
tested	NULL
specimens	NULL
of	NULL
ALL	NULL
,	NULL
CLL	NULL
,	NULL
or	NULL
normal	NULL
lymphocytes	NULL
(	NULL
see	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

In	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
learned	NULL
that	NULL
rapid	NULL
freezing	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
preservatives	NULL
can	NULL
lead	NULL
to	NULL
dramatic	NULL
changes	NULL
in	NULL
the	NULL
apparent	NULL
structure	NULL
of	NULL
the	NULL
receptors	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
such	NULL
changes	NULL
would	NULL
be	NULL
minimized	NULL
by	NULL
freezing	NULL
the	NULL
cells	NULL
at	NULL
a	NULL
slow	NULL
and	NULL
controlled	NULL
rate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum	NULL
and	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
as	NULL
recommended	NULL
for	NULL
the	NULL
recovery	NULL
of	NULL
viable	NULL
cells	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Rapid	NULL
freezing	NULL
of	NULL
some	NULL
specimens	NULL
altered	NULL
2	NULL
characteristics	NULL
of	NULL
the	NULL
ge	NULL
!	NULL

filtration	NULL
patterns	NULL
:	NULL
the	NULL
radius	NULL
of	NULL
the	NULL
largest	NULL
receptor	NULL
form	NULL
and	NULL
the	NULL
proportion	NULL
of	NULL
receptor	NULL
fragments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Chart	NULL
6	NULL
,	NULL
the	NULL
receptor	NULL
in	NULL
cytosol	NULL
prepared	NULL
from	NULL
one	NULL
fresh	NULL
ANLL	NULL
specimen	NULL
was	NULL
characterized	NULL
by	NULL
ARs	NULL
of	NULL
8.3	NULL
nm	NULL
,	NULL
and	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
SEPTEMBER	NULL
1984	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
4	NULL
)	NULL
-	NULL
'	NULL
J	NULL
T	NULL
I	NULL
10	NULL
%	NULL
``	NULL
x	NULL
dpm/fraction	NULL
CA	NULL
M	NULL
|	NULL
¥	NULL
|	NULL
t	NULL
1	NULL
[	NULL
H	NULL
]	NULL
Triamcinolone	NULL
acetonide	NULL
0.8	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
6	NULL
.	NULL

Effect	NULL
of	NULL
freezing	NULL
ANLL	NULL
cells	NULL
on	NULL
the	NULL
cytosolic	NULL
receptor	NULL
by	NULL
ge	NULL
!	NULL

filtration	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
.	NULL

Purified	NULL
cells	NULL
(	NULL
French-	NULL
American-British	NULL
Class	NULL
M2-M3	NULL
)	NULL
from	NULL
a	NULL
pediatric	NULL
patient	NULL
were	NULL
divided	NULL
into	NULL
180-mg	NULL
portions	NULL
,	NULL
one	NULL
of	NULL
whidnwasfrozenat—85	NULL
‘	NULL
for1	NULL
week	NULL
.	NULL

The	NULL
fresh	NULL
(	NULL
@	NULL
)	NULL
or	NULL
frozen	NULL
(	NULL
0	NULL
)	NULL
cells	NULL
were	NULL
in	NULL
4.4	NULL
volumes	NULL
of	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
homogenates	NULL
were	NULL
admstedtonsotoudtybymemumoﬁuwose	NULL
The	NULL
resultant	NULL
had	NULL
1.2	NULL
myoglobin	NULL
(	NULL
M	NULL
)	NULL
,	NULL
‘	NULL
mmymedmyrogobtm	NULL
(	NULL
T	NULL
)	NULL
.andwboricmy¢ase	NULL
(	NULL
CA	NULL
)	NULL
as	NULL
internal	NULL
standards	NULL
.	NULL

The	NULL
Stokes	NULL
radii	NULL
of	NULL
the	NULL
major	NULL
receptor	NULL
forms	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
mero-receptor	NULL
(	NULL
Ms	NULL
of	NULL
2.3	NULL
nm	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
cytosol	NULL
from	NULL
frozen	NULL
cells	NULL
.	NULL

Free	NULL
steroid	NULL
was	NULL
eluted	NULL
with	NULL
a	NULL
Kp	NULL
~1.1	NULL
.	NULL

of	NULL
fragmentation	NULL
.	NULL

in	NULL
contrast	NULL
,	NULL
the	NULL
pattern	NULL
obtained	NULL
using	NULL
frozen	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
specimen	NULL
revealed	NULL
a	NULL
conspicuous	NULL
peak	NULL
of	NULL
the	NULL
mero-receptor	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
Rs	NULL
of	NULL
the	NULL
larger	NULL
complex	NULL
,	NULL
compared	NULL
with	NULL
that	NULL
obtained	NULL
from	NULL
fresh	NULL
cells	NULL
.	NULL

This	NULL
decrease	NULL
,	NULL
from	NULL
8.3	NULL
to	NULL
7.3	NULL
nm	NULL
,	NULL
was	NULL
readily	NULL
detected	NULL
with	NULL
reference	NULL
to	NULL
the	NULL
2	NULL
internal	NULL
standards	NULL
which	NULL
migrate	NULL
close	NULL
to	NULL
the	NULL
receptor	NULL
in	NULL
these	NULL
columns	NULL
:	NULL
ferritin	NULL
[	NULL
A5	NULL
of	NULL
6.15	NULL
nm	NULL
(	NULL
50	NULL
)	NULL
}	NULL
;	NULL
and	NULL
**C-methylated	NULL
thyroglobulin	NULL
[	NULL
As	NULL
of	NULL
8.61	NULL
nm	NULL
(	NULL
13	NULL
)	NULL
]	NULL
.	NULL

Characterization	NULL
of	NULL
Salit-dissociated	NULL
Receptor	NULL
Forms	NULL
;	NULL
Effect	NULL
of	NULL
Freezing	NULL
the	NULL
Cells	NULL
.	NULL

In	NULL
contrast	NULL
with	NULL
the	NULL
results	NULL
shown	NULL
in	NULL
Table	NULL
2	NULL
,	NULL
agarose	NULL
filtration	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.4	NULL
m	NULL
KCI	NULL
revealed	NULL
extensive	NULL
degradation	NULL
of	NULL
the	NULL
receptors	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
(	NULL
Chart	NULL
7	NULL
)	NULL
.	NULL

While	NULL
a	NULL
single	NULL
,	NULL
symmetrical	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
(	NULL
As	NULL
of	NULL
6.1	NULL
nm	NULL
)	NULL
was	NULL
detected	NULL
in	NULL
cytosol	NULL
prepared	NULL
from	NULL
fresh	NULL
cells	NULL
,	NULL
the	NULL
cytosol	NULL
from	NULL
frozen	NULL
cells	NULL
contained	NULL
a	NULL
mixture	NULL
of	NULL
receptor	NULL
forms	NULL
,	NULL
of	NULL
which	NULL
the	NULL
ARs	NULL
of	NULL
~25	NULL
%	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
.	NULL

Chromatography	NULL
of	NULL
cytosol	NULL
from	NULL
the	NULL
same	NULL
frozen	NULL
cells	NULL
in	NULL
TTEG	NULL
+Mo	NULL
buffer	NULL
provided	NULL
no	NULL
evidence	NULL
of	NULL
receptor	NULL
cleavage	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
bound	NULL
steroid	NULL
was	NULL
characterized	NULL
by	NULL
As	NULL
8.3	NULL
nm	NULL
,	NULL
and	NULL
the	NULL
shape	NULL
of	NULL
the	NULL
peak	NULL
was	NULL
indistinguishable	NULL
from	NULL
that	NULL
obtained	NULL
using	NULL
fresh	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
specimen	NULL
(	NULL
see	NULL
Chart	NULL
9a	NULL
)	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Chart	NULL
7	NULL
and	NULL
the	NULL
results	NULL
of	NULL
corollary	NULL
experiments	NULL
indicate	NULL
that	NULL
the	NULL
use	NULL
of	NULL
cells	NULL
frozen	NULL
in	NULL
this	NULL
way	NULL
can	NULL
result	NULL
in	NULL
cleavage	NULL
of	NULL
the	NULL
receptor	NULL
into	NULL
fragments	NULL
that	NULL
are	NULL
intermediate	NULL
in	NULL
size	NULL
between	NULL
the	NULL
mero-receptor	NULL
(	NULL
As	NULL
of	NULL
2.3	NULL
nm	NULL
)	NULL
and	NULL
the	NULL
intact	NULL
3791	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Résearch	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

monomer	NULL
(	NULL
AMs	NULL
of	NULL
~6	NULL
nm	NULL
)	NULL
(	NULL
see	NULL
Table	NULL
3	NULL
)	NULL
.	NULL

These	NULL
intermediate	NULL
fragments	NULL
,	NULL
which	NULL
are	NULL
revealed	NULL
by	NULL
chromatography	NULL
in	NULL
hypertonic	NULL
buffer	NULL
,	NULL
may	NULL
not	NULL
be	NULL
formed	NULL
or	NULL
may	NULL
escape	NULL
detection	NULL
during	NULL
most	NULL
analyses	NULL
in	NULL
hypotonic	NULL
buffer	NULL
.	NULL

Receptor	NULL
fragments	NULL
of	NULL
similar	NULL
size	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
cytosols	NULL
from	NULL
rat	NULL
thymocytes	NULL
(	NULL
20	NULL
)	NULL
and	NULL
from	NULL
fresh	NULL
and	NULL
frozen	NULL
rat	NULL
liver	NULL
and	NULL
kidney	NULL
(	NULL
28	NULL
,	NULL
47	NULL
,	NULL
51	NULL
)	NULL
and	NULL
have	NULL
been	NULL
produced	NULL
by	NULL
chymotryptic	NULL
digestion	NULL
of	NULL
larger	NULL
receptor	NULL
forms	NULL
(	NULL
6	NULL
,	NULL
55	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
effects	NULL
of	NULL
freezing	NULL
the	NULL
cells	NULL
on	NULL
the	NULL
form	NULL
of	NULL
the	NULL
receptors	NULL
from	NULL
some	NULL
specimens	NULL
of	NULL
ALL	NULL
and	NULL
CLL	NULL
cells	NULL
were	NULL
less	NULL
dramatic	NULL
than	NULL
those	NULL
illustrated	NULL
in	NULL
Charts	NULL
6	NULL
and	NULL
7	NULL
.	NULL

Analyses	NULL
of	NULL
Receptor	NULL
Form	NULL
before	NULL
and	NULL
after	NULL
Freezing	NULL
Labeled	NULL
Cytosols	NULL
.	NULL

We	NULL
have	NULL
done	NULL
only	NULL
a	NULL
few	NULL
studies	NULL
of	NULL
the	NULL
effects	NULL
on	NULL
receptor	NULL
structure	NULL
of	NULL
freezing	NULL
the	NULL
labeled	NULL
+Mo	NULL
cytosols	NULL
,	NULL
as	NULL
opposed	NULL
to	NULL
freezing	NULL
the	NULL
intact	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
no	NULL
difference	NULL
was	NULL
found	NULL
between	NULL
the	NULL
elution	NULL
pattems	NULL
obtained	NULL
by	NULL
gel	NULL
filtration	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
of	NULL
aliquots	NULL
of	NULL
cytosol	NULL
from	NULL
a	NULL
specimen	NULL
of	NULL
fresh	NULL
CLL	NULL
cells	NULL
,	NULL
before	NULL
or	NULL
after	NULL
storage	NULL
for	NULL
3	NULL
months	NULL
at	NULL
-85°	NULL
.	NULL

Cytosol	NULL
was	NULL
also	NULL
prepared	NULL
in	NULL
+Mo	NULL
buffer	NULL
from	NULL
frozen	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
CLL	NULL
patient	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
,	NULL
and	NULL
aliquots	NULL
were	NULL
analyzed	NULL
by	NULL
filtration	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
on	NULL
the	NULL
day	NULL
of	NULL
preparation	NULL
and	NULL
after	NULL
3	NULL
days	NULL
at	NULL
-85°	NULL
.	NULL

No	NULL
difference	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
apparent	NULL
ARs	NULL
(	NULL
6.0	NULL
nm	NULL
)	NULL
or	NULL
in	NULL
the	NULL
shape	NULL
of	NULL
the	NULL
elution	NULL
profile	NULL
.	NULL

Similarly	NULL
,	NULL
portions	NULL
of	NULL
labeled	NULL
cytosol	NULL
from	NULL
a	NULL
fresh	NULL
ALL	NULL
specimen	NULL
I	NULL
I	NULL
T	NULL
I	NULL
Fresh	NULL
Cells	NULL
U	NULL
I	NULL
104	NULL
x	NULL
dpm	NULL
/fraction	NULL
N	NULL
[	NULL
°H	NULL
]	NULL
Triamcinolone	NULL
acetonide	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
7	NULL
.	NULL

Degradation	NULL
of	NULL
the	NULL
receptor	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
revealed	NULL
by	NULL
gel	NULL
filtration	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
.	NULL

Purified	NULL
cells	NULL
from	NULL
a	NULL
14-year-old	NULL
patient	NULL
were	NULL
divided	NULL
into	NULL
450-mg	NULL
portions	NULL
,	NULL
one	NULL
of	NULL
which	NULL
was	NULL
kept	NULL
at	NULL
-85°	NULL
for	NULL
6	NULL
weeks	NULL
.	NULL

The	NULL
fresh	NULL
(	NULL
@	NULL
)	NULL
or	NULL
frozen	NULL
(	NULL
C	NULL
)	NULL
cell	NULL
pellets	NULL
were	NULL
homogenized	NULL
in	NULL
3	NULL
volumes	NULL
of	NULL
TTE	NULL
+Mo	NULL
buffer	NULL
,	NULL
and	NULL
the	NULL
homogenates	NULL
were	NULL
adjusted	NULL
to	NULL
isotonicity	NULL
,	NULL
as	NULL
in	NULL
Chart	NULL
6	NULL
.	NULL

The	NULL
cytosols	NULL
had	NULL
protein	NULL
concentrations	NULL
of	NULL
15.7	NULL
mg/mi	NULL
(	NULL
@	NULL
)	NULL
and	NULL
18.5	NULL
mg/ml	NULL
(	NULL
0	NULL
)	NULL
.	NULL

They	NULL
were	NULL
incubated	NULL
with	NULL
86	NULL
nm	NULL
[	NULL
°HJTA	NULL
and	NULL
treated	NULL
with	NULL
charcoal	NULL
,	NULL
and	NULL
2.4-m	NULL
aliquots	NULL
were	NULL
filtered	NULL
on	NULL
agarose	NULL
columns	NULL
in	NULL
T	NULL
TEG	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
.	NULL

The	NULL
indicated	NULL
As	NULL
values	NULL
were	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
internal	NULL
standards	NULL
:	NULL
myoglobin	NULL
(	NULL
M	NULL
)	NULL
,	NULL
``	NULL
*C-methylated	NULL
B-amylase	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
carbonic	NULL
anhydrase	NULL
(	NULL
CA	NULL
)	NULL
.	NULL

For	NULL
approximately	NULL
7	NULL
%	NULL
(	NULL
@	NULL
)	NULL
and	NULL
25	NULL
%	NULL
(	NULL
0	NULL
)	NULL
of	NULL
the	NULL
labeled	NULL
complexes	NULL
,	NULL
As	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
.	NULL

3792	NULL
were	NULL
analyzed	NULL
by	NULL
filtration	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
before	NULL
and	NULL
after	NULL
storage	NULL
for	NULL
6	NULL
months	NULL
at	NULL
-85°	NULL
.	NULL

The	NULL
resultant	NULL
patterns	NULL
were	NULL
nearly	NULL
identical	NULL
with	NULL
respect	NULL
to	NULL
A	NULL
;	NULL
of	NULL
the	NULL
labeled	NULL
complex	NULL
(	NULL
6.1	NULL
to	NULL
6.2	NULL
nm	NULL
)	NULL
,	NULL
the	NULL
width	NULL
of	NULL
the	NULL
peak	NULL
(	NULL
5.2-7.3	NULL
nm	NULL
)	NULL
,	NULL
and	NULL
the	NULL
percentage	NULL
of	NULL
receptor	NULL
fragments	NULL
(	NULL
7	NULL
to	NULL
10	NULL
%	NULL
)	NULL
.	NULL

In	NULL
more	NULL
systematic	NULL
studies	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
,	NULL
the	NULL
large	NULL
receptor	NULL
form	NULL
in	NULL
+Mo	NULL
cyt	NULL
appeared	NULL
to	NULL
be	NULL
stable	NULL
during	NULL
several	NULL
months	NULL
of	NULL
storage	NULL
at	NULL
-85°	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Instability	NULL
of	NULL
Salt-dissociated	NULL
Receptor	NULL
Forms	NULL
during	NULL
Sequential	NULL
Fractionations	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Chart	NULL
8	NULL
were	NULL
obtained	NULL
with	NULL
-Mo	NULL
cytosol	NULL
prepared	NULL
from	NULL
the	NULL
same	NULL
frozen	NULL
leukapheresis	NULL
specimen	NULL
that	NULL
was	NULL
used	NULL
in	NULL
Chart	NULL
1	NULL
.	NULL

The	NULL
cytosol	NULL
was	NULL
incubated	NULL
with	NULL
steroid	NULL
at	NULL
4°	NULL
for	NULL
3	NULL
hr	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
usual	NULL
90	NULL
min	NULL
,	NULL
in	NULL
order	NULL
to	NULL
increase	NULL
the	NULL
quantity	NULL
of	NULL
receptor	NULL
fragments	NULL
available	NULL
for	NULL
further	NULL
characterization	NULL
.	NULL

Following	NULL
charcoal	NULL
treatment	NULL
,	NULL
the	NULL
cytosol	NULL
was	NULL
filtered	NULL
on	NULL
an	NULL
agarose	NULL
column	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
.	NULL

Two	NULL
receptor	NULL
forms	NULL
,	NULL
which	NULL
were	NULL
partially	NULL
resolved	NULL
by	NULL
the	NULL
initial	NULL
fractionation	NULL
(	NULL
Chart	NULL
8a	NULL
)	NULL
,	NULL
were	NULL
further	NULL
analyzed	NULL
by	NULL
rechro-matography	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Chart	NULL
8	NULL
,	NULL
b	NULL
and	NULL
c	NULL
)	NULL
or	NULL
by	NULL
centrifugation	NULL
through	NULL
glycerol	NULL
gradients	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
Chart	NULL
8	NULL
,	NULL
e	NULL
and	NULL
f	NULL
)	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
unfractionated	NULL
,	NULL
charcoal-treated	NULL
cytosol	NULL
were	NULL
also	NULL
subjected	NULL
to	NULL
centrifugation	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
Chart	NULL
80	NULL
)	NULL
.	NULL

Several	NULL
conclusions	NULL
can	NULL
be	NULL
drawn	NULL
from	NULL
the	NULL
results	NULL
in	NULL
Chart	NULL
8	NULL
and	NULL
the	NULL
corollary	NULL
experiments	NULL
.	NULL

(	NULL
a	NULL
)	NULL
The	NULL
larger	NULL
receptor	NULL
form	NULL
seen	NULL
in	NULL
Chart	NULL
8a	NULL
(	NULL
As	NULL
of	NULL
5	NULL
to	NULL
6	NULL
nm	NULL
)	NULL
is	NULL
relatively	NULL
unstable	NULL
with	NULL
respect	NULL
to	NULL
both	NULL
the	NULL
retention	NULL
of	NULL
bound	NULL
steroid	NULL
and	NULL
the	NULL
size	NULL
determined	NULL
by	NULL
refiltration	NULL
on	NULL
the	NULL
same	NULL
column	NULL
.	NULL

Of	NULL
the	NULL
total	NULL
radioactivity	NULL
in	NULL
the	NULL
pool	NULL
analyzed	NULL
as	NULL
shown	NULL
in	NULL
Chart	NULL
8b	NULL
,	NULL
~33	NULL
%	NULL
appeared	NULL
to	NULL
be	NULL
free	NULL
(	NULL
Kp	NULL
of	NULL
1.1	NULL
)	NULL
,	NULL
and	NULL
~67	NULL
%	NULL
of	NULL
the	NULL
residual	NULL
bound	NULL
radioactivity	NULL
migrated	NULL
with	NULL
an	NULL
apparent	NULL
Rs	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
.	NULL

(	NULL
b	NULL
)	NULL
The	NULL
Rs	NULL
values	NULL
calculated	NULL
for	NULL
both	NULL
the	NULL
small	NULL
receptor	NULL
form	NULL
in	NULL
Chart	NULL
8b	NULL
(	NULL
2.9	NULL
nm	NULL
)	NULL
and	NULL
the	NULL
single	NULL
broad	NULL
peak	NULL
in	NULL
Chart	NULL
8¢	NULL
(	NULL
2.8	NULL
nm	NULL
)	NULL
were	NULL
considerably	NULL
smaller	NULL
than	NULL
those	NULL
of	NULL
the	NULL
predominant	NULL
receptor	NULL
forms	NULL
in	NULL
Charts	NULL
7	NULL
or	NULL
8a	NULL
.	NULL

We	NULL
infer	NULL
that	NULL
further	NULL
proteolysis	NULL
and/or	NULL
more	NULL
complete	NULL
dissociation	NULL
of	NULL
the	NULL
cleavage	NULL
products	NULL
occurred	NULL
during	NULL
reanalysis	NULL
of	NULL
the	NULL
samples	NULL
.	NULL

(	NULL
c	NULL
)	NULL
The	NULL
As	NULL
value	NULL
corresponding	NULL
to	NULL
the	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
in	NULL
Chart	NULL
8¢	NULL
(	NULL
2.8	NULL
nm	NULL
)	NULL
is	NULL
slightly	NULL
larger	NULL
than	NULL
that	NULL
of	NULL
the	NULL
mero-receptor	NULL
(	NULL
2.3	NULL
nm	NULL
;	NULL
Charts	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
but	NULL
this	NULL
broad	NULL
peak	NULL
may	NULL
contain	NULL
a	NULL
mixture	NULL
of	NULL
the	NULL
mero-receptor	NULL
and	NULL
larger	NULL
fragments	NULL
.	NULL

(	NULL
d	NULL
)	NULL
For	NULL
the	NULL
discrimination	NULL
among	NULL
the	NULL
salt-dissociated	NULL
receptor	NULL
forms	NULL
,	NULL
agarose	NULL
filtration	NULL
is	NULL
a	NULL
far	NULL
more	NULL
sensitive	NULL
technique	NULL
than	NULL
density	NULL
gradient	NULL
centrifugation	NULL
.	NULL

Complexes	NULL
with	NULL
Rs	NULL
values	NULL
of	NULL
~3	NULL
nm	NULL
and	NULL
~5	NULL
nm	NULL
were	NULL
nearly	NULL
completely	NULL
resolved	NULL
on	NULL
the	NULL
column	NULL
(	NULL
Chart	NULL
8b	NULL
)	NULL
,	NULL
but	NULL
the	NULL
s2	NULL
,	NULL
.	NULL

,	NULL
values	NULL
of	NULL
all	NULL
were	NULL
~4S	NULL
(	NULL
Chart	NULL
8e	NULL
)	NULL
.	NULL

(	NULL
e	NULL
)	NULL
These	NULL
results	NULL
for	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
leukemic	NULL
cell	NULL
cytosol	NULL
resemble	NULL
those	NULL
obtained	NULL
for	NULL
the	NULL
receptor	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
analyzed	NULL
under	NULL
similar	NULL
conditions	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Apparent	NULL
Size	NULL
and	NULL
Shape	NULL
of	NULL
Salt-dissociated	NULL
Receptors	NULL
under	NULL
Various	NULL
Conditions	NULL
.	NULL

Analyses	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffers	NULL
of	NULL
receptors	NULL
from	NULL
6	NULL
leukemic	NULL
cell	NULL
specimens	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
3	NULL
.	NULL

Definitive	NULL
characterization	NULL
of	NULL
the	NULL
salt-dissociated	NULL
complexes	NULL
was	NULL
precluded	NULL
by	NULL
their	NULL
instability	NULL
under	NULL
these	NULL
conditions	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Chart	NULL
8	NULL
for	NULL
the	NULL
receptor	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
.	NULL

Even	NULL
using	NULL
+Mo	NULL
cytosol	NULL
from	NULL
CLL	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
the	NULL
receptor	NULL
appears	NULL
to	NULL
be	NULL
relatively	NULL
stable	NULL
,	NULL
we	NULL
have	NULL
not	NULL
achieved	NULL
the	NULL
complete	NULL
dissociation	NULL
of	NULL
the	NULL
receptor	NULL
into	NULL
subunits	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
proteolysis	NULL
.	NULL

For	NULL
example	NULL
,	NULL
when	NULL
cytosol	NULL
from	NULL
frozen	NULL
CLL	NULL
cells	NULL
was	NULL
filtered	NULL
as	NULL
shown	NULL
in	NULL
Charts	NULL
7	NULL
and	NULL
8a	NULL
for	NULL
ALL	NULL
cell	NULL
cytosols	NULL
,	NULL
the	NULL
peak	NULL
of	NULL
bound	NULL
steroid	NULL
had	NULL
As	NULL
of	NULL
6.3	NULL
nm	NULL
,	NULL
and	NULL
~10	NULL
%	NULL
of	NULL
the	NULL
complexes	NULL
were	NULL
eluted	NULL
with	NULL
As	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
.	NULL

When	NULL
this	NULL
``	NULL
6.3-nm	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

s	NULL
o	NULL
300	NULL
48	NULL
225	NULL
36	NULL
150	NULL
f	NULL
24	NULL
g	NULL
12	NULL
J	NULL
~-0	NULL
5.	NULL
t	NULL
am	NULL
>	NULL
<	NULL
£	NULL
.	NULL

4.8	NULL
&	NULL
3.6	NULL
8	NULL
&	NULL
2.4	NULL
8	NULL
o	NULL
1.2	NULL
a	NULL
C	NULL
G	NULL
€	NULL
-S	NULL
0	NULL
E	NULL
.9	NULL
t	NULL
i-	NULL
<	NULL
m-1	NULL
~*	NULL
IC	NULL
Lo	NULL
L_J	NULL
-	NULL
1.8	NULL
4	NULL
]	NULL
1.2	NULL
los	NULL
0	NULL
Lannnaanant	NULL
bP	NULL
s	NULL
m	NULL
+	NULL
4A	NULL
``	NULL
ca	NULL
m	NULL
-O	NULL
1	NULL
1_t	NULL
A1	NULL
L	NULL
pt___1_tt	NULL
j	NULL
0	NULL
0.4	NULL
0.8	NULL
1.2	NULL
I	NULL
15	NULL
30	NULL
Top	NULL
Distribution	NULL
Coefficient	NULL
Fraction	NULL
Number	NULL
Chart	NULL
8	NULL
.	NULL

Sait-dissociated	NULL
receptor	NULL
forms	NULL
and	NULL
fragments	NULL
in	NULL
cytosol	NULL
from	NULL
frozen	NULL
ALL	NULL
cells	NULL
;	NULL
sequential	NULL
analyses	NULL
by	NULL
gel	NULL
filtration	NULL
and	NULL
uftracentrifugation	NULL
.	NULL

Cytosol	NULL
was	NULL
prepared	NULL
in	NULL
T	NULL
TES	NULL
buffer	NULL
containing	NULL
30	NULL
mm	NULL
KCI	NULL
from	NULL
a	NULL
leukapheresis	NULL
specimen	NULL
that	NULL
had	NULL
been	NULL
kept	NULL
at	NULL
-85°	NULL
for	NULL
1	NULL
year	NULL
(	NULL
the	NULL
same	NULL
specimen	NULL
as	NULL
in	NULL
Chart	NULL
1	NULL
)	NULL
.	NULL

The	NULL
cytosol	NULL
was	NULL
incubated	NULL
with	NULL
81	NULL
nm	NULL
[	NULL
°H	NULL
]	NULL
JTA	NULL
for	NULL
3	NULL
hr	NULL
at	NULL
4°	NULL
.	NULL

In	NULL
a	NULL
,	NULL
charcoal-treated	NULL
cytosol	NULL
(	NULL
4	NULL
mi	NULL
)	NULL
was	NULL
filtered	NULL
on	NULL
an	NULL
agarose	NULL
column	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
,	NULL
as	NULL
in	NULL
Chart	NULL
7	NULL
.	NULL

Two	NULL
pools	NULL
of	NULL
receptor	NULL
,	NULL
characterized	NULL
by	NULL
A	NULL
&	NULL
of	NULL
~5.8	NULL
nm	NULL
(	NULL
range	NULL
,	NULL
5.2	NULL
to	NULL
6.5	NULL
nm	NULL
;	NULL
&	NULL
2	NULL
)	NULL
and	NULL
A	NULL
&	NULL
of	NULL
~3.3	NULL
nm	NULL
(	NULL
2.9	NULL
to	NULL
3.7	NULL
nm	NULL
;	NULL
&	NULL
)	NULL
,	NULL
were	NULL
further	NULL
analyzed	NULL
.	NULL

In	NULL
b	NULL
and	NULL
c	NULL
,	NULL
4-mi	NULL
aliquots	NULL
of	NULL
the	NULL
receptor	NULL
pools	NULL
with	NULL
A	NULL
&	NULL
of	NULL
~5.8	NULL
nm	NULL
(	NULL
b	NULL
)	NULL
and	NULL
~3.3	NULL
nm	NULL
(	NULL
c	NULL
)	NULL
were	NULL
filtered	NULL
on	NULL
agarose	NULL
,	NULL
as	NULL
in	NULL
a	NULL
.	NULL

This	NULL
revealed	NULL
further	NULL
ion	NULL
and/or	NULL
dissociation	NULL
of	NULL
the	NULL
receptor	NULL
and	NULL
the	NULL
release	NULL
of	NULL
free	NULL
steroid	NULL
(	NULL
K	NULL
,	NULL
of	NULL
~1.1	NULL
)	NULL
.	NULL

In	NULL
a	NULL
,	NULL
b	NULL
,	NULL
and	NULL
c	NULL
,	NULL
the	NULL
standards	NULL
were	NULL
myoglobin	NULL
(	NULL
M	NULL
)	NULL
and	NULL
'*C-methylated	NULL
S-amylase	NULL
(	NULL
B	NULL
)	NULL
and	NULL
carbonic	NULL
anhydrase	NULL
(	NULL
CA	NULL
)	NULL
on	NULL
'*C-methylated	NULL
serum	NULL
albumin	NULL
(	NULL
S	NULL
)	NULL
.	NULL

In	NULL
d	NULL
,	NULL
aliquots	NULL
of	NULL
charcoal-treated	NULL
cytosol	NULL
(	NULL
0.37	NULL
mi	NULL
)	NULL
were	NULL
centrifuged	NULL
for	NULL
22	NULL
hr	NULL
at	NULL
369,000	NULL
x	NULL
g	NULL
through	NULL
gradients	NULL
of	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
in	NULL
TTE	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
.	NULL

Values	NULL
of	NULL
sx	NULL
,	NULL
,	NULL
were	NULL
calculated	NULL
relative	NULL
to	NULL
the	NULL
internal	NULL
standards	NULL
:	NULL
M	NULL
,	NULL
CA	NULL
,	NULL
and	NULL
**C-methylated	NULL
aldolase	NULL
(	NULL
A	NULL
)	NULL
.	NULL

In	NULL
e	NULL
and	NULL
,	NULL
aliquots	NULL
(	NULL
0.38	NULL
mi	NULL
)	NULL
of	NULL
the	NULL
receptor	NULL
pools	NULL
from	NULL
a	NULL
with	NULL
R	NULL
&	NULL
of	NULL
~5.8	NULL
nim	NULL
(	NULL
e	NULL
)	NULL
and	NULL
~3.3	NULL
nm	NULL
(	NULL
f	NULL
)	NULL
were	NULL
centrifuged	NULL
through	NULL
glycerol	NULL
gradients	NULL
,	NULL
as	NULL
in	NULL
d.	NULL
complex	NULL
``	NULL
was	NULL
reanalyzed	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Chart	NULL
8b	NULL
for	NULL
the	NULL
ALL	NULL
cell	NULL
complex	NULL
,	NULL
the	NULL
Rs	NULL
of	NULL
the	NULL
major	NULL
complex	NULL
had	NULL
decreased	NULL
to	NULL
5.4	NULL
nm	NULL
and	NULL
the	NULL
As	NULL
of	NULL
~33	NULL
%	NULL
of	NULL
the	NULL
complexes	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Variations	NULL
among	NULL
the	NULL
estimates	NULL
of	NULL
As	NULL
in	NULL
Table	NULL
3	NULL
were	NULL
small	NULL
.	NULL

SEPTEMBER	NULL
1984	NULL
were	NULL
ce	NULL
n	NULL
maul	NULL
ey	NULL
nya	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
In	NULL
contrast	NULL
,	NULL
the	NULL
apparent	NULL
values	NULL
of	NULL
sz	NULL
,	NULL
.	NULL

,	NULL
and	NULL
the	NULL
resultant	NULL
estimates	NULL
of	NULL
molecular	NULL
weight	NULL
varied	NULL
widely	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
experimental	NULL
conditions	NULL
.	NULL

For	NULL
both	NULL
ALL	NULL
cell	NULL
cytosol	NULL
(	NULL
Patient	NULL
1	NULL
)	NULL
and	NULL
CLL	NULL
cell	NULL
cytosol	NULL
(	NULL
Patient	NULL
6	NULL
)	NULL
,	NULL
the	NULL
sx	NULL
,	NULL
,	NULL
values	NULL
obtained	NULL
after	NULL
charcoal	NULL
treatment	NULL
of	NULL
the	NULL
labeled	NULL
cytosols	NULL
were	NULL
higher	NULL
than	NULL
those	NULL
obtained	NULL
after	NULL
Sephadex	NULL
LH-20	NULL
chromatography	NULL
in	NULL
hypertonic	NULL
buffer	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
s20	NULL
.	NULL

,	NULL
value	NULL
obtained	NULL
for	NULL
the	NULL
receptor	NULL
in	NULL
cytosol	NULL
from	NULL
ANLL	NULL
cells	NULL
(	NULL
Patient	NULL
5	NULL
)	NULL
was	NULL
higher	NULL
after	NULL
Sephadex	NULL
LH-20	NULL
chromatography	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
than	NULL
after	NULL
chromatography	NULL
on	NULL
the	NULL
same	NULL
type	NULL
of	NULL
column	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
.	NULL

These	NULL
differences	NULL
could	NULL
result	NULL
from	NULL
proteolysis	NULL
of	NULL
the	NULL
receptor	NULL
during	NULL
the	NULL
latter	NULL
procedure	NULL
and/or	NULL
the	NULL
incomplete	NULL
dissociation	NULL
of	NULL
the	NULL
oligomeric	NULL
complex	NULL
into	NULL
subunits	NULL
under	NULL
the	NULL
other	NULL
conditions	NULL
.	NULL

Chromatography	NULL
in	NULL
glycerol-free	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
favors	NULL
dissociation	NULL
of	NULL
the	NULL
complex	NULL
,	NULL
since	NULL
the	NULL
samples	NULL
are	NULL
diluted	NULL
slightly	NULL
and	NULL
exposed	NULL
to	NULL
a	NULL
buffer	NULL
of	NULL
high	NULL
conductivity	NULL
.	NULL

In	NULL
the	NULL
density	NULL
gradients	NULL
,	NULL
and	NULL
to	NULL
some	NULL
extent	NULL
in	NULL
the	NULL
agarose	NULL
columns	NULL
,	NULL
the	NULL
dielectric	NULL
constant	NULL
of	NULL
the	NULL
buffers	NULL
and	NULL
hence	NULL
the	NULL
effectiveness	NULL
of	NULL
the	NULL
salt	NULL
are	NULL
reduced	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
glycerol	NULL
[	NULL
16	NULL
to	NULL
41	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
in	NULL
the	NULL
gradients	NULL
,	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
in	NULL
the	NULL
columns	NULL
]	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Our	NULL
interpretation	NULL
of	NULL
the	NULL
data	NULL
in	NULL
Table	NULL
3	NULL
is	NULL
that	NULL
the	NULL
higher	NULL
estimates	NULL
of	NULL
s	NULL
»	NULL
,	NULL
and	NULL
M	NULL
,	NULL
reflect	NULL
the	NULL
incomplete	NULL
dissociation	NULL
of	NULL
the	NULL
oligomeric	NULL
complex	NULL
.	NULL

Accordingly	NULL
,	NULL
the	NULL
lower	NULL
estimates	NULL
Of	NULL
S20	NULL
,	NULL
(	NULL
4.4	NULL
to	NULL
4.88	NULL
)	NULL
and	NULL
of	NULL
molecular	NULL
weight	NULL
(	NULL
M	NULL
,	NULL
100,000	NULL
to	NULL
110,000	NULL
)	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
resemble	NULL
the	NULL
parameters	NULL
of	NULL
the	NULL
monomeric	NULL
subunit	NULL
.	NULL

The	NULL
latter	NULL
molecular	NULL
weight	NULL
values	NULL
are	NULL
in	NULL
reasonable	NULL
agreement	NULL
with	NULL
our	NULL
results	NULL
for	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
(	NULL
47	NULL
)	NULL
,	NULL
those	NULL
of	NULL
Holbrook	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
for	NULL
the	NULL
rat	NULL
thy-mocyte	NULL
receptor	NULL
,	NULL
those	NULL
of	NULL
Stevens	NULL
et	NULL
al	NULL
.	NULL

(	NULL
56	NULL
)	NULL
for	NULL
the	NULL
human	NULL
CLL	NULL
cell	NULL
receptor	NULL
,	NULL
and	NULL
those	NULL
of	NULL
Foster	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
for	NULL
the	NULL
covalently	NULL
labeled	NULL
,	NULL
denatured	NULL
receptor	NULL
from	NULL
human	NULL
leukemic	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
their	NULL
high	NULL
affinity	NULL
for	NULL
nuclei	NULL
or	NULL
DNA	NULL
,	NULL
the	NULL
monomeric	NULL
forms	NULL
of	NULL
the	NULL
receptors	NULL
in	NULL
these	NULL
and	NULL
other	NULL
systems	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
transformed	NULL
or	NULL
activated	NULL
receptors	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

49	NULL
)	NULL
.	NULL

Relationship	NULL
of	NULL
Receptor	NULL
Structure	NULL
and	NULL
Cleavage	NULL
to	NULL
Diag-nosis	NULL
.	NULL

The	NULL
hydrodynamic	NULL
parameters	NULL
of	NULL
the	NULL
molybdate-stabilized	NULL
and	NULL
salt-dissociated	NULL
receptor	NULL
forms	NULL
have	NULL
been	NULL
summarized	NULL
in	NULL
Tables	NULL
2	NULL
and	NULL
3	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
general	NULL
,	NULL
the	NULL
properties	NULL
of	NULL
the	NULL
major	NULL
receptor	NULL
form	NULL
detected	NULL
in	NULL
each	NULL
buffer	NULL
system	NULL
were	NULL
remarkably	NULL
similar	NULL
among	NULL
the	NULL
different	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

The	NULL
most	NULL
conspicuous	NULL
difference	NULL
among	NULL
the	NULL
gel	NULL
filtration	NULL
patterns	NULL
was	NULL
the	NULL
apparent	NULL
degradation	NULL
of	NULL
receptors	NULL
in	NULL
cytosols	NULL
from	NULL
several	NULL
normal	NULL
and	NULL
malignant	NULL
specimens	NULL
.	NULL

Cleavage	NULL
products	NULL
of	NULL
3	NULL
types	NULL
were	NULL
distinguished	NULL
.	NULL

The	NULL
mero-receptor	NULL
(	NULL
R	NULL
;	NULL
of	NULL
2.3	NULL
to	NULL
2.4	NULL
nm	NULL
)	NULL
and	NULL
slightly	NULL
degraded	NULL
oligomers	NULL
(	NULL
Rs	NULL
of	NULL
7.0	NULL
to	NULL
7.5	NULL
nm	NULL
)	NULL
were	NULL
detected	NULL
by	NULL
filtration	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
(	NULL
Charts	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
complexes	NULL
are	NULL
clearly	NULL
smaller	NULL
than	NULL
the	NULL
intact	NULL
oligomers	NULL
(	NULL
ARs	NULL
of	NULL
8.0	NULL
to	NULL
8.5	NULL
nm	NULL
;	NULL
see	NULL
Chart	NULL
6	NULL
)	NULL
,	NULL
but	NULL
they	NULL
are	NULL
clearly	NULL
larger	NULL
than	NULL
the	NULL
monomer	NULL
(	NULL
A5	NULL
;	NULL
of	NULL
~6	NULL
nm	NULL
)	NULL
.	NULL

Fragments	NULL
with	NULL
A	NULL
;	NULL
of	NULL
3	NULL
to	NULL
4	NULL
nm	NULL
,	NULL
that	NULL
are	NULL
intermediate	NULL
in	NULL
size	NULL
between	NULL
the	NULL
monomer	NULL
and	NULL
the	NULL
mero-receptor	NULL
,	NULL
were	NULL
detected	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
Charts	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
express	NULL
the	NULL
extent	NULL
of	NULL
degradation	NULL
quantitatively	NULL
,	NULL
we	NULL
considered	NULL
elution	NULL
patterns	NULL
in	NULL
which	NULL
the	NULL
As	NULL
of	NULL
>	NULL
20	NULL
%	NULL
of	NULL
the	NULL
complexes	NULL
was	NULL
<	NULL
4	NULL
nm	NULL
and/or	NULL
the	NULL
radius	NULL
of	NULL
the	NULL
molybdate-stabilized	NULL
complex	NULL
was	NULL
<	NULL
7.5	NULL
nm	NULL
to	NULL
reflect	NULL
significant	NULL
degradation	NULL
.	NULL

Among	NULL
the	NULL
fresh	NULL
specimens	NULL
studied	NULL
,	NULL
such	NULL
degradation	NULL
was	NULL
observed	NULL
in	NULL
2	NULL
of	NULL
8	NULL
cases	NULL
of	NULL
ALL	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
0	NULL
of	NULL
5	NULL
other	NULL
leukemic	NULL
cell	NULL
specimens	NULL
.	NULL

Among	NULL
the	NULL
frozen	NULL
specimens	NULL
,	NULL
degradation	NULL
was	NULL
observed	NULL
in	NULL
0	NULL
of	NULL
7	NULL
cases	NULL
of	NULL
ALL	NULL
,	NULL
2	NULL
of	NULL
6	NULL
specimens	NULL
3793	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

Table	NULL
3	NULL
Parameters	NULL
of	NULL
the	NULL
major	NULL
salt-dissociated	NULL
receptor	NULL
form	NULL
and	NULL
extent	NULL
of	NULL
cleavage	NULL
of	NULL
leukemic	NULL
cell	NULL
receptors	NULL
Fresh	NULL
or	NULL
frozen	NULL
cells	NULL
from	NULL
6	NULL
patients	NULL
with	NULL
the	NULL
indicated	NULL
were	NULL
used	NULL
for	NULL
cytosol	NULL
preparation	NULL
in	NULL
buffer	NULL
containing	NULL
either	NULL
30	NULL
mm	NULL
KCI	NULL
(	NULL
-Mo	NULL
)	NULL
or	NULL
20	NULL
mu	NULL
Na	NULL
;	NULL
MoOQ	NULL
,	NULL
(	NULL
+Mo	NULL
)	NULL
.	NULL

Free	NULL
PH	NULL
]	NULL
JTA	NULL
was	NULL
removed	NULL
from	NULL
labeled	NULL
cytosols	NULL
either	NULL
by	NULL
CD	NULL
``	NULL
treatment	NULL
or	NULL
by	NULL
chromatography	NULL
on	NULL
Sephadex	NULL
LH-20	NULL
columns	NULL
in	NULL
TTE	NULL
buffer	NULL
containing	NULL
either	NULL
20	NULL
mm	NULL
Na	NULL
;	NULL
MoO	NULL
,	NULL
or	NULL
0.4	NULL
m	NULL
KCI	NULL
.	NULL

Stokes	NULL
radii	NULL
and	NULL
sedimentation	NULL
coefficients	NULL
were	NULL
evaluated	NULL
as	NULL
in	NULL
Charts	NULL
7	NULL
and	NULL
84	NULL
,	NULL
respectively	NULL
.	NULL

Molecular	NULL
weights	NULL
and	NULL
axial	NULL
ratios	NULL
were	NULL
calculated	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Diagnosis	NULL
and	NULL
Cells	NULL
_	NULL
+Mo	NULL
%	NULL
M	NULL
,	NULL
x	NULL
patient	NULL
_	NULL
frozen	NULL
-	NULL
cytosol	NULL
CD	NULL
or	NULL
LH	NULL
As	NULL
(	NULL
rm	NULL
)	NULL
fragment	NULL
``	NULL
=	NULL
(	NULL
S	NULL
)	NULL
10°	NULL
_-	NULL
afb	NULL
ALL	NULL
1°	NULL
+	NULL
-	NULL
CD	NULL
55402	NULL
(	NULL
f	NULL
27+7	NULL
48+003	NULL
(	NULL
6	NULL
)	NULL
110°	NULL
11	NULL
+	NULL
-	NULL
LH-	NULL
__	NULL
5.6	NULL
(	NULL
1	NULL
)	NULL
_-	NULL
30	NULL
4.4	NULL
+	NULL
0.05	NULL
(	NULL
3	NULL
)	NULL
100	NULL
|	NULL
12	NULL
+	NULL
+	NULL
CD	NULL
5.8	NULL
(	NULL
1	NULL
)	NULL
23	NULL
I	NULL
-	NULL
+	NULL
LH-	NULL
_	NULL
6.0	NULL
(	NULL
1	NULL
)	NULL
_	NULL
18	NULL
3°	NULL
-	NULL
+	NULL
CD	NULL
6.2+01	NULL
(	NULL
2	NULL
)	NULL
g+2	NULL
57+002	NULL
(	NULL
2	NULL
)	NULL
150	NULL
-	NULL
12	NULL
+	NULL
+	NULL
CD	NULL
6.1	NULL
(	NULL
1	NULL
)	NULL
25	NULL
ANLL	NULL
47	NULL
-	NULL
+	NULL
CD	NULL
6.1	NULL
(	NULL
1	NULL
)	NULL
0	NULL
11	NULL
5.3+0.04	NULL
(	NULL
2	NULL
)	NULL
-	NULL
140	NULL
_	NULL
12	NULL
5	NULL
-	NULL
+	NULL
LH+	NULL
5.7	NULL
+	NULL
0.27	NULL
(	NULL
2	NULL
)	NULL
LH-	NULL
4.4	NULL
+	NULL
0.01	NULL
(	NULL
2	NULL
)	NULL
CLL	NULL
6	NULL
)	NULL
+	NULL
+	NULL
CD	NULL
61+02	NULL
(	NULL
3	NULL
)	NULL
10	NULL
%	NULL
1	NULL
58	NULL
%	NULL
@	NULL
015	NULL
(	NULL
@	NULL
)	NULL
150	NULL
11	NULL
+	NULL
+	NULL
LH-	NULL
4.8	NULL
+	NULL
0.02	NULL
(	NULL
2	NULL
)	NULL
Combined	NULL
5.9+0.3	NULL
(	NULL
12	NULL
)	NULL
data	NULL
®	NULL
CD	NULL
,	NULL
charcoal-dextran	NULL
;	NULL
LH+	NULL
,	NULL
Sephadex	NULL
LH-20	NULL
columns	NULL
in	NULL
TTE	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
NagMoO	NULL
,	NULL
;	NULL
LH-	NULL
,	NULL
Seghadexu-l-ZOookmishTTEbuﬂef	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
.	NULL

of	NULL
steroid-receptor	NULL
complexes	NULL
with	NULL
elution	NULL
volumes	NULL
corresponding	NULL
to	NULL
As	NULL
of	NULL
<	NULL
4	NULL
nm	NULL
;	NULL
the	NULL
number	NULL
of	NULL
determinations	NULL
is	NULL
the	NULL
same	NULL
as	NULL
for	NULL
As	NULL
.	NULL

©	NULL
``	NULL
Null	NULL
cells	NULL
``	NULL
from	NULL
a	NULL
30-year-old	NULL
woman	NULL
(	NULL
same	NULL
specimen	NULL
as	NULL
in	NULL
Charts	NULL
1	NULL
and	NULL
8	NULL
)	NULL
.	NULL

©	NULL
Mean	NULL
+	NULL
S.D	NULL
.	NULL

”	NULL
lNumbetsin	NULL
parentheses	NULL
,	NULL
number	NULL
of	NULL
determinations	NULL
.	NULL

``	NULL
Null	NULL
calls	NULL
``	NULL
from	NULL
a	NULL
13-year-old	NULL
girl	NULL
.	NULL

9	NULL
T	NULL
cells	NULL
from	NULL
a	NULL
14-year-old	NULL
boy	NULL
(	NULL
same	NULL
specimen	NULL
as	NULL
in	NULL
Charts	NULL
7	NULL
and	NULL
9	NULL
)	NULL
.	NULL

7Memwﬁcbukamacels	NULL
(	NULL
FMAmBnﬁshGassM58	NULL
)	NULL
mu~ywddboy	NULL
.	NULL

Acute	NULL
monocytic	NULL
leukemia	NULL
cells	NULL
(	NULL
French-American-British	NULL
Class	NULL
MSB	NULL
)	NULL
from	NULL
a	NULL
35-year-old	NULL
woman	NULL
.	NULL

!	NULL

B	NULL
cells	NULL
from	NULL
a	NULL
66-year-old	NULL
woman	NULL
.	NULL

of	NULL
normal	NULL
lymphocytes	NULL
(	NULL
see	NULL
Chart	NULL
4	NULL
)	NULL
,	NULL
1	NULL
of	NULL
2	NULL
cases	NULL
of	NULL
CML	NULL
(	NULL
Chart	NULL
5	NULL
)	NULL
,	NULL
and	NULL
1	NULL
of	NULL
3	NULL
cases	NULL
of	NULL
ANLL	NULL
(	NULL
Chart	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
number	NULL
of	NULL
samples	NULL
analyzed	NULL
to	NULL
date	NULL
is	NULL
small	NULL
,	NULL
it	NULL
is	NULL
apparent	NULL
that	NULL
the	NULL
detectable	NULL
cleavage	NULL
of	NULL
receptors	NULL
is	NULL
not	NULL
restricted	NULL
to	NULL
frozen	NULL
cells	NULL
or	NULL
to	NULL
a	NULL
particular	NULL
type	NULL
of	NULL
leukemic	NULL
cell	NULL
or	NULL
to	NULL
malignant	NULL
cells	NULL
,	NULL
in	NULL
general	NULL
.	NULL

Concomitant	NULL
Analyses	NULL
of	NULL
the	NULL
Glucocorticoid	NULL
Receptor	NULL
and	NULL
Several	NULL
Peptidases	NULL
in	NULL
Leukemic	NULL
Cell	NULL
Cytosols	NULL
.	NULL

The	NULL
observed	NULL
degradation	NULL
of	NULL
receptors	NULL
in	NULL
certain	NULL
cytosols	NULL
stimulated	NULL
our	NULL
interest	NULL
in	NULL
the	NULL
endogenous	NULL
peptidases	NULL
.	NULL

The	NULL
use	NULL
of	NULL
fluorescent	NULL
substrates	NULL
,	NULL
in	NULL
particular	NULL
aminoacy	NULL
!	NULL

and	NULL
peptidyl	NULL
derivatives	NULL
of	NULL
AMC	NULL
,	NULL
has	NULL
facilitated	NULL
the	NULL
detection	NULL
of	NULL
enzymes	NULL
of	NULL
various	NULL
specificities	NULL
in	NULL
small	NULL
volumes	NULL
of	NULL
cytosol	NULL
and	NULL
in	NULL
fractions	NULL
from	NULL
the	NULL
columns	NULL
or	NULL
gradients	NULL
in	NULL
which	NULL
the	NULL
receptor	NULL
was	NULL
also	NULL
analyzed	NULL
(	NULL
47	NULL
,	NULL
52	NULL
)	NULL
.	NULL

Chart	NULL
9	NULL
illustrates	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
agarose	NULL
filtration	NULL
of	NULL
[	NULL
°H	NULL
]	NULL
TA-labeled	NULL
cytosol	NULL
from	NULL
fresh	NULL
ALL	NULL
cells	NULL
,	NULL
under	NULL
conditions	NULL
in	NULL
which	NULL
the	NULL
receptor	NULL
was	NULL
in	NULL
either	NULL
the	NULL
molybdate-stabilized	NULL
(	NULL
oligomeric	NULL
)	NULL
form	NULL
or	NULL
the	NULL
salt-dissociated	NULL
(	NULL
monomeric	NULL
)	NULL
form	NULL
.	NULL

Aminopeptidase	NULL
activity	NULL
was	NULL
assayed	NULL
with	NULL
leucyl-AMC	NULL
and	NULL
the	NULL
endopeptidases	NULL
with	NULL
oligopeptide	NULL
derivatives	NULL
of	NULL
AMC	NULL
in	NULL
which	NULL
the	NULL
amino-terminal	NULL
residues	NULL
were	NULL
blocked	NULL
.	NULL

Aminopeptidases	NULL
of	NULL
various	NULL
specificities	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
in	NULL
normal	NULL
leukocytes	NULL
and	NULL
leukemic	NULL
cells	NULL
(	NULL
27	NULL
,	NULL
39	NULL
)	NULL
.	NULL

More	NULL
detailed	NULL
characterization	NULL
of	NULL
these	NULL
and	NULL
other	NULL
enzymes	NULL
from	NULL
leukemic	NULL
cells	NULL
with	NULL
respect	NULL
to	NULL
catalytic	NULL
and	NULL
physicochemical	NULL
properties	NULL
will	NULL
be	NULL
published	NULL
elsewhere	NULL
.	NULL
``	NULL

The	NULL
following	NULL
observations	NULL
,	NULL
however	NULL
,	NULL
are	NULL
relevant	NULL
to	NULL
the	NULL
present	NULL
study	NULL
.	NULL

Using	NULL
the	NULL
assay	NULL
conditions	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Meth-	NULL
*M.	NULL
R.	NULL
Sherman	NULL
,	NULL
F.	NULL
B.	NULL
Tuazon	NULL
,	NULL
and	NULL
Y-W.	NULL
Stevens	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
.	NULL

3794	NULL
ods	NULL
,	NULL
``	NULL
we	NULL
detected	NULL
significant	NULL
activities	NULL
of	NULL
leucine	NULL
aminopeptidase	NULL
and	NULL
at	NULL
least	NULL
3	NULL
endopeptidases	NULL
in	NULL
cytosols	NULL
from	NULL
various	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
small	NULL
aliquots	NULL
(	NULL
2	NULL
to	NULL
50	NULL
LI	NULL
)	NULL
of	NULL
the	NULL
cytosol	NULL
used	NULL
for	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Chart	NULL
9	NULL
were	NULL
assayed	NULL
at	NULL
pH	NULL
7.4	NULL
and	NULL
25°	NULL
,	NULL
using	NULL
20	NULL
um	NULL
solutions	NULL
of	NULL
leucyI-AMC	NULL
and	NULL
the	NULL
oligopeptide	NULL
substrates	NULL
in	NULL
which	NULL
the	NULL
carboxyl-terminal	NULL
residues	NULL
were	NULL
lysine	NULL
,	NULL
phenylalanine	NULL
,	NULL
or	NULL
tyrosine	NULL
.	NULL

The	NULL
reaction	NULL
velocities	NULL
,	NULL
normalized	NULL
to	NULL
10	NULL
ul	NULL
of	NULL
cytosol	NULL
,	NULL
were	NULL
440	NULL
,	NULL
84	NULL
,	NULL
140	NULL
,	NULL
and	NULL
590	NULL
RFU/hr	NULL
,	NULL
respectively	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
velocities	NULL
as	NULL
low	NULL
as	NULL
10	NULL
RFU/hr	NULL
can	NULL
be	NULL
measured	NULL
with	NULL
reasonable	NULL
precision	NULL
(	NULL
+1	NULL
RFU/hr	NULL
)	NULL
.	NULL

The	NULL
activities	NULL
detected	NULL
with	NULL
the	NULL
peptidyl	NULL
substrates	NULL
may	NULL
reflect	NULL
the	NULL
direct	NULL
cleavage	NULL
of	NULL
the	NULL
bond	NULL
between	NULL
the	NULL
carboxyl-terminal	NULL
residue	NULL
and	NULL
the	NULL
amino	NULL
group	NULL
of	NULL
AMC	NULL
,	NULL
or	NULL
a	NULL
sequence	NULL
of	NULL
reactions	NULL
,	NULL
involving	NULL
initial	NULL
cleavage	NULL
at	NULL
a	NULL
more	NULL
distal	NULL
peptide	NULL
bond	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
assays	NULL
of	NULL
the	NULL
enzymes	NULL
recovered	NULL
from	NULL
agarose	NULL
columns	NULL
,	NULL
as	NULL
in	NULL
Chart	NULL
9	NULL
,	NULL
the	NULL
rate	NULL
of	NULL
release	NULL
of	NULL
AMC	NULL
from	NULL
the	NULL
phenylalanine	NULL
derivative	NULL
increased	NULL
progressively	NULL
during	NULL
5	NULL
hr	NULL
,	NULL
to	NULL
approximately	NULL
twice	NULL
the	NULL
initial	NULL
rate	NULL
.	NULL

This	NULL
kinetic	NULL
behavior	NULL
suggests	NULL
that	NULL
the	NULL
enzyme	NULL
requires	NULL
activation	NULL
and/or	NULL
that	NULL
more	NULL
than	NULL
one	NULL
peptidase	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
cleavage	NULL
of	NULL
this	NULL
substrate	NULL
.	NULL

Regardless	NULL
of	NULL
the	NULL
detailed	NULL
mechanisms	NULL
of	NULL
these	NULL
reactions	NULL
,	NULL
the	NULL
use	NULL
of	NULL
substrates	NULL
of	NULL
this	NULL
type	NULL
has	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
neutral	NULL
peptidases	NULL
of	NULL
diverse	NULL
specificities	NULL
and	NULL
sizes	NULL
in	NULL
leukemic	NULL
cell	NULL
cytosols	NULL
.	NULL

When	NULL
labeled	NULL
ALL	NULL
cell	NULL
cytosol	NULL
was	NULL
filtered	NULL
on	NULL
agarose	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
,	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
was	NULL
eluted	NULL
earlier	NULL
than	NULL
the	NULL
predominant	NULL
forms	NULL
of	NULL
the	NULL
enzymes	NULL
assayed	NULL
(	NULL
Chart	NULL
9	NULL
,	NULL
a	NULL
and	NULL
b	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
radius	NULL
of	NULL
the	NULL
CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

W	NULL
(	NULL
0+	NULL
)	NULL
ls	NULL
]	NULL
Percent	NULL
of	NULL
Recovered	NULL
Activity	NULL
(	NULL
oe	NULL
)	NULL
7	NULL
C	NULL
&	NULL
w	NULL
mugs	NULL
P	NULL
3	NULL
1	NULL
it	NULL
08	NULL
1.2	NULL
0	NULL
Distribution	NULL
Coefficient	NULL
Chart	NULL
9	NULL
.	NULL

Concomitant	NULL
of	NULL
the	NULL
glucocorticoid	NULL
receptor	NULL
and	NULL
peptidases	NULL
of	NULL
4	NULL
specificities	NULL
in	NULL
cytosol	NULL
from	NULL
ALL	NULL
cells	NULL
by	NULL
gel	NULL
filtration	NULL
in	NULL
hypotonic	NULL
+Mo	NULL
buffer	NULL
(	NULL
top	NULL
)	NULL
or	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

Molybdate-containing	NULL
cytosol	NULL
from	NULL
the	NULL
same	NULL
fresh	NULL
specimen	NULL
used	NULL
in	NULL
Chart	NULL
7	NULL
was	NULL
labeled	NULL
with	NULL
88	NULL
nu	NULL
[	NULL
°HJTA	NULL
.	NULL

Aliquots	NULL
(	NULL
2.4	NULL
mi	NULL
)	NULL
of	NULL
charcoal-treated	NULL
cytosol	NULL
were	NULL
filtered	NULL
on	NULL
agarose	NULL
columns	NULL
either	NULL
in	NULL
TTEG	NULL
0.4	NULL
0.8	NULL
+Mo	NULL
buffer	NULL
(	NULL
fop	NULL
)	NULL
,	NULL
with	NULL
the	NULL
same	NULL
standards	NULL
as	NULL
in	NULL
Chart	NULL
1a	NULL
,	NULL
or	NULL
in	NULL
TTEG	NULL
buffer	NULL
containing	NULL
0.4	NULL
m	NULL
KCI	NULL
(	NULL
bottom	NULL
)	NULL
,	NULL
with	NULL
the	NULL
same	NULL
standards	NULL
as	NULL
in	NULL
Chart	NULL
7	NULL
.	NULL

The	NULL
results	NULL
from	NULL
each	NULL
column	NULL
are	NULL
shown	NULL
in	NULL
2	NULL
panels	NULL
for	NULL
clarity	NULL
of	NULL
presentation	NULL
.	NULL

Portions	NULL
of	NULL
the	NULL
1.6-mi	NULL
fractions	NULL
were	NULL
used	NULL
for	NULL
determinations	NULL
of	NULL
the	NULL
radioactivity	NULL
,	NULL
peptidase	NULL
activ-ities	NULL
,	NULL
and	NULL
absorbance	NULL
(	NULL
to	NULL
detect	NULL
feritin	NULL
or	NULL
myoglobin	NULL
)	NULL
.	NULL

Peptidases	NULL
were	NULL
assayed	NULL
in	NULL
TEG	NULL
buffer	NULL
containing	NULL
(	NULL
)	NULL
)	NULL
or	NULL
lacking	NULL
20	NULL
mm	NULL
CaCl	NULL
,	NULL
with	NULL
one	NULL
of	NULL
the	NULL
following	NULL
substrates	NULL
,	NULL
at	NULL
20	NULL
um	NULL
:	NULL
leucyl-AMC	NULL
(	NULL
Leu	NULL
)	NULL
,	NULL
AMC	NULL
(	NULL
Phe	NULL
)	NULL
,	NULL
(	NULL
Tyr	NULL
)	NULL
,	NULL
and	NULL
t-butyloxycarbor-yi-valyl-leucyt-lysyl-AMC	NULL
(	NULL
Lys	NULL
)	NULL
.	NULL

Column	NULL
fractions	NULL
were	NULL
assayed	NULL
on	NULL
the	NULL
day	NULL
of	NULL
collection	NULL
(	NULL
®	NULL
in	NULL
a	NULL
;	NULL
A	NULL
in	NULL
b	NULL
)	NULL
or	NULL
after	NULL
storage	NULL
at	NULL
-85°	NULL
for	NULL
7	NULL
to	NULL
13	NULL
days	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
sample	NULL
were	NULL
stored	NULL
at	NULL
-85°	NULL
and	NULL
assayed	NULL
together	NULL
with	NULL
the	NULL
column	NULL
fractions	NULL
.	NULL

The	NULL
results	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
recoveries	NULL
of	NULL
the	NULL
4	NULL
from	NULL
the	NULL
columns	NULL
:	NULL
Leu	NULL
,	NULL
66	NULL
%	NULL
(	NULL
a	NULL
and	NULL
c	NULL
)	NULL
;	NULL
Phe	NULL
,	NULL
9	NULL
%	NULL
(	NULL
a	NULL
)	NULL
,	NULL
12	NULL
%	NULL
(	NULL
c	NULL
)	NULL
;	NULL
Tyr	NULL
22	NULL
%	NULL
(	NULL
b	NULL
)	NULL
,	NULL
17	NULL
%	NULL
(	NULL
d	NULL
)	NULL
,	NULL
Lys	NULL
,	NULL
16	NULL
%	NULL
(	NULL
b	NULL
)	NULL
,	NULL
4	NULL
%	NULL
(	NULL
d	NULL
)	NULL
.	NULL

All	NULL
data	NULL
are	NULL
shown	NULL
as	NULL
percentage	NULL
of	NULL
recovered	NULL
.	NULL

The	NULL
smkesradiofmeraceptorfotmsweteasmnhhypotouc+Mobuﬁer	NULL
(	NULL
a	NULL
)	NULL
am	NULL
6.1	NULL
nm	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
(	NULL
c	NULL
)	NULL
.	NULL

As	NULL
values	NULL
for	NULL
the	NULL
major	NULL
peaks	NULL
of	NULL
enzyme	NULL
activity	NULL
(	NULL
excluding	NULL
those	NULL
near	NULL
the	NULL
void	NULL
volume	NULL
)	NULL
were	NULL
:	NULL
Leu	NULL
,	NULL
5.5	NULL
nm	NULL
(	NULL
a	NULL
)	NULL
,	NULL
5.8	NULL
nm	NULL
(	NULL
c	NULL
)	NULL
;	NULL
Phe	NULL
,	NULL
3.7	NULL
nm	NULL
(	NULL
a	NULL
)	NULL
,	NULL
3.6	NULL
nm	NULL
(	NULL
c	NULL
)	NULL
,	NULL
Tyr	NULL
,	NULL
5.7	NULL
nm	NULL
(	NULL
b	NULL
)	NULL
,	NULL
5.6	NULL
nm	NULL
(	NULL
d	NULL
)	NULL
,	NULL
Lys	NULL
,	NULL
2.7	NULL
and	NULL
5.9	NULL
rm	NULL
(	NULL
b	NULL
)	NULL
,	NULL
2.4	NULL
and	NULL
5.5	NULL
nm	NULL
(	NULL
d	NULL
)	NULL
.	NULL

receptor	NULL
(	NULL
8.5	NULL
nm	NULL
)	NULL
was	NULL
at	NULL
least	NULL
2.6	NULL
nm	NULL
larger	NULL
than	NULL
those	NULL
of	NULL
the	NULL
proteins	NULL
in	NULL
the	NULL
major	NULL
peaks	NULL
of	NULL
peptidase	NULL
activity	NULL
.	NULL

Resolution	NULL
of	NULL
the	NULL
receptor	NULL
from	NULL
most	NULL
proteolytic	NULL
enzymes	NULL
is	NULL
likely	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
stability	NULL
of	NULL
the	NULL
receptor	NULL
isolated	NULL
from	NULL
such	NULL
columns	NULL
during	NULL
subsequent	NULL
analyses	NULL
by	NULL
other	NULL
techniques	NULL
(	NULL
see	NULL
Chart	NULL
1	NULL
)	NULL
.	NULL

Analogous	NULL
results	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
receptor	NULL
and	NULL
peptidases	NULL
were	NULL
obtained	NULL
by	NULL
filtration	NULL
of	NULL
rat	NULL
liver	NULL
cytosol	NULL
under	NULL
similar	NULL
conditions	NULL
(	NULL
47	NULL
)	NULL
.	NULL

in	NULL
contrast	NULL
with	NULL
the	NULL
preceding	NULL
results	NULL
,	NULL
filtration	NULL
in	NULL
hypertonic	NULL
-Mo	NULL
buffer	NULL
promotes	NULL
the	NULL
dissociation	NULL
of	NULL
the	NULL
receptor	NULL
into	NULL
a	NULL
form	NULL
that	NULL
is	NULL
sufficiently	NULL
small	NULL
to	NULL
comigrate	NULL
with	NULL
several	NULL
peptidases	NULL
(	NULL
Chart	NULL
9	NULL
,	NULL
c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
radius	NULL
of	NULL
the	NULL
receptor	NULL
(	NULL
6.1	NULL
nm	NULL
)	NULL
is	NULL
in	NULL
the	NULL
same	NULL
range	NULL
as	NULL
those	NULL
of	NULL
the	NULL
leucine	NULL
aminopeptidase	NULL
(	NULL
5.8	NULL
nm	NULL
)	NULL
and	NULL
the	NULL
endopeptidase	NULL
(	NULL
s	NULL
)	NULL
detected	NULL
with	NULL
succinyt-leucyl-leucyl-valyl-tyrosy-AMC	NULL
(	NULL
5.6	NULL
nm	NULL
)	NULL
and	NULL
t-butyl-oxycarbonyl-valyl-leucyl-lysyl-AMC	NULL
(	NULL
5.5	NULL
nm	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
the	NULL
SEPTEMBER	NULL
1984	NULL
Human	NULL
Leukemic	NULL
Cell	NULL
Glucocorticoid	NULL
Receptors	NULL
receptor	NULL
preparations	NULL
obtained	NULL
by	NULL
gel	NULL
filtration	NULL
as	NULL
shown	NULL
in	NULL
Charts	NULL
7	NULL
,	NULL
8a	NULL
,	NULL
and	NULL
9¢	NULL
are	NULL
contaminated	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
peptidases	NULL
.	NULL

These	NULL
enzymes	NULL
and/or	NULL
others	NULL
of	NULL
similar	NULL
size	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
instability	NULL
of	NULL
the	NULL
sait-dissociated	NULL
receptor	NULL
forms	NULL
during	NULL
fractionation	NULL
of	NULL
cytosols	NULL
.	NULL

This	NULL
degradation	NULL
was	NULL
apparent	NULL
in	NULL
the	NULL
experiments	NULL
shown	NULL
in	NULL
Chart	NULL
8	NULL
and	NULL
in	NULL
analogous	NULL
studies	NULL
of	NULL
the	NULL
receptor	NULL
in	NULL
rat	NULL
liver	NULL
cytosol	NULL
(	NULL
47	NULL
,	NULL
52	NULL
)	NULL
.	NULL

In	NULL
recent	NULL
analyses	NULL
of	NULL
apparent	NULL
receptor	NULL
cleavage	NULL
in	NULL
human	NULL
leukemic	NULL
cell	NULL
cytosols	NULL
by	NULL
a	NULL
rapid	NULL
minicolumn	NULL
technique	NULL
,	NULL
Holbrook	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
found	NULL
that	NULL
cytosols	NULL
from	NULL
myelocytic	NULL
subtypes	NULL
of	NULL
ANLL	NULL
cells	NULL
contained	NULL
a	NULL
higher	NULL
proportion	NULL
of	NULL
the	NULL
mero-receptor	NULL
than	NULL
did	NULL
cytosols	NULL
from	NULL
monocytic	NULL
subtypes	NULL
.	NULL

They	NULL
have	NULL
also	NULL
reported	NULL
that	NULL
a	NULL
factor	NULL
in	NULL
CLL	NULL
cells	NULL
appears	NULL
to	NULL
stabilize	NULL
the	NULL
receptor	NULL
from	NULL
ANLL	NULL
cells	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
underlying	NULL
these	NULL
observations	NULL
are	NULL
currently	NULL
being	NULL
explored	NULL
in	NULL
our	NULL
laboratory	NULL
,	NULL
using	NULL
direct	NULL
assays	NULL
of	NULL
peptidase	NULL
activities	NULL
by	NULL
the	NULL
methods	NULL
illustrated	NULL
in	NULL
Chart	NULL
9	NULL
.	NULL

*	NULL
Conclusions	NULL
.	NULL

We	NULL
have	NULL
demosntrated	NULL
that	NULL
the	NULL
glucocorticoid-receptor	NULL
complexes	NULL
from	NULL
various	NULL
types	NULL
of	NULL
leukemic	NULL
cells	NULL
are	NULL
nearly	NULL
identical	NULL
in	NULL
size	NULL
,	NULL
shape	NULL
,	NULL
and	NULL
subunit	NULL
structure	NULL
to	NULL
each	NULL
other	NULL
and	NULL
to	NULL
the	NULL
complexes	NULL
from	NULL
normal	NULL
tissues	NULL
including	NULL
lym-phocytes	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
,	NULL
however	NULL
,	NULL
that	NULL
numerous	NULL
experimental	NULL
factors	NULL
can	NULL
alter	NULL
these	NULL
structures	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
the	NULL
need	NULL
for	NULL
caution	NULL
in	NULL
attributing	NULL
clinical	NULL
significance	NULL
to	NULL
observations	NULL
,	NULL
such	NULL
as	NULL
those	NULL
of	NULL
McCaffrey	NULL
et	NULL
al	NULL
.	NULL

(	NULL
30	NULL
)	NULL
,	NULL
that	NULL
``	NULL
abnormal	NULL
``	NULL
receptors	NULL
occur	NULL
in	NULL
certain	NULL
human	NULL
leukemic	NULL
specimens	NULL
,	NULL
particularly	NULL
when	NULL
the	NULL
results	NULL
were	NULL
based	NULL
on	NULL
analyses	NULL
in	NULL
molybdate-free	NULL
buffers	NULL
of	NULL
receptors	NULL
obtained	NULL
from	NULL
rapidly	NULL
frozen	NULL
cells	NULL
.	NULL

In	NULL
general	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
most	NULL
of	NULL
the	NULL
apparent	NULL
structural	NULL
differences	NULL
among	NULL
the	NULL
receptors	NULL
in	NULL
extracts	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
other	NULL
tissues	NULL
are	NULL
the	NULL
consequence	NULL
of	NULL
in	NULL
vitro	NULL
degradation	NULL
by	NULL
endogenous	NULL
proteases	NULL
.	NULL

The	NULL
properties	NULL
and	NULL
possible	NULL
physiological	NULL
functions	NULL
of	NULL
these	NULL
enzymes	NULL
are	NULL
intriguing	NULL
subjects	NULL
for	NULL
future	NULL
research	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Kathleen	NULL
P.	NULL
Cavanaugh	NULL
,	NULL
Dr.	NULL
Roberto	NULL
E.	NULL
Garola	NULL
,	NULL
Regina	NULL
M.	NULL
Neal	NULL
,	NULL
and	NULL
Joseph	NULL
A.	NULL
Carlino	NULL
for	NULL
skillful	NULL
assistance	NULL
with	NULL
several	NULL
of	NULL
these	NULL
experiments	NULL
;	NULL
to	NULL
Dr.	NULL
Denis	NULL
R.	NULL
Miller	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Ors	NULL
.	NULL

Michaet	NULL
Andreeff	NULL
and	NULL
Arlene	NULL
Redner	NULL
of	NULL
the	NULL
Investigative	NULL
Cytology	NULL
,	NULL
Dr.	NULL
Benjamin	NULL
Koziner	NULL
of	NULL
the	NULL
Lymphocyte	NULL
Surface	NULL
Markers	NULL
Laboratory	NULL
,	NULL
Stephen	NULL
Ellis	NULL
and	NULL
Claudia	NULL
Little	NULL
of	NULL
the	NULL
Hematology/Lymphoma	NULL
Service	NULL
,	NULL
Dr.	NULL
R.	NULL
S.	NULL
K.	NULL
Chaganti	NULL
of	NULL
the	NULL
Cancer	NULL
Genetics	NULL
and	NULL
,	NULL
Drs	NULL
.	NULL

Morton	NULL
K.	NULL
Schwartz	NULL
and	NULL
Martin	NULL
Fleisher	NULL
of	NULL
the	NULL
Department	NULL
of	NULL
Clinical	NULL
Chemistry	NULL
,	NULL
and	NULL
the	NULL
Tumor	NULL
Procurement	NULL
Service	NULL
of	NULL
this	NULL
Center	NULL
for	NULL
providing	NULL
the	NULL
clinical	NULL
specimens	NULL
and	NULL
other	NULL
data	NULL
concerning	NULL
the	NULL
patients	NULL
;	NULL
to	NULL
Dr.	NULL
Susan	NULL
Groshen	NULL
for	NULL
assistance	NULL
with	NULL
statistical	NULL
analyses	NULL
;	NULL
to	NULL
Drs	NULL
.	NULL

Allan	NULL
Munck	NULL
and	NULL
Nikki	NULL
J.	NULL
Holbrook	NULL
for	NULL
providing	NULL
their	NULL
manuscripts	NULL
prior	NULL
to	NULL
publication	NULL
and	NULL
for	NULL
insightful	NULL
reviews	NULL
of	NULL
this	NULL
report	NULL
;	NULL
and	NULL
to	NULL
Drs	NULL
.	NULL

John	NULL
Stevens	NULL
and	NULL
Alex	NULL
Silberberg	NULL
for	NULL
many	NULL
constructive	NULL
discussions	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Artin	NULL
,	NULL
Z	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
Clarkson	NULL
,	NULL
B.	NULL
D.	NULL
The	NULL
treatment	NULL
of	NULL
acute	NULL
nonlymphoblastic	NULL
leukemia	NULL
in	NULL
adults	NULL
.	NULL

in	NULL
:	NULL
G.	NULL
H.	NULL
Stollerman	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Advances	NULL
in	NULL
Internal	NULL
Medicine	NULL
,	NULL
~	NULL
Oncol	NULL
.	NULL

,	NULL
1	NULL
:	NULL
131-148	NULL
,	NULL
1982	NULL
.	NULL

3	NULL
.	NULL

Bennett	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Catovsky	NULL
,	NULL
D.	NULL
,	NULL
Daniel	NULL
,	NULL
M.-T.	NULL
,	NULL
Flandrin	NULL
,	NULL
G.	NULL
,	NULL
Galton	NULL
,	NULL
D.	NULL
A.	NULL
G.	NULL
,	NULL
matol	NULL
.	NULL

,	NULL
33	NULL
:	NULL
451—458	NULL
1976	NULL
.	NULL

4	NULL
.	NULL

Bahlen	NULL
P.	NULL
,	NULL
Stein	NULL
,	NULL
S.	NULL
,	NULL
Dairman	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Udenfriend	NULL
,	NULL
S.	NULL
Fluorometric	NULL
assay	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
nanogram	NULL
range	NULL
.	NULL

Arch	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

,	NULL
155	NULL
:	NULL
213-220	NULL
,	NULL
1973	NULL
.	NULL

5	NULL
.	NULL

Bgyum	NULL
,	NULL
A	NULL
.	NULL

Isolation	NULL
of	NULL
,	NULL
granulocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Scand	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
5	NULL
(	NULL
Suppl	NULL
.	NULL

5	NULL
)	NULL
9-15	NULL
,	NULL
1976	NULL
.	NULL

6.	NULL
mama	NULL
.	NULL

»	NULL
Wrange	NULL
,	NULL
O.	NULL
,	NULL
Okret	NULL
,	NULL
S.	NULL
,	NULL
Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Gustafsson	NULL
,	NULL
J.-A	NULL
.	NULL

Functional	NULL
dummrweptorbylmted	NULL
proteolysis	NULL
.	NULL

In	NULL
:	NULL
A.	NULL
K.	NULL
Roy	NULL
and	NULL
J.	NULL
H.	NULL
Clark	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Gene	NULL
Regulation	NULL
by	NULL
Steroid	NULL
Hormones	NULL
,	NULL
Vol	NULL
.	NULL

2	NULL
,	NULL
pp	NULL
.	NULL

151-180	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Springer-Verlag	NULL
,	NULL
1983	NULL
.	NULL

3795	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

M.	NULL
R.	NULL
Sherman	NULL
et	NULL
al	NULL
.	NULL

7	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

21	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25.	NULL
.	NULL

Kramers	NULL
,	NULL
M.	NULL
T.	NULL
C.	NULL
,	NULL
andCatovskyDCelmembrane	NULL
Chaganti	NULL
,	NULL
R.	NULL
S.	NULL
K.	NULL
,	NULL
Jhanwar	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Arin	NULL
,	NULL
Z.	NULL
,	NULL
Koziner	NULL
,	NULL
B.	NULL
,	NULL
Ambati	NULL
,	NULL
A.	NULL
,	NULL
Andreeff	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Clarkson	NULL
,	NULL
B.	NULL
D.	NULL
Non-T	NULL
,	NULL
mn-BaanelymphoblastiCIeukema	NULL
(	NULL
L3	NULL
)	NULL
wml	NULL
t	NULL
(	NULL
8,22	NULL
)	NULL
mdtwo14q+dnrmnosomes	NULL
Cancer	NULL
Genet	NULL
.	NULL

Cytogenet	NULL
.	NULL

,	NULL
10	NULL
:	NULL
95-103	NULL
,	NULL
1983.	NULL
.	NULL

Collins	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Gallo	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
and	NULL
Gallagher	NULL
,	NULL
R.	NULL
E.	NULL
Continuous	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
mysioid	NULL
leukaemic	NULL
cells	NULL
in	NULL
suspension	NULL
culture	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
270	NULL
:	NULL
347-349	NULL
,	NULL
1977.	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Bloomfield	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
McKenna	NULL
,	NULL
R.	NULL
W.	NULL
,	NULL
Peterson	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
HHdebrandtL	NULL
MMMAGIuoooorﬂcoidreoeptorsandlnvltro	NULL
Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
SmnhKA	NULL
and	NULL
Munck	NULL
,	NULL
A.	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
of	NULL
isolated	NULL
human	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
38	NULL
:	NULL
4268-4272	NULL
,	NULL
1978	NULL
.	NULL

Crabtree	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Smith	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Munck	NULL
,	NULL
A.	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
sensitivity	NULL
in	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
.	NULL

Results	NULL
and	NULL
methodologic	NULL
considerations	NULL
.	NULL

in	NULL
:	NULL
E.	NULL
B.	NULL
Thompson	NULL
and	NULL
M.	NULL
E.	NULL
Lippman	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Steroid	NULL
Receptors	NULL
and	NULL
the	NULL
Management	NULL
of	NULL
Cancer	NULL
,	NULL
Vol	NULL
.	NULL

1	NULL
,	NULL
pp	NULL
.	NULL

81-97	NULL
.	NULL

Boca	NULL
Raton	NULL
,	NULL
FL	NULL
:	NULL
CRC	NULL
Press	NULL
,	NULL
1979	NULL
.	NULL

Dahmer	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
Housley	NULL
,	NULL
P.	NULL
R.	NULL
,	NULL
and	NULL
Pratt	NULL
,	NULL
W.	NULL
B	NULL
.	NULL

Effects	NULL
of	NULL
molybdate	NULL
and	NULL
endogenous	NULL
inhibitors	NULL
on	NULL
steroid-receptor	NULL
inactivation	NULL
,	NULL
transformation	NULL
,	NULL
and	NULL
translocation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Physiol	NULL
.	NULL

,	NULL
46	NULL
:	NULL
67-81	NULL
,	NULL
1984	NULL
.	NULL

Edethoch	NULL
,	NULL
H.	NULL
The	NULL
ies	NULL
of	NULL
thyroglobulin	NULL
.	NULL

I	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
alkali	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
235	NULL
:	NULL
1326-1334	NULL
,	NULL
1960	NULL
.	NULL

Foster	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Eisen	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Bloomfield	NULL
,	NULL
C.	NULL
D.	NULL
Covalent	NULL
labeling	NULL
of	NULL
rat	NULL
andhunmlymphoidglucooomooidreceptas	NULL
Cancer	NULL
Res	NULL
.	NULL

,	NULL
43	NULL
:	NULL
5273-5277	NULL
,	NULL
1983	NULL
.	NULL

Hanks	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Wallace	NULL
,	NULL
R.	NULL
E.	NULL
Relation	NULL
of	NULL
oxygen	NULL
and	NULL
temperature	NULL
in	NULL
the	NULL
preservation	NULL
of	NULL
tissues	NULL
by	NULL
refrigeration	NULL
.	NULL

Proc	NULL
.	NULL

Soc	NULL
.	NULL

Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
71	NULL
:	NULL
196-	NULL
200	NULL
,	NULL
1949	NULL
.	NULL

Harmon	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Schmidt	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B	NULL
.	NULL

Defective	NULL
steroid	NULL
receptors	NULL
in	NULL
a	NULL
resistant	NULL
clone	NULL
of	NULL
a	NULL
human	NULL
leukemic	NULL
cell	NULL
line	NULL
.	NULL

/n	NULL
:	NULL
W.	NULL
W.	NULL
Leavitt	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Hormones	NULL
and	NULL
Cancer	NULL
,	NULL
pp	NULL
.	NULL

301-313	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Plenum	NULL
Publish	NULL
ing	NULL
Corp.	NULL
,	NULL
1982	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bloomfield	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
Munck	NULL
,	NULL
A	NULL
.	NULL

Analysis	NULL
of	NULL
activated	NULL
and	NULL
nonactivated	NULL
oornplexesfromhunanleu—	NULL
HobmokNJ	NULL
BbomﬁeidCD	NULL
and	NULL
Munck	NULL
,	NULL
A	NULL
.	NULL

Stabilization	NULL
of	NULL
labile	NULL
ghmoaﬁcdd—reoeptoroonmbxesﬁunmenaﬂymphocyﬁcwmﬂs	NULL
by	NULL
a	NULL
factor	NULL
from	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
44	NULL
:	NULL
407-414	NULL
,	NULL
1984	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bodwelt	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Jeffries	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Munck	NULL
,	NULL
A	NULL
.	NULL

Characterization	NULL
of	NULL
nonactivated	NULL
and	NULL
activated	NULL
glucocorticoid-receptor	NULL
complexes	NULL
from	NULL
intact	NULL
rat	NULL
cells	NULL
.	NULL

J.	NULL
Biot	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
258	NULL
:	NULL
6477-6485	NULL
,	NULL
1983.	NULL
.	NULL

Holbrook	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Bodwell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
and	NULL
Munck	NULL
,	NULL
A	NULL
.	NULL

Effects	NULL
of	NULL
ATP	NULL
and	NULL
pyrophos-	NULL
phate	NULL
on	NULL
properties	NULL
of	NULL
glucocorticoid-receptor	NULL
complexes	NULL
from	NULL
rat	NULL
thymus	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
258	NULL
:	NULL
14885-14894	NULL
,	NULL
1983	NULL
.	NULL

Homo-Delarche	NULL
,	NULL
F.	NULL
Glucocorticoid	NULL
receptors	NULL
and	NULL
steroid	NULL
sensitivity	NULL
in	NULL
normai	NULL
and	NULL
neoplastic	NULL
human	NULL
lymphoid	NULL
tissues	NULL
:	NULL
a	NULL
review	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
44	NULL
:	NULL
431-437	NULL
,	NULL
1984.	NULL
.	NULL

lacobelli	NULL
,	NULL
S.	NULL
,	NULL
Natoli	NULL
,	NULL
V.	NULL
,	NULL
Longo	NULL
,	NULL
P.	NULL
,	NULL
Ranalletti	NULL
,	NULL
F.	NULL
O.	NULL
,	NULL
De	NULL
Rossi	NULL
,	NULL
G.	NULL
,	NULL
Pasqualetti	NULL
,	NULL
D.	NULL
,	NULL
Mandeli	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
in	NULL
leukemia	NULL
patients	NULL
using	NULL
cytosol	NULL
and	NULL
whole-cell	NULL
assays	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
47	NULL
:	NULL
3979-3984	NULL
,	NULL
1981	NULL
.	NULL

Kato	NULL
,	NULL
H.	NULL
,	NULL
Adachi	NULL
,	NULL
N.	NULL
,	NULL
Ohno	NULL
,	NULL
Y.	NULL
,	NULL
Iwanaga	NULL
,	NULL
S.	NULL
,	NULL
Takada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sakakibara	NULL
,	NULL
S.	NULL
Newﬁtuogerncpeptbeswsuawsforplamh	NULL
J.	NULL
Bind-ism	NULL
(	NULL
Tokyo	NULL
)	NULL
,	NULL
88	NULL
:	NULL
183-190	NULL
,	NULL
1980	NULL
.	NULL

Koeffier	NULL
,	NULL
H.	NULL
P.	NULL
,	NULL
and	NULL
Golde	NULL
,	NULL
D.	NULL
W.	NULL
Acute	NULL
myelogenous	NULL
leukemia	NULL
:	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
ive	NULL
to	NULL
colony-stimulating	NULL
activity	NULL
.	NULL

Science	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
,	NULL
200	NULL
:	NULL
1153-1154	NULL
,	NULL
1978	NULL
.	NULL

Korsmeyer	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Amold	NULL
,	NULL
A.	NULL
,	NULL
Bakhshi	NULL
,	NULL
A.	NULL
,	NULL
Ravetch	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Hieter	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sharrow	NULL
,	NULL
S.	NULL
O.	NULL
,	NULL
LeBienTw	NULL
KaseyJH	NULL
PophckDG	NULL
Leder	NULL
,	NULL
P.	NULL
,	NULL
andeanamTAlrmumoglobtm	NULL
WWMW	NULL
antigen	NULL
expression	NULL
in	NULL
acute	NULL
MMchelchelprwm	NULL
originsJCInlnvest	NULL
71	NULL
:	NULL
301-313	NULL
,	NULL
1983.	NULL
.	NULL

Koziner	NULL
,	NULL
B.	NULL
,	NULL
Merteismann	NULL
,	NULL
R.	NULL
,	NULL
Filippa	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Good	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Clarkson	NULL
,	NULL
8	NULL
.	NULL

D.	NULL
Adult	NULL
moptasiasofT-andmﬁ-celtypes.ln	NULL
:	NULL
B.Clarksm.P.A	NULL
.	NULL

Marks	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Till	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Differentiation	NULL
of	NULL
Normal	NULL
and	NULL
Neoplastic	NULL
Hemato-poletic	NULL
Celis	NULL
,	NULL
Book	NULL
B	NULL
,	NULL
pp	NULL
.	NULL

843-857	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1978.	NULL
:	NULL
1~y-glutamyl	NULL
enzymes	NULL
:	NULL
trumspepﬁdaselewmﬂmopepﬂdase	NULL
and	NULL
trehalase	NULL
in	NULL
normal	NULL
and	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Haematol	NULL
.	NULL

,	NULL
38	NULL
:	NULL
453-461	NULL
,	NULL
1978	NULL
.	NULL

.LeeHJ	NULL
BradowHLMoranMC	NULL
and	NULL
Sherman	NULL
,	NULL
M.	NULL
R.	NULL
Binding	NULL
of	NULL
giucoconiooidm-oicacidsmdestersto	NULL
tors	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
14	NULL
:	NULL
1325-1335	NULL
,	NULL
1981.	NULL
ed	NULL
hepatic	NULL
recep-	NULL
.	NULL

Lippman	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Human-l	NULL
Leventhal	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Perry	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Thompson	NULL
,	NULL
E.	NULL
B.	NULL
Glucocorticoid-binding	NULL
proteins	NULL
in	NULL
human	NULL
acute	NULL
lymphoblastic	NULL
leukemic	NULL
biast	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
52	NULL
:	NULL
1715-1725	NULL
,	NULL
1973.	NULL
.	NULL

McCaffrey	NULL
,	NULL
R.	NULL
,	NULL
Liliquist	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Bell	NULL
,	NULL
R.	NULL
Abnormal	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
31.	NULL
acute	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
,	NULL
59	NULL
:	NULL
393-400	NULL
,	NULL
1982	NULL
.	NULL

Martelsmann	NULL
,	NULL
R.	NULL
,	NULL
Merteismann	NULL
,	NULL
I.	NULL
,	NULL
Koziner	NULL
,	NULL
B.	NULL
,	NULL
Moore	NULL
,	NULL
M.	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Clarkson	NULL
,	NULL
B.	NULL
D.	NULL
Improved	NULL
biochemical	NULL
assay	NULL
for	NULL
terminal	NULL
deoxynucieotidy	NULL
!	NULL

transferase	NULL
in	NULL
3796	NULL
37	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

47	NULL
.	NULL

49	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

57.	NULL
.	NULL

Rautenberg	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Tschesche	NULL
,	NULL
H.	NULL
.Sherman	NULL
,	NULL
M.R	NULL
.	NULL

Sherman	NULL
,	NULL
M	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Moran	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Neal	NULL
,	NULL
R.	NULL
M	NULL
human	NULL
blood	NULL
cells	NULL
:	NULL
results	NULL
in	NULL
89	NULL
adult	NULL
patients	NULL
with	NULL
lymphoid	NULL
leukemias	NULL
and	NULL
malignant	NULL
lymphomas	NULL
in	NULL
leukemic	NULL
phase	NULL
.	NULL

Leuk	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
2	NULL
:	NULL
57-69	NULL
,	NULL
1978.	NULL
.	NULL

Miller	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
Niu	NULL
,	NULL
E.-M.	NULL
,	NULL
and	NULL
Sherman	NULL
,	NULL
M.	NULL
R.	NULL
Human	NULL
breast	NULL
tumor	NULL
estrogen	NULL
receptor	NULL
:	NULL
effects	NULL
of	NULL
molybdate	NULL
and	NULL
electrophoretic	NULL
analyses	NULL
.	NULL

Endocrinology	NULL
,	NULL
108	NULL
:	NULL
1369-1378	NULL
,	NULL
1981.	NULL
.	NULL

Moore	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Gemer	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
and	NULL
Franklin	NULL
,	NULL
H.	NULL
A	NULL
.	NULL

Culture	NULL
of	NULL
normal	NULL
human	NULL
leukocytes	NULL
.	NULL

J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL

,	NULL
199	NULL
;	NULL
519-524	NULL
,	NULL
1967.	NULL
.	NULL

Murakami	NULL
,	NULL
K.	NULL
,	NULL
Ohsawa	NULL
,	NULL
T.	NULL
,	NULL
Hirose	NULL
,	NULL
S.	NULL
,	NULL
Takada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sakakibara	NULL
,	NULL
S.	NULL
New	NULL
substrates	NULL
for	NULL
renin	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
110	NULL
;	NULL
232-239	NULL
,	NULL
1981.	NULL
fluorogenic	NULL
.	NULL

Nishiya	NULL
,	NULL
K.	NULL
,	NULL
Chiao	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
De	NULL
Sousa	NULL
,	NULL
M.	NULL
Iron	NULL
binding	NULL
proteins	NULL
in	NULL
selected	NULL
human	NULL
peripheral	NULL
blood	NULL
cell	NULL
sets	NULL
:	NULL
immunofluorescence	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Haematol	NULL
.	NULL

,	NULL
46	NULL
:	NULL
235-245	NULL
,	NULL
1980.	NULL
.	NULL

Niu	NULL
,	NULL
E.-M.	NULL
,	NULL
Neal	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
V.	NULL
K.	NULL
,	NULL
and	NULL
Sherman	NULL
,	NULL
M.	NULL
R.	NULL
Structural	NULL
similarity	NULL
of	NULL
molybdate-stabilized	NULL
steroid	NULL
receptors	NULL
in	NULL
human	NULL
breast	NULL
tumors	NULL
,	NULL
uteri	NULL
and	NULL
leukocytes	NULL
.	NULL

J.	NULL
Steroid	NULL
Biochem	NULL
.	NULL

,	NULL
15	NULL
;	NULL
1-10	NULL
,	NULL
1981	NULL
.	NULL

Okret	NULL
,	NULL
S.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
Carlstedt-Duke	NULL
,	NULL
J.	NULL
,	NULL
Wrange	NULL
,	NULL
O.	NULL
,	NULL
Gustafsson	NULL
,	NULL
J.-A	NULL
.	NULL

,	NULL
andStevsnsJ	NULL
Absencein	NULL
of	NULL
a	NULL
glucocorticoid	NULL
receptor	NULL
Res	NULL
.	NULL

,	NULL
43	NULL
:	NULL
3127-3131	NULL
,	NULL
1983.	NULL
.	NULL

Raaka	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
and	NULL
Samuels	NULL
,	NULL
H.	NULL
H.	NULL
The	NULL
glucocorticoid	NULL
receptor	NULL
in	NULL
GH	NULL
,	NULL
cells	NULL
.	NULL

Evidence	NULL
from	NULL
dense	NULL
amino	NULL
acid	NULL
labeling	NULL
and	NULL
whole	NULL
cell	NULL
studies	NULL
for	NULL
an	NULL
equilibrium	NULL
model	NULL
explaining	NULL
the	NULL
influence	NULL
of	NULL
hormone	NULL
on	NULL
the	NULL
intracellular	NULL
distribution	NULL
of	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
258	NULL
:	NULL
417-425	NULL
,	NULL
1983.	NULL
h	NULL
from	NULL
human	NULL
leucocytes	NULL
.	NULL

's	NULL
Z.	NULL
Physiol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
365	NULL
:	NULL
49-58	NULL
,	NULL
1984	NULL
.	NULL

Hoppe-Seyler	NULL
.	NULL

Rice	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Means	NULL
,	NULL
G.	NULL
E.	NULL
Radioactive	NULL
labeling	NULL
of	NULL
proteins	NULL
in	NULL
vitro	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
246	NULL
:	NULL
831-832	NULL
,	NULL
1971	NULL
.	NULL

Scatchard	NULL
,	NULL
G.	NULL
The	NULL
attractions	NULL
of	NULL
proteins	NULL
for	NULL
small	NULL
molecules	NULL
and	NULL
ions	NULL
.	NULL

Ann	NULL
.	NULL

NY	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
51	NULL
:	NULL
660-672	NULL
,	NULL
1949.	NULL
in	NULL
Biochemistry	NULL
,	NULL
p.	NULL
239	NULL
.	NULL

New	NULL
York	NULL
:	NULL
deadmmHK	NULL
Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
1959.	NULL
.	NULL

Physical-chemical	NULL
of	NULL
steroid	NULL
hormone	NULL
receptors	NULL
.	NULL

Enzymol	NULL
36	NULL
:	NULL
211-234	NULL
,	NULL
1975.	NULL
,	NULL
Atienza	NULL
,	NULL
S.	NULL
B.	NULL
P.	NULL
,	NULL
Shansky	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Hoffman	NULL
,	NULL
L.	NULL
M.	NULL
ofdtiekovncmcts	NULL
``	NULL
subunit	NULL
``	NULL
formed	NULL
with	NULL
divalent	NULL
cations	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
249	NULL
:	NULL
5351-5363	NULL
,	NULL
1974.	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Barzilai	NULL
,	NULL
D.	NULL
,	NULL
Pine	NULL
.	NULL

P.	NULL
R.	NULL
,	NULL
and	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
Glucocorticoid	NULL
receptor	NULL
cleavage	NULL
by	NULL
leupeptin-sensitive	NULL
enzymes	NULL
in	NULL
rat	NULL
kidney	NULL
cytosol	NULL
.	NULL

in	NULL
:	NULL
W.	NULL
W.	NULL
Leavitt	NULL
and	NULL
J.	NULL
H.	NULL
Clark	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Steroid	NULL
Hormone	NULL
Receptor	NULL
Systems	NULL
,	NULL
pp	NULL
.	NULL

357-375	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Plenum	NULL
Corp..	NULL
1979.	NULL
,	NULL
Niu	NULL
,	NULL
E.-M.	NULL
,	NULL
and	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
Wastedzaﬁonoimwdate-stabﬁzedgkmoorﬂoddmoeptors	NULL
healthy	NULL
and	NULL
malignant	NULL
tissues	NULL
.	NULL

in	NULL
:	NULL
H.	NULL
J.	NULL
Lee	NULL
and	NULL
T.	NULL
J.	NULL
Fitzgerald	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Progress	NULL
in	NULL
Research	NULL
and	NULL
Clinical	NULL
Applications	NULL
of	NULL
Corticosteroids	NULL
,	NULL
pp	NULL
.	NULL

45-66	NULL
.	NULL

Philadelphia	NULL
:	NULL
Heyden	NULL
&	NULL
Son	NULL
,	NULL
Inc.	NULL
,	NULL
1982	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Moran	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Stevens	NULL
,	NULL
Y.-W	NULL
.	NULL

Structure	NULL
,	NULL
dissociation	NULL
,	NULL
and	NULL
proteolysis	NULL
of	NULL
mammalian	NULL
steroid	NULL
receptors	NULL
.	NULL

Multiplicity	NULL
of	NULL
glucocorticoid	NULL
receptor	NULL
forms	NULL
and	NULL
proteolytic	NULL
enzymes	NULL
in	NULL
rat	NULL
liver	NULL
and	NULL
kidney	NULL
cytosols	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
258	NULL
:	NULL
10366-10377	NULL
,	NULL
1983.	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Pickering	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Rollwagen	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
L.	NULL
K.	NULL
Mero-receptors	NULL
:	NULL
fragments	NULL
of	NULL
receptors	NULL
containing	NULL
the	NULL
steroid-binding	NULL
site	NULL
.	NULL

Fed	NULL
.	NULL

Proc	NULL
.	NULL

,	NULL
37	NULL
:	NULL
167-173	NULL
,	NULL
1978	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R	NULL
and	NULL
Stevens	NULL
,	NULL
J	NULL
.	NULL

Structure	NULL
of	NULL
mammalian	NULL
steroid	NULL
receptors	NULL
:	NULL
evotvhgcomepmmdnwmodologiealdevelopmemsmmvmysu	NULL
46	NULL
;	NULL
83-105	NULL
,	NULL
1984	NULL
.	NULL

.ShennanMR	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
Miller	NULL
,	NULL
L.	NULL
K.	NULL
Estrogen	NULL
receptor	NULL
cleavage	NULL
plasnhogmacﬁvaﬁmbyenzymeshhunmbraastnmcymsd	NULL
Endocrinology	NULL
,	NULL
106	NULL
:	NULL
1715-1727	NULL
,	NULL
1980	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
and	NULL
SOmijen	NULL
,	NULL
G.	NULL
J	NULL
.	NULL

Stabilization	NULL
and	NULL
cleavage	NULL
ofstaoidraceptaszeﬁecwofbwepmmmoiybdatemmkidmym	NULL
corticoid	NULL
receptors	NULL
.	NULL

in	NULL
:	NULL
R.	NULL
J.	NULL
Soto	NULL
,	NULL
A	NULL
.	NULL

De	NULL
Nicola	NULL
,	NULL
and	NULL
J.	NULL
Blaquier	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Physiopathology	NULL
of	NULL
Endocrine	NULL
Diseases	NULL
and	NULL
Mechanisms	NULL
of	NULL
Hormone	NULL
Action	NULL
,	NULL
pp	NULL
.	NULL

321-337	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Alan	NULL
R.	NULL
Liss	NULL
,	NULL
1981	NULL
.	NULL

Sherman	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Tuazon	NULL
,	NULL
F.	NULL
B.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Niu	NULL
,	NULL
E.-M.	NULL
Oligomeric	NULL
mmmmmmmofmmoaaﬁmm	NULL
In	NULL
:	NULL
H.	NULL
Eriksson	NULL
and	NULL
J.-A	NULL
.	NULL

Gustafsson	NULL
(	NULL
eds	NULL
.	NULL
)	NULL

,	NULL
Steroid	NULL
Hormone	NULL
Receptors	NULL
:	NULL
Structure	NULL
and	NULL
Function	NULL
,	NULL
pp	NULL
.	NULL

3-24	NULL
.	NULL

Amsterdam	NULL
:	NULL
Elsevier/North-Holland	NULL
Biomed-ical	NULL
Press	NULL
,	NULL
1983.	NULL
.	NULL

Snedecor	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
and	NULL
Cochran	NULL
,	NULL
W.	NULL
G.	NULL
Statistical	NULL
Methods	NULL
,	NULL
Ed	NULL
.	NULL

6	NULL
.	NULL

Ames	NULL
,	NULL
lowa	NULL
:	NULL
towa	NULL
State	NULL
University	NULL
Press	NULL
,	NULL
1967.	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
Glucocorticoid	NULL
receptors	NULL
in	NULL
human	NULL
leukemia	NULL
andlymphoma	NULL
and	NULL
clinical	NULL
significance	NULL
.	NULL

In	NULL
:	NULL
V.	NULL
P.	NULL
Hollander	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Hormone	NULL
Responsive	NULL
Tumors	NULL
.	NULL

Orlando	NULL
,	NULL
FL	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
in	NULL
press	NULL
,	NULL
1985.	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Haubenstock	NULL
,	NULL
H.	NULL
Molecular	NULL
basis	NULL
of	NULL
glucocorticoid	NULL
resistance	NULL
in	NULL
e	NULL
and	NULL
human	NULL
leukemia	NULL
.	NULL

in	NULL
:	NULL
G.	NULL
Litwack	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Biochemical	NULL
Actions	NULL
of	NULL
Hormones	NULL
,	NULL
Vol	NULL
.	NULL

10	NULL
,	NULL
pp	NULL
.	NULL

383-446	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Academic	NULL
Press	NULL
,	NULL
Inc.	NULL
,	NULL
1983.	NULL
.	NULL

Stevens	NULL
,	NULL
J.	NULL
,	NULL
Stevens	NULL
,	NULL
Y.-W.	NULL
,	NULL
and	NULL
Rosenthal	NULL
,	NULL
R.	NULL
L.	NULL
Characterization	NULL
of	NULL
cytosolic	NULL
nudea	NULL
and	NULL
glucocorticoid-binding	NULL
in	NULL
human	NULL
leukemic	NULL
tympho-cytes	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
39	NULL
:	NULL
4939-4948	NULL
,	NULL
1979	NULL
.	NULL

Yarbro	NULL
,	NULL
G.	NULL
S.	NULL
K.	NULL
,	NULL
UppmanME	NULL
Johnson	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
and	NULL
Leventhal	NULL
,	NULL
B.	NULL
G.	NULL
mammhwmammmmm	NULL
leukemia	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

,	NULL
37	NULL
:	NULL
2688-2695	NULL
,	NULL
1977	NULL
.	NULL

CANCER	NULL
RESEARCH	NULL
VOL	NULL
.	NULL

44	NULL
Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

AAGR	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
Cancer	NULL
Research	NULL
The	NULL
Journal	NULL
of	NULL
Cancer	NULL
Research	NULL
(	NULL
1916-1930	NULL
)	NULL
|	NULL
The	NULL
American	NULL
Journal	NULL
of	NULL
Cancer	NULL
(	NULL
1931-1940	NULL
)	NULL
Multiple	NULL
Forms	NULL
and	NULL
Fragments	NULL
of	NULL
Cytosolic	NULL
Glucocorticoid	NULL
Receptors	NULL
from	NULL
Human	NULL
Leukemic	NULL
Cells	NULL
and	NULL
Normal	NULL
Lymphocytes	NULL
Merry	NULL
R.	NULL
Sherman	NULL
,	NULL
Yee-Wan	NULL
Stevens	NULL
and	NULL
Fe	NULL
B.	NULL
Tuazon	NULL
Cancer	NULL
Res	NULL
1984	NULL
;	NULL
44:3783-3796	NULL
.	NULL

Updated	NULL
version	NULL
Access	NULL
the	NULL
most	NULL
recent	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/44/9/3783	NULL
E-mail	NULL
alerts	NULL
Reprints	NULL
and	NULL
Subscriptions	NULL
Permissions	NULL
Sign	NULL
up	NULL
to	NULL
receive	NULL
free	NULL
email-alerts	NULL
related	NULL
to	NULL
this	NULL
article	NULL
or	NULL
journal	NULL
.	NULL

To	NULL
order	NULL
reprints	NULL
of	NULL
this	NULL
article	NULL
or	NULL
to	NULL
subscribe	NULL
to	NULL
the	NULL
journal	NULL
,	NULL
contact	NULL
the	NULL
AACR	NULL
Publications	NULL
Department	NULL
at	NULL
pubs	NULL
@	NULL
aacr.org	NULL
.	NULL

To	NULL
request	NULL
permission	NULL
to	NULL
re-use	NULL
all	NULL
or	NULL
part	NULL
of	NULL
this	NULL
article	NULL
,	NULL
use	NULL
this	NULL
link	NULL
http	NULL
:	NULL
//cancerres.aacrjournals.org/content/44/9/3783	NULL
.	NULL

Click	NULL
on	NULL
``	NULL
Request	NULL
Permissions	NULL
``	NULL
which	NULL
will	NULL
take	NULL
you	NULL
to	NULL
the	NULL
Copyright	NULL
Clearance	NULL
Center	NULL
's	NULL
(	NULL
CCC	NULL
)	NULL
Rightslink	NULL
site	NULL
.	NULL

Downloaded	NULL
from	NULL
cancerres.aacrjournals.org	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

©	NULL
1984	NULL
American	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
.	NULL

